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HOW TO READ KAPLAN MEIER GRAFT SURVIVAL PLOTS 
 
 
HOW TO READ OUR KAPLAN-MEIER 
GRAFT SURVIVAL PLOTS 
 
 
1. The vertical axis shows the probability of graft survival. 
"Perfect" survival (no failures) equates to a probability of 1.0. 
It may help to think of this as 100% survival. 
 
2. The horizontal axis shows time elapsed since the event being 
considered - in this context, the date of graft.  
 
3. The numbers of recipients "at risk" (ie, being followed) at 
given times after graft are shown below the curves. At time 
zero, all patients in the given cohort are at risk. At the 
furthermost point on the right hand side of any curve, one 
patient in the cohort (the one who has been followed for the 
longest time) is at risk. 
 
 We suggest that you interpret the curves with this in mind. A 
sudden dramatic "dip" in survival at the far right of a given 
curve may merely mean, for example, that one of only two 
grafts that have been followed for this length of time has 
failed. 
 
 When the survival curve drops to zero, the probability of graft 
survival beyond that time is zero. This means that all grafts 
that have reached this time elapsed from graft have failed. It 
does not mean that all grafts in this stratum have failed. 
 
4. The p values shown have been calculated by log-rank 
analysis and reflect a comparison of the behaviour of the 
curves as a whole (taking all available data into 
consideration), rather than at any one time-point. 
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INTRODUCTION 
 
 
The Australian Corneal Graft Registry (ACGR) opened in May 
1985 and thus has now been in operation for over 26 years. 
However, the census dates for this report was 01/06/2010 for 
penetrating grafts and 12/10/2011 for lamellar grafts. Over the 
years, we have collected data on more than 23,000 corneal grafts. 
The majority of corneal grafts registered have been penetrating, 
but increasing numbers of lamellar grafts have also been 
registered over recent years, as patterns of surgical practice 
change. 
 
At registration, we seek information on the recipient, the donor, the 
eye bank practices and the operative procedure. Follow-up then 
occurs at approximately yearly intervals for an indefinite period, 
and ceases upon loss of the graft, or the death or loss-to-follow-up 
of the patient. At each round of follow-up, we request information 
on the graft and visual outcome, and upon relevant post-operative 
events and treatments. 
 
The data are entered into an Access database and checked for 
consistency. Descriptive, univariate and multivariate analyses are 
subsequently performed using SPSS and Stata software, and the 
report is eventually collated. 
 
We thank all our many contributors for their tireless efforts on our 
behalf. We hope you enjoy reading this report and that it may be 
useful in your clinical practice. 
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1. OVERVIEW AND CONTRIBUTOR 
INFORMATION 
 
1.1 CURRENT DATABASE 
 
1.1.1 Synopsis of the current database 
 
A synopsis of the current state of the database is shown in Table 1.1. 
 
Table 1.1 Synopsis of the current database (census date for penetrating and 
limbal grafts 01/06/2010 and 12/10/2011 for lamellar grafts)  
 
 
Graft status 
Whole 
database Penetrating Lamellar Limbal 
 No. % No. % No. % No. % 
Number registered 23048 100% 19952 100% 2983 100% 113 100% 
 
        
Number followed 18139 79% 16291 82% 1751 59% 97 86% 
Followed for <1 year 4338 24% 3597 22% 701 40% 40 41% 
Followed ≥1 & <6 years 10453 58% 9446 58% 959 55% 48 49% 
Followed ≥6 & <12 years 2469 14% 2388 15% 74 4% 7 7% 
Followed ≥12 & <18 years 740 4% 724 4% 14 <1% 2 2% 
Followed ≥18 years 138 <1% 136 <1% 2 <1% 0 0% 
         
Number lost with at least 
one follow-up 5414 23% 4894 25% 494 17% 26 23% 
Number lost prior to 
follow-up* 
2114 9% 1796 9% 312 10% 10 9% 
Total number lost 7528 33% 6690 34% 806 27% 36 32% 
         
Number with no follow-up 
information provided  
2795 12% 1865 9% 924 31% 6 5% 
         
Known recipient deaths 5168 22% 4845 24% 297 10% 26 23% 
         
Graft has failed 4222 18% 3794 19% 383 13% 45 40% 
Graft surviving when last 
seen (registration or 
follow-up) 
18826 82% 16158 81% 2600 87% 68 60% 
 
        
Grafts currently being 
followed (not failed, lost 
or deceased)** 
7455 32% 5873 29% 1567 52% 15 13% 
 
*Though follow-up forms have generally been received from surgeons for these grafts, the only additional information 
provided is that they have been lost to follow-up (i.e. failed to show for their first follow-up appointment). They are therefore 
counted as “not followed”. 
# Number of grafted eyes – some recipients have had more than one graft. 
**The categories of failed and deceased are not mutually exclusive. 
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Penetrating grafts   86.5% of total database 
Lamellar grafts    13.0% of total database 
Limbal grafts       0.5% of total database 
 
 
 
The main indication for graft in recipients who were lost to follow-up was 
keratoconus (50%) with a median age of 38 years. The main indication for 
recipients who have died since graft is bullous keratopathy (45.6%). This was also 
the largest group in those patients who died with a surviving graft (46.7%). The 
median age of these recipients was 77 years. 
 
1.1.2   Limbal Grafts 
 
Figure 1.1 - Number of limbal grafts performed per year 
 
The number of limbal grafts being performed has dwindled since 1998 with only 12 
grafts being performed since 2004. 
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1.1.3 Survival of penetrating, lamellar and limbal grafts 
 
Kaplan-Meier plots of the survival of penetrating and limbal corneal grafts are presented in 
Figure 1.2 (Log Rank Statistic=50.799; df=1; p<0.001). The census date for this analysis is 
1/6/2010. 
 
Figure 1.2  Survival of penetrating and limbal stem cell grafts 
 
 
 
Number at Risk 
Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
24 
years 
Penetrating 16291 6660 3252 15857 860 400 136 36 0 
Limbal 97 25 11 6 2 0 n/a n/a n/a 
 
 
Probability of Graft Survival (at years post-graft) Type of 
Graft  
No. initially 
at risk 1 5 10 15 20 
Penetrating  16291 .87 .73 .60 .46 .26 
Limbal 97 .64 .43 .27 .00 n/a 
 
      n/a = not applicable 
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Since the census date used for analysis of penetrating and limbal grafts, further follow-up 
data have been recorded on newer lamellar procedures. For this reason all analyses for 
lamellar grafts in this report were calculated as of the census date 12/10/2011. Further 
analyses of lamellar grafts can be found in Chapter 8. 
 
 
 
Figure 1.3  Survival of lamellar corneal grafts 
 
 
 
Number at Risk 
Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
24 
years 
Lamellar 1751 274 90 41 16 5 2 n/a n/a 
 
 
Probability of Graft Survival (at years post-graft) Type of 
Graft  
No. initially 
at risk 1 5 10 15 20 
Lamellar 1751 .80 .67 .53 .41 n/a 
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OVERALL CORNEAL GRAFT SURVIVAL 
TYPE OF GRAFT 
Penetrating corneal graft survival:  87% at 1 year 
 Mean Survival 12.94 years   73% at 5 years 
 (SE=0.17; 95% CI: 12.61, 13.26)  60% at 10 years 
 Median Survival 14 years   46% at 15 years 
       26% at 20 years 
Lamellar corneal graft survival:   80% at 1 year 
 Mean Survival 10.47 years   67% at 5 years 
 (SE=0.51; 95% CI: 9.47, 11.47)  53% at 10 years 
 Median Survival 13 years   41% at 15 years 
Limbal corneal graft survival:   64% at 1 year 
 Mean Survival 6.23 years   43% at 5 years 
 (SE=0.88, 95% CI: 4.51, 7.96)  27% at 10 years 
 Median Survival 4 years     0% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability
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1.2 GRAFTS REGISTERED BY STATE, 
TERRITORY AND INDIVIDUAL  
 
1.2.1 Grafts entered by Australian State and territory 
 
Table 1.2 Grafts entered and followed from each Australian State 
 
 PENETRATING LAMELLAR LIMBAL TOTAL 
State Entered Followed Entered Followed Entered Followed Entered Followed 
 No. No. % No. No. % No. No. % No. No. % 
1 7355 5806 79% 1361 773 57% 35 27 77% 8751 6605 75% 
2 2096 1956 93% 183 130 71% 44 41 93% 2323 2127 92% 
3 4436 3692 83% 368 216 59% 15 13 87% 4819 3921 81% 
4 3257 2738 84% 719 402 56% 4 2 50% 3980 3142 79% 
5 2347 1682 72% 267 166 62% 12 11 92% 2626 1859 71% 
6 461 417 90% 85 64 75% 3 3 100% 549 484 88% 
TOTAL 19952 16291 82% 2983 1751 59% 113 97 86% 23048 18138 79% 
 
1.2.2 Contributors in each State 
 
Table 1.3 Percentage of penetrating grafts performed by surgeons with                
≥ 50 grafts 
 
 Total transplant surgeons Surgeons with total ≥ 50 grafts  
State No. Grafts 
performed 
No. Grafts 
performed 
% 
1 122 7355 26 5983 81% 
2 44 2096 6 1733 83% 
3 115 4436 16 3424 77% 
4 34 3257 5 3074 94% 
5 60 2347 8 1770 75% 
6 9 461 1 337 73% 
TOTAL 384 19952 62 16321 82% 
 
It can be seen that 62 ophthalmologists, 16% of transplant surgeons or 9% of all 
contributors, performed 82% of all penetrating grafts recorded. 
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All Kaplan-Meier plots and associated tables in the remainder of this chapter have 
been calculated using penetrating grafts only. 
 
Figure 1.4 compares the graft survival for each state for penetrating grafts only (Log Rank 
Statistic=37.444; df=5; p<0.001). Individual states have been de-identified. 
 
Figure 1.4 Penetrating graft survival from each Australian State 
 
 
Number At Risk 
Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
24 
years 
State 1 5806 2359 1101 503 249 99 16 n/a n/a 
State 2 1956 889 472 240 135 69 32 11 n/a 
State 3 3692 1506 806 421 239 114 44 16 n/a 
State 4 2738 987 433 205 112 61 20 4 1 
State 5 1682 703 354 178 111 51 22 5 0 
State 6 417 149 82 38 13 6 2 n/a n/a 
 
 
Graft survival (at years post-graft) Identity 1 5 10 15 20 
State 1 .87 .72 .59 .44 .08 
State 2 .85 .71 .59 .50 .40 
State 3 .88 .73 .62 .48 .34 
State 4 .89 .74 .59 .49 .09 
State 5 .87 .73 .60 .44 .23 
State 6 .75 .61 .52 .46 n/a 
      n/a = not applicable 
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PENETRATING CORNEAL GRAFT SURVIVAL 
BY STATE 
State 1:      87% at 1 year 
 Mean Survival 11.72 years   72% at 5 years 
 (SE= 0.20, 95% CI: 11.32, 12.12)  59% at 10 years 
 Median Survival 13 years   44% at 15 years 
          8% at 20 years 
State 2:      85% at 1 year 
 Mean Survival 13.67 years   71% at 5 years 
 (SE = 0.37, 95% CI: 12.95, 14.402)   59% at 10 years 
  Median Survival 16 years   50% at 15 years 
        40% at 20 years 
State 3:      88% at 1 year 
 Mean Survival 13.40 years   73% at 5 years 
 (SE= 0.29, 95% CI: 12.83, 13.97)  62% at 10 years 
 Median Survival 15 years   48% at 15 years 
        34% at 20 years 
State 4:      89% at 1 year 
 Mean Survival 12.18 years   74% at 5 years 
 (SE = 0.33, 95% CI: 11.55, 12.82)   59% at 10 years 
 Median Survival 14 years   49% at 15 years 
          9% at 20 years 
State 5:      87% at 1 year 
 Mean Survival 12.77 years   73% at 5 years 
 (SE = 0.41, 95% CI: 11.98, 13.579)   60% at 10 years 
 Median Survival 14 years   44% at 15 years 
        23% at 20 years 
State 6:      75% at 1 year 
 Mean Survival 10.64 years   61% at 5 years 
 (SE =0.617, 95% CI: 9.44, 11.84)   52% at 10 years 
 Median Survival 11 years   46% at 15 years 
         
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability  
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1.2.3 Outcome: influence of surgeon workload per year 
 
Figure 1.5 shows the survival of all penetrating grafts for keratoconus performed by 
surgeons with a workload of 25 or more penetrating grafts per year on average, compared 
with those whose workload was less than 25 grafts per year (Log Rank Statistic=21.56; 
df=1; p<0.001).  
 
Figure 1.5 Number of grafts performed/year (penetrating grafts for keratoconus 
only) 
 
Number At Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
≥ 25 grafts/year 2870 1399 773 457 272 154 58 19 1 
< 25 grafts/year 2002 1022 584 317 194 94 38 7 0 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
≥ 25 grafts/year 2870 .98 .96 .92 .80 .52 
< 25 grafts/year 2002 .96 .92 .85 .73 .33 
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Figure 1.6 compares graft survival for grafts excluding those first grafts for keratoconus 
(Log Rank Statistic=10.13; df=1; p=0.001). 
 
 
Figure 1.6 Number of grafts performed/year (penetrating grafts only, keratoconus 
excluded) 
 
 
Number At Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
≥ 25 grafts/year 5692 2070 907 392 193 73 23 5 n/a 
< 25 grafts/year 5727 2109 988 419 201 79 17 5 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
≥ 25 grafts/year 5692 .84 .64 .46 .31 .13 
< 25 grafts/year 5727 .81 .61 .46 .30 .15 
 
      n/a = not applicable 
 
The survival curves appear very similar for both groups, despite the statistically significant 
difference between them. This suggests that the impact of this variable at a practical, 
clinical level is likely to be small. 
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PENETRATING CORNEAL GRAFT SURVIVAL  
KERATOCONUS ONLY: EFFECT OF CASE-LOAD 
≥ 25 grafts/year:     98% at 1 year 
 Mean Survival 18.84 years   96% at 5 years 
 (SE=0.37; 95% CI: 18.12, 19.55)  91% at 10 years 
 Median Survival 21 years   80% at 15 years 
       52% at 20 years 
< 25 grafts/year:      96% at 1 year 
 Mean Survival 17.35 years   92% at 5 years 
 (SE=0.38; 95% CI: 16.59, 18.09)  85% at 10 years 
 Median Survival 19 years   73% at 15 years 
       33% at 20 years 
 
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL  
KERATOCONUS EXCLUDED: EFFECT OF CASE-LOAD 
≥ 25 grafts/year:     84% at 1 year 
 Mean Survival 10.31 years   64% at 5 years 
 (SE=0.23; 95% CI: 9.86, 10.77)  46% at 10 years 
 Median Survival 9 years   31% at 15 years 
       13% at 20 years 
< 25 grafts/year:      81% at 1 year 
 Mean Survival 10.10 years   61% at 5 years 
 (SE=0.25; 95% CI: 9.60, 10.60)  46% at 10 years 
 Median Survival 9 years   30% at 15 years 
       15% at 20 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability  
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1.2.4 The ‘centre effect’ – penetrating grafts 
 
Penetrating graft survival stratified by individual high volume surgeons is shown in figures 
1.7 & 1.8. 
 
Figure 1.7 shows graft survival for those grafts performed by surgeons who performed ≥ 25 
penetrating grafts with follow up for keratoconus (Log Rank Statistic=77.96; df=28; 
p<0.001). 
 
Figure 1.7 Penetrating grafts (keratoconus only) – high volume surgeons 
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Figure 1.8 shows graft survival for penetrating grafts performed by surgeons who 
performed ≥ 25 penetrating grafts with follow up, excluding those performed for 
keratoconus (Log rank Statistic=452.45; df=78; p<0.001). 
 
 
 
Figure 1.8 Penetrating grafts (keratoconus excluded) - high volume surgeons 
 
 
 
 
A total of 104 surgeons performed ≥ 25 penetrating grafts with follow-up. Twenty nine 
surgeons performed these grafts for keratoconus and 79 performed grafts for indicators 
other than keratoconus. Four surgeons performed ≥ 25 penetrating grafts with follow-up for 
keratoconus and separately for indications other than keratoconus. 
 
While significant differences were found when comparing surgeons who undertook ≥ 25 
penetrating grafts per year to those who did fewer than 25, further exploration of the 
survival rates for individual surgeons who performed ≥ 25 grafts also showed a large 
amount of variation, as shown in Figure 1.7 and Figure 1.8. This indicates that, although 
surgeon workload does appear to have a significant impact on graft survival, there is still an 
unexplained “centre effect” amongst these surgeons, with some enjoying greater success 
rates than others. This is even the case when only those grafts performed for keratoconus 
are examined. However, case-mix is likely to exert some effect (see Chapter 9). 
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1.2.5 Outcome: according to era 
 
A comparison of graft survival since the Australian Corneal Graft Registry began is shown 
in Figure 1.9. Due to the nature of this particular analysis, in that grafts performed in earlier 
eras are more likely to have up-to-date information and longer follow-up than more recent 
grafts, Figure 1.9 analyses grafts performed to the original census date (01/06/10) using 
follow-up data to the second census date (12/10/11). Grafts performed in 5 year blocks, 
1985-1989, 1990-1994, 1995-2000, 2000-2004 and 2005-2010 were compared (Log Rank 
Statistic=6.690; df=4; p=0.153). When the graft was performed has no significant influence 
on graft survival.  
 
Figure 1.9 Graft outcome measured in groups of years (1st penetrating grafts 
only) 
 
Number At Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
1985 - 1989 1860 971 621 391 298 167 91 31 1 
1990 - 1994 3795 1764 1043 631 385 224 75 2 n/a 
1995 - 1999 2814 1281 699 382 165 24 n/a n/a n/a 
2000 - 2004 2938 1206 473 80 n/a n/a n/a n/a n/a 
2005 - 2010 1758 488 18 n/a n/a n/a n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
1985 - 1989 1860 .88 .77 .68 .57 .32 
1990 - 1994 3795 .88 .76 .66 .51 .35 
1995 - 1999 2814 .89 .78 .64 .47 n/a 
2000 - 2004 2938 .91 .78 .57 n/a n/a 
2005 - 2010 1758 .93 .70 n/a n/a n/a 
 
      n/a = not applicable 
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PENETRATING CORNEAL GRAFT SURVIVAL 
STRATIFIED BY ERA 
1985-1989:       88% at 1 year 
 Mean Survival 14.32 years   77% at 5 years 
 (SE=0.30; 95% CI: 13.73, 14.90)  68% at 10 years 
 Median Survival 17 years   57% at 15 years 
       32% at 20 years 
1990-1994:      88% at 1 year 
 Mean Survival 13.42 years   76% at 5 years 
 (SE=0.21; 95% CI: 13.02, 13.82)  66% at 10 years 
 Median Survival 16 years   51% at 15 years 
       35% at 20 years 
1995-1999:      89% at 1 year 
 Mean Survival 11.28 years   78% at 5 years 
  (SE=0.17; 95% CI: 10.95, 11.62)   64% at 10 years 
  Median Survival 14 years   47% at 15 years 
2000-2004:      91% at 1 year  
 Mean Survival 8.47 years   78% at 5 years 
 (SE=0.11; 95% CI: 8.25, 8.68)   57% at 10 years 
 Median Survival approx. 11 years   
2005-2010:      93% at 1 year 
 Mean Survival 5.08 years   70% at 5 years 
 (SE =0.06; 95% CI: 4.96, 5.20)    
 Median Survival approx. 6 years    
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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1.2.6 Outcome: whether followed by contributing 
surgeon or another practitioner 
 
Figure 1.10 compares penetrating graft outcome for first grafts for keratoconus, stratified by 
whether the graft was followed by the contributing surgeon or by another practitioner (Log 
Rank Statistic=12.82; df=1; p<0.001).  
 
Figure 1.10   Follow-up surgeon/other practitioner - 1st graft for keratoconus only 
 
 
 
Number At Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Followed by surgeon 3846 1850 1027 577 347 174 65 19 1 
Followed elsewhere 1022 570 329 196 118 74 31 7 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
Followed by surgeon 3846 .97 .94 .88 .74 .42 
Followed elsewhere 1022 .98 .97 .96 .85 .54 
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Figure 1.11 compares the outcome for all penetrating grafts excluding those performed for 
keratoconus, followed by the contributing surgeon or by another practitioner (Log Rank 
Statistic=182.96; df=1; p<0.001). 
 
 
Figure 1.11 Follow-up surgeon/other practitioner - keratoconus excluded 
 
 
 
Number At Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Followed by surgeon 9461 3295 1492 641 310 103 28 8 n/a 
Followed elsewhere 1962 885 404 172 85 49 12 2 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
Followed by surgeon 9461 .81 .59 .43 .27 .13 
Followed elsewhere 1962 .92 .78 .61 .48 .25 
 
      n/a = not applicable 
 
Survival of penetrating grafts was better in both keratoconus and non-keratoconus patients 
when they were followed elsewhere. We hypothesize that surgeons refer on the follow-up 
of patients whose grafts are doing well, while continuing to see more complex cases 
themselves. 
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PENETRATING CORNEAL GRAFT SURVIVAL  
FOLLOWUP SURGEON; KERATOCONUS ONLY 
Followed by surgeon:     97% at 1 year 
 Mean Survival 17.84 years   94% at 5 years 
 (SE=0.33; 95% CI: 17.20, 18.48)  88% at 10 years 
 Median Survival 19 years   74% at 15 years 
       42% at 20 years 
Followed elsewhere:    98% at 1 year 
 Mean Survival 18.95 years   97% at 5 years 
 (SE=0.46; 95% CI: 18.05, 19.85)  96% at 10 years 
 Median Survival 21 years   85% at 15 years 
       54% at 20 years 
 
 
 
 
 
 
 
OVERALL CORNEAL GRAFT SURVIVAL  
FOLLOWUP SURGEON; KERATOCONUS EXCLUDED 
Followed by surgeon:     80% at 1 year 
 Mean Survival 9.55 years   59% at 5 years 
 (SE=0.18; 95% CI: 9.21, 9.85)  42% at 10 years 
 Median Survival 8 years   27% at 15 years 
       13% at 20 years 
Followed elsewhere:    92% at 1 year 
 Mean Survival 13.32 years   78% at 5 years 
 (SE=0.46; 95% CI: 12.41, 14.23)  61% at 10 years 
 Median Survival 15 years   47% at 15 years 
       24% at 20 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
Australian Corneal Graft Registry Report 2012 
OVERVIEW AND CONTRIBUTOR INFORMATION 
30 
 
1.3 SUMMARY OF OVERVIEW AND 
CONTRIBUTOR INFORMATION 
 
 23,048 registered grafts are considered in this report, of which 86.5% were 
penetrating, 13% were lamellar, and 0.5% were limbal. 
 Overall, 88% of grafts have been followed on at least one occasion, 33% of 
grafts are known to be lost to follow-up, 22% of grafts can no longer be 
followed because of recipient death, and 18% of grafts have failed. 
 Penetrating corneal graft survival is 73% at 5 years. 
Lamellar corneal graft survival is 67% at 5 years. 
Limbal allograft survival is 43% at 5 years. 
 82% of penetrating grafts have been performed by 16% of transplant 
surgeons. 
 A centre effect operates within the database. 
 Surgeons who performed 25 or more penetrating grafts per year on 
average achieved better results in terms of graft survival than did those who 
performed fewer grafts, although the difference in terms of graft survival 
was small.  
 Patients with penetrating grafts who were followed up by another 
practitioner had a better outcome compared with patients who were 
followed up by the surgeon. This is probably due to case selection. 
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2. DONORS AND EYE-BANKING 
 
2.1 CAUSE OF DONOR DEATH 
 
 
The major cause of donor death for all graft types is listed in Table 2.1. Diseases of the 
cardiac/circulatory system remain the most common cause of death in corneal donors, 
followed by malignancies, strokes and other haemorrhages. 
 
Table 2.1 Causes of donor death 
 
 
Cause of death related to Number of 
eyes 
% 
Cardiac/circulatory system  6851 30% 
Malignancy 4478 19% 
Cerebrovascular system 4423 19% 
Trauma/accident/poisoning/medical misadventure 2317 10% 
Respiratory system 2220 10% 
Other specified cause 1536 7% 
Unknown to ACGR 1190 5% 
Total 23015 100% 
 
In 33 of the 23,048 grafts performed, the cornea was sourced from the recipient’s other 
eye, not a separate donor. 
 
 
With the exception of Table 2.1 and Figure 2.2, all Kaplan-Meier plots and associated 
tables in this chapter have been calculated using penetrating grafts only. 
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Kaplan-Meier survival curves for penetrating grafts for the most common causes of donor 
death are shown in Figure 2.1. 
 
When donors dying from trauma are removed from the analysis, there is no longer a 
significant difference amongst groups (Log Rank Statistic=7.268; df=4; p=0.122). 
 
Figure 2.1 Cause of donor death (penetrating grafts only) 
 
Number At Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Stroke/bleed 3137 1280 603 285 147 78 19 6 1 
Malignancy 2761 1035 487 243 130 51 22 2 n/a 
Trauma/accident 1628 756 384 187 105 42 16 4 n/a 
Respiratory 1664 659 298 144 89 34 14 1 n/a 
Other 1134 467 242 88 39 17 3 n/a n/a 
Cardiac/circulatory 4949 2007 1004 485 242 124 42 18 n/a 
 
Graft survival (at years post-graft) Identity 
No. 
initially at 
risk 1 5 10 15 20 
Stroke/bleed 3137 .86 .73 .57 .47 .25 
Malignancy 2761 .86 .70 .57 .42 .10 
Trauma/accident 1628 .90 .80 .70 .57 .35 
Respiratory 1664 .87 .70 .60 .49 .17 
Other 1134 .88 .75 .61 .47 n/a 
Cardiac/circulatory 4949 .87 .71 .58 .43 .29 
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OVERALL CORNEAL GRAFT SURVIVAL  
CAUSE OF DONOR DEATH 
Stroke/bleed:     86% at 1 year 
 Mean Survival 13.03 years   73% at 5 years 
 (SE=0.40; 95% CI: 12.25, 13.81)  57% at 10 years 
 Median Survival 14 years   47% at 15 years 
       25% at 20 years 
Malignancy:      86% at 1 year 
 Mean Survival 11.61 years   70% at 5 years 
 (SE=0.30; 95% CI: 11.02, 12.20)   57% at 10 years 
 Median Survival 12 years   42% at 15 years 
       10% at 20 years 
Trauma/accident:     89% at 1 year 
 Mean Survival 14.69 years   80% at 5 years 
 (SE=0.44; 95% CI: 13.83, 15.55)   70% at 10 years 
 Median Survival 18 years   57% at 15 years 
       35% at 20 years 
Respiratory:     87% at 1 year 
 Mean Survival 12.86 years   70% at 5 years 
 (SE=0.42; 95% CI: 12.03, 13.69)  60% at 10 years 
 Median Survival 17 years   49% at 15 years 
       17% at 20 years 
Other :      88% at 1 year 
 Mean Survival 12.65 years   75% at 5 years 
 (SE=0.47; 95% CI: 11.72, 13.57)   61% at 10 years 
 Median Survival 15 years   47% at 15 years 
 
Cardiac/circulatory:    87% at 1 year 
 Mean Survival 12.62 years   71% at 5 years 
 (SE=0.26; 95% CI: 12.10, 13.14)  58% at 10 years 
 Median Survival 13 years   43% at 15 years 
       29% at 20 years 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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2.2 DONOR SEX 
 
The sex of corneal donors continues to show the expected preponderance of males (Table 
2.2), given the causes of donor death (see Table 2.1). 
 
Table 2.2 Donor Sex 
 
Penetrating 
grafts 
Lamellar 
grafts 
Limbal 
grafts 
Total Sex 
No. % No. % No. % No. % 
Male 12235 53% 1785 8% 74 <1% 14094 61% 
Female 6889 30% 1141 5% 35 <1% 8065 35% 
Unknown 828 4% 57 <1% 4 <1% 889 4% 
TOTAL 19952 86% 2983 13% 113 <1% 23048 100% 
 
2.3 DONOR AGE 
 
The age distribution is plotted in histogram form in Figure 2.2. 
 
Figure 2.2 Donor age in decades 
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Figures 2.3, 2.4 and 2.5 show the influence of donor age on corneal graft survival. Figure 
2.3 shows the influence of donor age in 20 year blocks on the cohort of penetrating grafts 
(Log Rank Statistic=164.59; df=4; p=0.001). 
 
Figure 2.3 Donor age in 20 year blocks (penetrating grafts only) 
 
 
 
Number At Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
  1-20 years 767 354 169 93 52 17 4 2 n/a 
21-40 years 1602 706 386 204 112 52 17 4 1 
41-60 years 4470 1878 931 446 257 116 43 12 0 
61-80 years 7881 3082 1467 690 357 169 57 15 n/a 
  >80 years 1214 409 193 86 44 25 11 2 n/a 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
  1-20 years  767 .91 .83 .74 .49 n/a 
21-40 years 1602 .90 .82 .74 .63 .31 
41-60 years  4470 .89 .76 .63 .49 .29 
61-80 years 7881 .86 .68 .54 .41 .22 
  >80 years 1214 .83 .66 .51 .42 .24 
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Figure 2.4 shows the influence of donor age on grafts for keratoconus only (Log Rank 
Statistic=2.555; df=4; p=0.635). The differences are not significant. 
 
Figure 2.4 Donor age (penetrating grafts for keratoconus only) 
 
 
 
 
Number At Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
1-20 years 406 207 104 61 33 9 3 1 n/a 
21-40 years 815 403 227 126 66 35 12 2 1 
41-60 years 1628 776 416 223 139 73 29 8 0 
61-80 years 1746 876 506 297 183 100 38 12 n/a 
>80 years 179 97 62 36 24 17 10 2 n/a 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
1-20 years  406 .97 .94 .85 n/a n/a 
21-40 years 815 .97 .95 .90 .79 .28 
41-60 years  1628 .97 .95 .90 .77 .36 
61-80 years 1746 .97 .94 .88 .75 .46 
>80 years 179 .99 .96 .88 .78 .53 
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Figure 2.5 shows the influence of donor age on the survival of grafts performed for all 
indications excluding keratoconus (Log Rank Statistic=30.413; df=4; p=0.001). 
 
Figure 2.5 Donor age (penetrating grafts, keratoconus excluded) 
 
 
Number At Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
1-20 years 361 147 65 32 19 8 1 n/a n/a 
21-40 years 787 303 159 78 46 17 5 2 n/a 
41-60 years 2842 1102 515 223 118 43 14 4 n/a 
61-80 years 6135 2206 961 393 174 69 19 3 n/a 
>80 years 1035 312 131 50 20 8 1 n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
1-20 years  361 .84 .71 .61 .15 n/a 
21-40 years 787 .82 .69 .57 .42 n/a 
41-60 years  2842 .84 .65 .48 .32 .18 
61-80 years 6135 .82 .60 .43 .28 .11 
>80 years 1035 .80 .58 .41 .27 n/a 
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Figure 2.3 shows that graft survival declines as donor age increases in 20 year blocks, 
suggesting that survival was better when corneas were sourced from younger donors. This 
finding could be confounded by the use of corneas from younger donors for grafts in certain 
categories of recipients, e.g. greater proportions in recipients with keratoconus. 
 
Figure 2.4 illustrates that graft survival in recipients with keratoconus is similar across 
donor age groups and the differences are not significant. Recipients with keratoconus 
exhibited good graft survival regardless of donor age. 
 
Having removed recipients with keratoconus from the analysis, a significant difference 
across donor age groups was present in the balance of the database, as shown in Figure 
2.5. This still follows the trend of better graft survival in eyes with corneas sourced from 
younger compared to older donors. However, donor age is not a significant variable in 
multivariate analysis (see Chapter 9). 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
DONOR AGE IN 20 YEAR BLOCKS 
1-20 years:      91% at 1 year 
 Mean Survival 15.35 years   83% at 5 years 
 (SE=0.72; 95% CI: 13.94, 16.76)  74% at 10 years 
 Median Survival 16 years   49% at 15 years 
21-40 years:      90% at 1 year 
 Mean Survival 15.71 years   82% at 5 years 
 (SE=0.56; 95% CI: 14.60, 16.81)  74% at 10 years 
 Median Survival 18 years   63% at 15 years 
       31% at 20 years 
41-60 years:      88% at 1 year 
 Mean Survival 13.54 years   76% at 5 years 
 (SE=0.28; 95% CI: 12.98, 14.09)   63% at 10 years 
 Median Survival 15 years   49% at 15 years 
       29% at 20 years 
61-80 years:      86% at 1 year 
 Mean Survival 11.80 years   68% at 5 years 
 (SE=0.21; 95% CI: 11.39, 12.21)   54% at 10 years 
 Median Survival 12 years   41% at 15 years 
       22% at 20 years 
>80 years:      83% at 1 year 
 Mean Survival 12.94 years   65% at 5 years 
 (SE=0.17; 95% CI: 12.60, 13.27)   51% at 10 years 
 Median Survival 14 years   42% at 15 years 
       24% at 20 years 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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PENETRATING CORNEAL GRAFT SURVIVAL 
DONOR AGE; KERATOCONUS ONLY 
1-20 years:      97% at 1 year 
 Mean Survival 18.07 years   94% at 5 years 
 (SE=0.59; 95% CI: 16.92, 19.22)  85% at 10 years 
 Median Survival >10 years    
21-40 years:      97% at 1 year 
 Mean Survival 18.30 years   95% at 5 years 
 (SE=0.79; 95% CI: 16.75, 19.85)  90% at 10 years 
 Median Survival 19 years    
41-60 years:      97% at 1 year 
 Mean Survival 18.05 years   95% at 5 years 
 (SE=0.43; 95% CI: 17.20, 18.90)   90% at 10 years 
 Median Survival 19 years    
61-80 years:      97% at 1 year 
 Mean Survival 17.50 years   94% at 5 years 
 (SE=0.34; 95% CI: 16.84, 18.16)   88% at 10 years 
 Median Survival 20 years    
>80 years:      99% at 1 year 
 Mean Survival 17.87 years   97% at 5 years 
 (SE=0.72; 95% CI: 16.45, 19.28)   88% at 10 years 
 Median Survival >20 years    
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
DONOR AGE; KERATOCONUS EXCLUDED 
1-20 years:      84% at 1 year 
 Mean Survival 11.31 years   71% at 5 years 
 (SE=0.97; 95% CI: 9.41, 13.21)   61% at 10 years 
 Median Survival 13 years    
21-40 years:      82% at 1 year 
 Mean Survival 12.27 years   69% at 5 years 
 (SE=0.62; 95% CI: 11.06, 13.49)  57% at 10 years 
 Median Survival 13 years    
41-60 years:      84% at 1 year 
 Mean Survival 10.72 years   65% at 5 years 
 (SE=0..32; 95% CI: 10.09, 11.35)   48% at 10 years 
 Median Survival 10 years    
61-80 years:      82% at 1 year 
 Mean Survival 9.63 years   60% at 5 years 
 (SE=0.23; 95% CI: 9.18, 10.08)    43% at 10 years 
 Median Survival 8 years    
>80 years:      80% at 1 year 
 Mean Survival 8.86 years   58% at 5 years 
 (SE=0.42; 95% CI: 8.04, 9.69)    41% at 10 years 
 Median Survival 7 years    
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
p = probability 
Cl = confidence interval 
 df = degrees of freedom 
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2.4 DEATH-TO-ENUCLEATION AND  
DEATH-TO-GRAFT TIMES 
 
Death-to-enucleation and death-to-graft times for penetrating grafts are shown in Table 2.3.  
 
 
Table 2.3       Corneal collection times for penetrating grafts 
 
 
 
Penetrating Grafts 
Median time Time Total 
Days 
Range 
(Days) 
Death-to-enucleation times  19493 <1       0 - 3 
Death-to-graft times 16457 3 0 - 41 
Death-to-graft times for storage in:  
  
Optisol 
MK medium 
CSM 
K-Sol 
Moist Pot 
Organ Culture 
7789 
4105 
3179 
644 
283 
229 
4 
<2 
3 
4 
<1 
15 
 0 - 41 
0 - 17 
0 - 34 
0 - 32 
0 - 16 
1 - 30 
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The influence of increasing death-to-enucleation time on penetrating graft survival is 
illustrated in Figure 2.6 (Log Rank Statistic=7.277; df=4; p=0.122). Death to enucleation 
time exerted no significant difference on graft survival. 
 
Figure 2.6 Death-to-enucleation times (penetrating grafts only) 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
>0 and ≤3 hours 4265 1938 1086 613 363 189 60 16 1 
>3 and ≤6 hours 4303 1747 863 418 233 106 45 12 n/a 
>6 and ≤9 hours 3680 1446 693 308 144 55 16 4 n/a 
>9 and ≤12 hours 2747 1028 440 179 83 37 10 2 n/a 
>12 hours 1268 430 169 67 37 13 5 2 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
>0 and ≤3 hours 4265 .87 .75 .62 .50 .23 
>3 and ≤6 hours 4303 .86 .72 .60 .47 .30 
>6 and ≤9 hours 3680 .87 .70 .56 .41 .19 
>9 and ≤12 hours 2747 .87 .72 .58 .44 .33 
>12 hours 1268 .88 .74 .62 .46 .37 
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PENETRATING CORNEAL GRAFT SURVIVAL 
DEATH TO ENUCLEATION TIME 
>0 and ≤3 hours:     87% at 1 year 
 Mean Survival 13.15 years   75% at 5 years 
 (SE=0.25; 95% CI: 12.65, 13.65)   62% at 10 years 
 Median Survival 15 years   50% at 15 years 
       23% at 20 years 
>3 and ≤6 hours:     86% at 1 year 
 Mean Survival 12.82 years   72% at 5 years 
 (SE=0.26; 95% CI: 12.31, 13.33)  60% at 10 years 
 Median Survival 14 years   47% at 15 years 
       30% at 20 years 
>6 and ≤9 hours:     87% at 1 year 
 Mean Survival 11.78 years   70% at 5 years 
 (SE=0.30; 95% CI: 11.19, 12.37)   56% at 10 years 
 Median Survival 14 years   41% at 15 years 
       19% at 20 years 
>9 and ≤12 hours:     87% at 1 year 
 Mean Survival 13.13 years   72% at 5 years 
 (SE=0.48; 95% CI: 12.18, 14.08)  58% at 10 years 
 Median Survival 14 years   44% at 15 years 
       33% at 20 years 
>12 hours:      88% at 1 year 
 Mean Survival 13.16 years   74% at 5 years 
 (SE=0.63; 95% CI: 11.93, 14.39)  62% at 10 years 
 Median Survival 14 years   46% at 15 years 
       37% at 20 years 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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Figure 2.7 shows death-to-graft times stratified in number of days for penetrating grafts 
(Log Rank Statistic=9.45; df=7; p=0.222). There was no significant difference amongst 
these curves. 
 
Figure 2.7 Death-to-graft times (penetrating grafts only) 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
1 day 1155 547 341 203 128 72 34 15 n/a 
2 days 2592 1185 662 349 196 101 41 11 n/a 
3 days 2764 1229 615 320 193 75 25 4 n/a 
4 days 2359 983 464 222 109 54 18 3 1 
5 days 1890 698 325 149 70 25 6 2 n/a 
6 days 1463 548 249 82 43 18 3 n/a n/a 
7 days 807 295 109 42 15 5 2 n/a n/a 
Over 7 days 683 215 91 37 16 4 2 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
1 day 1155 .84 .72 .60 .51 .30 
2 days 2592 .87 .73 .61 .51 .24 
3 days 2764 .87 .72 .62 .48 .28 
4 days 2359 .87 .71 .58 .43 .28 
5 days 1890 .88 .73 .60 .42 .29 
6 days 1463 .88 .75 .58 .42 .28 
7 days 807 .86 .72 .47 .35 n/a 
Over 7 days 683 .85 .705 .56 .35 n/a 
44  Australian Corneal Graft Registry Report 2012 
DONORS AND EYE-BANKING 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
DEATH TO GRAFT TIME 
1 day:      84% at 1 year 
 Mean Survival 12.84 years   72% at 5 years 
 (SE=0.38; 95% CI: 12.12, 13.58)  60% at 10 years 
 Median Survival 16 years   51% at 15 years 
       30% at 20 years 
2 days:      87% at 1 year 
 Mean Survival 13.02 years   73% at 5 years 
 (SE=0.30; 95% CI: 12.44, 13.60)  61% at 10 years 
 Median Survival 16 years   51% at 15 years 
       24% at 20 years 
3 days:      87% at 1 year 
 Mean Survival 12.92 years   72% at 5 years 
 (SE=0.32; 95% CI: 12.29, 13.54)  62% at 10 years 
 Median Survival 14 years   48% at 15 years 
       28% at 20 years 
4 days:      87% at 1 year 
 Mean Survival 13.01 years   71% at 5 years 
 (SE=0.44; 95% CI: 12.14, 13.88)  58% at 10 years 
 Median Survival 14 years   43% at 15 years 
       28% at 20 years 
5 days:      88% at 1 year 
 Mean Survival 12.31 years   73% at 5 years 
 (SE=0.44; 95% CI: 11.45, 13.16)  60% at 10 years 
 Median Survival 12 years   42% at 15 years 
       29% at 20 years 
6 days:      88% at 1 year 
 Mean Survival 12.30 years   75% at 5 years 
 (SE=0.46; 95% CI: 11.40, 13.20)  58% at 10 years 
 Median Survival 13 years   42% at 15 years 
       28% at 20 years 
7 days:      86% at 1 year 
 Mean Survival 10.63 years   72% at 5 years 
 (SE=0.66; 95% CI: 9.33, 11.93)  47% at 10 years 
 Median Survival 10 years   35% at 15 years 
Over 7 days:     85% at 1 year 
 Mean Survival 10.98 years   70% at 5 years 
 (SE=0.65; 95% CI: 9.70, 12.25)  56% at 10 years 
 Median Survival 11 years   35% at 15 years 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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2.5 CORNEAL STORAGE MEDIA 
 
The corneal storage media in which donor corneas were preserved are shown in Table 2.4. 
 
 
Table 2.4 Corneal storage media 
 
 
Storage medium No. of Grafts 
Optisol 
(1991 – present) 
10068 50% 
M-K medium 
(1985 – 2002) 
4548 23% 
CSM 
(1987 – 2003) 
3554 18% 
Moist Pot 
(1985 – present) 
332 2% 
K-Sol 
(1987 – 2000) 
681 3% 
DexSol 
(1989 – 1999) 
186 <1% 
Organ Culture   
(1985 – 1997) 91 <1% 
(2007 – present) 334 2% 
Other 3 <1% 
Unknown to ACGR 155 <1% 
Total 19952 100% 
 
 
 
 
Several types of storage media have now been superseded. Table 2.4 shows the eras in 
which each was in use. The majority of corneas used in contemporary grafts were stored in 
Optisol. Organ Culture, used sparingly from 1985 to 1997, has the advantage of allowing 
longer storage time than Optisol and has had a recent resurgence in use. Small numbers of 
corneas have continued to be preserved using the Moist Pot technique since the 
establishment of the Registry. 
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2.5.1 Optisol storage time 
 
Figure 2.8 compares graft outcome for Optisol-preserved corneas stored for periods of  
0-48 hours, 49-96 hours, 97-144 hours and more than 144 hours (Log Rank 
Statistic=6.902; df=3; p=0.075). The differences are not significant. 
 
Figure 2.8  Optisol storage time (penetrating grafts only) 
 
 
Number at Risk 
 
Identity Initially 3 years 6 years 9 years 12 years 15 years 18 years 
<=48 hours 1830 670 276 58 10 4 n/a 
49 - 96 hours 1937 726 248 50 14 n/a n/a 
97-144 hours 1732 647 259 53 16 3 n/a 
>=145 hours 654 203 74 28 8 1 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially   
at risk 1 5 10 15 20 
<=48 hours 1830 .89 .73 .54 .36 n/a 
49 - 96 hours 1937 .90 .74 .54 n/a n/a 
97-144 hours 1732 .89 .75 .52 .35 n/a 
>=145 hours 654 .86 .71 .49 .26 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
OPTISOL STORAGE TIME 
0 - 48 hours:     89% at 1 year 
 Mean Survival 10.39 years   73% at 5 years 
 (SE=0.35; 95% CI: 9.70, 11.08)  54% at 10 years 
 Median Survival 11 years   36% at 15 years 
49 - 96 hours:     90% at 1 year 
 Mean Survival 9.64 years   74% at 5 years 
 (SE=0.28; 95% CI: 9.09, 10.20)  54% at 10 years 
 Median Survival 11 years    
97 - 144 hours:     89% at 1 year 
 Mean Survival 10.10 years   75% at 5 years 
 (SE=0.37; 95% CI: 9.37, 10.84)  52% at 10 years 
          Median Survival approx. 12 years  36% at 15 years 
≥145 hours:      86% at 1 year 
 Mean Survival 9.47 years   70% at 5 years 
 (SE=0.51; 95% CI: 8.47, 10.47)  49% at 10 years 
 Median Survival 10 years   26% at 15 years 
  
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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2.6  DONOR PROCUREMENT SOURCE 
 
Figure 2.9 shows the influence of donor procurement source on corneal graft survival. For 
the Kaplan-Meier curves below, the Eye Banks have been de-identified. Procurement 
sources included the Eye Banks in SA, QLD, NSW, WA and VIC (including corneas 
procured from Victorian Forensic Pathology) and corneas that were privately procured, 
years ago, by the operating surgeon. Where a surgeon did not record an eye bank number, 
the graft was included with the eye bank of the State where it was sourced (Log Rank 
Statistic=17.005, df=5; p=0.004).  
 
Figure 2.9 Corneal procurement source (penetrating grafts only) 
 
 
Graft survival (at years post-graft) Identity 1 5 10 15 20 
Non eye bank  .88 .76 .66 .55 .28 
Eye bank 1  .87 .72 .58 .44 .09 
Eye bank 2  .88 .72 .51 .38 n/a 
Eye bank 3  .84 .70 .59 .49 .36 
Eye bank 4  .87 .71 .57 .39 n/a 
Eye bank 5  .87 .74 .60 .43 .25 
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PENETRATING CORNEAL GRAFT SURVIVAL 
DONOR CORNEA PROCUREMENT SOURCE 
Private procurement:     88% at 1 year 
 Mean Survival 13.99 years   76% at 5 years 
 (SE=0.32; 95% CI: 13.35, 14.62)  66% at 10 years 
 Median Survival 17 years   55% at 15 years 
       28% at 20 years 
Eye bank 1:      87% at 1 year 
 Mean Survival 11.72 years   72% at 5 years 
 (SE=0.21; 95% CI: 11.31, 12.13)  58% at 10 years 
 Median Survival 12 years   44% at 15 years 
         9% at 20 years 
Eye bank 2:      88% at 1 year 
 Mean Survival 10.16 years   72% at 5 years 
 (SE=0.34; 95% CI: 9.50, 10.82)  51% at 10 years 
 Median Survival approx. 11 years  38% at 15 years 
Eye bank 3:      84% at 1 year 
 Mean Survival 13.32 years   70% at 5 years 
 (SE=0.34; 95% CI: 12.66, 13.99)  59% at 10 years 
 Median Survival 15 years   49% at 15 years 
       36% at 20 years 
Eye bank 4:      87% at 1 year 
 Mean Survival 10.62 years   71% at 5 years 
 (SE=0.23; 95% CI: 10.17, 11.06)  57% at 10 years 
 Median Survival 13 years   39% at 15 years 
Eye bank 5:      87% at 1 year 
 Mean Survival 12.97 years   74% at 5 years 
 (SE=0.45; 95% CI: 12.09, 13.85)  60% at 10 years 
 Median Survival 14 years   43% at 15 years 
       25% at 20 years 
 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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Figure 2.10 examines the State in which the cornea was sourced, and the influence that 
transporting corneas to a different State exerted on graft survival. The inset plot looks in 
more depth at the first 10 years post graft, where the difference was more apparent.         
(Log Rank Statistic=27.559; df=1; p<0.001). 
 
Figure 2.10 Cornea origin State and graft operation State 
 
 
Number At Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Cornea from 
different State 860 325 178 76 39 20 8 3 n/a 
Cornea from same 
State 13750 5378 2479 1127 562 232 64 15 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
Cornea from 
different State 860 .78 .65 .55 .45 .21 
Cornea from same 
State 13750 .88 .72 .58 .44 .26 
 
Grafts performed in the same State from which the cornea originated showed significantly 
better survival than those performed in a different State. This suggests that something 
relating to the transportation of corneas from one State to another reduced the likelihood of 
graft survival. This difference was particularly pronounced in the first 10 years post graft. 
Sixteen percent of corneas transported interstate were provided for emergency procedures 
or high risk cases compared to 10% of those performed in the same State, which may be a 
factor in these analyses. 
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PENETRATING CORNEAL GRAFT SURVIVAL  
CORNEA ORIGIN STATE AND GRAFT OPERATION STATE 
Cornea from different State:   78% at 1 year 
 Mean Survival 11.31 years   65% at 5 years 
 (SE=0.497; 95% CI: 10.34, 12.28)  55% at 10 years 
 Median Survival 14 years   45% at 15 years 
       21% at 20 years 
Cornea from same State:     88% at 1 year 
 Mean Survival 12.73 years   72% at 5 years 
 (SE=0.19; 95% CI: 12.36, 13.10)  58% at 10 years 
 Median Survival 13 years   44% at 15 years 
       26% at 20 years 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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2.7 MULTI-ORGAN DONORS 
 
One thousand, six hundred and eighty one corneas, representing 7% of those registered, 
were collected from multi-organ donors and used for 1,414 penetrating, 258 lamellar and 9 
limbal grafts. Follow-up after graft has been recorded for 1,019 penetrating grafts, 116 
lamellar grafts and 8 limbal grafts. Figure 2.11 shows the survival curve for the 1,019 
penetrating grafts for which follow-up was available (Log Rank Statistic=17.351; df=1; 
p=0.001). Forty four percent of corneas retrieved from multi-organ donors were used for 
keratoconic recipients. 
 
Figure 2.11 Multi-organ donors (penetrating grafts only) 
 
 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Cardiac death donors 15272 6193 3092 1519 837 388 134 36 1 
Multi-organ donors 1019 407 160 66 23 12 2 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
Cardiac death donors 15272 .87 .72 .59 .46 .26 
Multi-organ donors 1019 .91 .80 .63 .79 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
MULTI-ORGAN DONORS 
Cardiac death donors:    87% at 1 year 
 Mean Survival 12.88 years   72% at 5 years 
 (SE=0.17; 95% CI: 12.55, 13.21)  59% at 10 years 
 Median Survival 14 years   46% at 15 years 
       26% at 20 years 
Multi-organ donors:    91% at 1 year 
 Mean Survival 12.16 years   80% at 5 years 
 (SE=0.47; 95% CI: 11.24, 13.07)  63% at 10 years 
 Median Survival 14 years   49% at 15 years 
  
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
 
 
 
 
 
2.7.1 Multi-Organ Donors vs. Cardiac Death Donors 
 
Tables 2.5, 2.6, and 2.7 compare sex, cause of death, death-to-enucleation times and 
death-to-graft times of multi-organ donors and cardiac death donors.  
 
 
 
Table 2.5 Sex of multi-organ donors (penetrating grafts only) 
 
 Multi-organ donors Cardiac death donors 
Sex No. of eyes % No. of eyes % 
Male 
Female 
Unknown to ACGR 
784 
609 
21 
56% 
43% 
1% 
11451 
6280 
807 
62% 
34% 
4% 
Total 1414 100% 18538 100% 
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Figure 2.12 compares age of multi-organ and cardiac death donors.  
 
Figure 2.12 Age of multi-organ donors (penetrating grafts only) 
 
 
Multi-organ donors were generally younger than were cardiac death donors. 
 
Table 2.6 Cause of donor death in cardiac death and multi-organ donors 
(penetrating grafts only) 
 
 Cause of Donor Death Multi-organ Donor 
Cardiac Death 
Donors 
 
No. of 
eyes % 
No. of 
eyes % 
Cardiac/circulatory   84 6% 5887 32% 
Malignancy   22 2% 3572 19% 
Stroke/bleed 813 57% 3038 16% 
Respiratory   19 1% 1931 10% 
Trauma/accident/poisoning 319 23% 1798 10% 
Other specified cause 152 11% 1206 7% 
Unknown     5 <1% 1106 6% 
Total 1414 100% 18538 100% 
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Table 2.7 Death-to-enucleation and death-to-graft times for multi-organ donors 
 
 Multi-organ donors Cardiac Death donors 
 Death-to- 
enucleation 
time 
Death-to- 
graft time 
Death-to -
enucleation 
time 
Death-to-
graft time 
Median time (hours) 3 83 7 82 
Range (hours) 1-23 3-1664 1-129 2-1183 
Number of grafts 
with data available 1560 (98%) 1196 (75%) 20222 (98%) 17076 (82%) 
 
An independent samples t-test indicated that the death to enucleation time for corneas from 
multi-organ donors (M=4.07 hours, SD=3.68) was shorter than for corneas from cardiac 
death donors (M=7.45 hours, SD=4.64) and that this difference was significant (t=34.47, 
p<0.001). The magnitude of the differences in the means (mean difference=3.38, 95% CI: 
3.19 to 3.57) was small to moderate (eta squared=.053). 
 
 
 
2.8 PRIMARY NON-FUNCTIONING GRAFTS 
 
 
 
Grafts that fail to clear in the early post-operative period are considered to be primary non-
functioning grafts. 
 
Thus far, 243 primary non-functioning grafts have been recorded by 83 surgeons, out of the 
18,139 grafts that have been followed. This number represents penetrating, lamellar and 
limbal grafts (census date 01/06/10 for penetrating and limbal grafts, 12/10/2011 for 
lamellar grafts). Of these, four ‘pairs’ of cornea (from the same donor), representing eight 
(8) primary non-functioning grafts, have been recorded in the Australian Corneal Graft 
Registry. The remaining 235 primary non-functioning grafts were from separate donors. 
 
151 (62%) of the primary non-functioning grafts were penetrating grafts, including the four 
pairs of corneas. Table 2.8 shows features of corneas used in primary non-functioning 
penetrating grafts as compared to the features of all penetrating grafts. 
 
 
 
56  Australian Corneal Graft Registry Report 2012 
DONORS AND EYE-BANKING 
 
 
Table 2.8 Features of primary non-functioning grafts (penetrating grafts only) 
 
 
Primary Failures All Penetrating 
Grafts Feature 
No. % No. % 
Procurement source: 
    
Private: 4    3% 1710 9% 
Eyebank: 147   97% 18242 91% 
1 79 52% 7137 36% 
4 23 15% 3795 19% 
3 22 15% 2466 12% 
2 15 10% 2819 14% 
5 8 5% 2025 10% 
Death to enucleation times 
    
≤6 hours 63 42% 9914 50% 
>6 hours 88 58% 9982 50% 
Unknown to ACGR 0 0% 56 <1% 
Storage medium 
    
Optisol 59 39% 10066 51% 
CSM 53 35% 3556 18% 
MK medium 30 20% 4548 23% 
Moist pot 3       2% 332 2% 
K-Sol 3 2% 681 3% 
Other 0 0% 614 3% 
Unknown to ACGR 3 2% 155 <1% 
Donor age 
    
≤10 years 1 <1% 143 <1% 
11 to 20 years 4 3% 836 4% 
21 to 60 years 45 30% 7687 39% 
61 to 80 years 84 56% 9439 47% 
>80 years 13 9% 1462 7% 
Unknown to ACGR 4 3% 385 2% 
Main indication for graft 
    
Keratoconus  43 28% 6149 31% 
Pseudophakic bullous keratopathy 39 26% 3850 19% 
Previous failed graft 22 15% 3563 18% 
Aphakic bullous keratopathy 12 8% 928 5% 
Fuchs' dystrophy 9 6% 1243 6% 
Scars 6 4% 1282 6% 
Perforation 6 4% 465 2% 
Interstitial keratitis/abscess 3 2% 232 1% 
Peters' anomaly 2 1% 30 <1% 
Miscellaneous 9 6% 2210 11% 
 
Total corneas 
 
151 
 
 
100% 
 
19952 100% 
 
A total of 17 primary non-function grafts were recorded in the past 5 years. 
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2.9 DONOR CORNEAL ENDOTHELIAL CELL 
COUNT 
 
In recent years, the Registry has been collecting information on donor corneal endothelial 
cell counts as depicted in Figure 2.13. Due to the short time period over which these data 
have been collected, all analyses are calculated in months post graft (Log Rank 
Statistic=0.570; df=1; p=0.450). Donor corneal endothelial cell count, as stratified, exerted 
no significant influence on penetrating graft survival. 
 
Figure 2.13 Donor corneal endothelial cell count (penetrating grafts only) 
 
 
 
Number at Risk 
 
Identity Initially 12 months 24 months 36 months 48 months 
1000 to 2999 cells/mm2 362 298 146 23 0 
3000 to 4999 cells/mm2 349 287 120 14 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 2 3 
1000 to 2999 cells/mm2 362 .92 .87 .70 
3000 to 4999 cells/mm2 349 .93 .88 .77 
 
*Range chosen as only 42 donors available with endothelial cell count below 2400 cells/mm2, 
however, when compared, stratification had no effect on graft survival. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
DONOR ENDOTHELIAL CELL COUNT 
1000 to 2999 cells/mm2 :   92% at 1 year 
 Mean Survival 39.53 months  87% at 2 years 
 (SE=0.98; 95% CI: 37.60, 41.45)  70% at 3 years 
 Median Survival approx 47 months    
3000 to 4999 cells/mm2 :   93% at 1 year 
 Mean Survival 39.32 months  88% at 2 years 
 (SE=0.86; 95% CI: 37.64, 41.00)  77% at 3 years 
 Median Survival approx 45 months    
  
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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2.10 SUMMARY OF DONOR AND  
EYE-BANKING INFORMATION 
 
 The most common causes of donor death were related to diseases of the 
cardiac/circulatory system, followed by malignancy and strokes and other 
haemorrhages. No influence of cause of donor death on penetrating graft 
survival was observed, other than that corneas collected from victims of 
traumatic or accidental death appeared to show improved survival. 
However, such corneas were preferentially used for recipients with 
keratoconus.  
 Corneas used for transplantation were collected from men and women in 
the ratio of approximately 1.8:1. 
 Approximately 69% of corneas were retrieved from donors aged 51-80 
years at the time of death. Donor age exerted no influence on survival of 
grafts performed for keratoconus, but for all other indications for penetrating 
keratoplasty, better survival was achieved with corneas from younger 
donors, at least in univariate analysis. However, the effect disappears in 
multivariate analysis (see Chapter 9). 
 Median death-to-enucleation time for penetrating grafts was 7 hours. 
Median death-to-graft time was 79 hours. Neither death-to-enucleation nor 
death-to-graft time affected corneal graft survival significantly. 
 Most corneas are currently stored in Optisol in Eye Banks. Corneal storage 
time in Optisol did not affect graft survival. 
 Over 92% of all corneas used for penetrating grafts were retrieved from 
cardiac death donors and 8% from multi-organ donors. The multi-organ 
donor pool had quite different characteristics from the pool from which the 
majority of corneas were drawn. In particular, multi-organ donors tended to 
be younger and were more likely to have died from strokes/haemorrhage or 
from traumatic or accidental death than cardiac death donors. Corneas 
from multi-organ donors exhibited better survival after transplantation than 
did those from cardiac death donors, however, 44% of these cornea were 
used for recipients with keratoconus.  
 Fewer than 1% of corneas used in penetrating grafts failed to function in the 
immediate post-operative period. 
 Grafts performed in the same State from which the cornea originated have 
better graft survival than those performed in a different State. This is 
particularly pronounced in the first 10 years post graft.  
 Donor corneal endothelial cell count has no significant influence on 
penetrating graft survival. 
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3. RECIPIENT AGE AND SEX   
 
 
3.1 RECIPIENT AGE AT GRAFT 
 
 
Recipient age at graft varied from 14 days to 97 years and 5 months with a median age of 
59 years. Figure 3.1 shows the spread of recipient ages, with peaks in the  
21-40 and 61-80 age ranges. 
 
 
Figure 3.1 Age at graft 
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Except where indicated, all Kaplan-Meier plots and associated tables in this chapter 
have been calculated using penetrating grafts only. 
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Figure 3.2 shows graft survival for all penetrating grafts for keratoconus. Age at graft had 
no significant effect on survival in this cohort (Log Rank Statistic=2.267; df=2; p= 0.322). 
 
Figure 3.2 Recipient age (keratoconus only) 
 
 
 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
≤24 years 1478 737 380 214 122 59 28 8 1 
25 - 34 years 1619 754 400 223 143 89 33 10 0 
≥35 years 1775 930 577 337 201 100 35 8 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially  
at risk 1 5 10 15 20 
≤24 years 1478 .96 .94 .89 .85 .45 
25 - 34 years 1619 .98 .96 .89 .73 .44 
≥35 years 1775 .97 .94 .86 .76 .47 
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Figure 3.3 shows graft survival for all penetrating grafts excluding keratoconus. Age at graft 
had no significant effect on graft survival when keratoconus is excluded (Log Rank 
Statistic=6.029; df=4; p=0.197). 
 
Figure 3.3 Recipient age (keratoconus excluded) 
 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
≤49 years 2060 868 454 235 142 73 26 5 n/a 
50 - 59 years 1235 529 273 144 77 30 7 n/a n/a 
60 - 69 years 2102 907 471 224 109 34 5 1 n/a 
70 - 79 years 3548 1316 541 176 62 14 2 1 n/a 
≥80 years 2467 558 156 32 4 1 n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
≤49 years 2060 .81 .62 .51 .36 .15 
50 - 59 years 1235 .64 .46 .29 .10 n/a 
60 - 69 years 2102 .82 .62 .45 .26 .23 
70 - 79 years 3548 .83 .61 .42 .30 .21 
≥80 years 2467 .83 .61 .41 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
RECIPIENT AGE; KERATOCONUS ONLY 
Aged ≤24 years:     96% at 1 year   
  Mean Survival 19.13 years   94% at 5 years 
 (SE=0.53; 95% CI: 18.08, 20.17)  89% at 10 years 
 Median Survival 20 years   85% at 15 years 
       46% at 20 years 
Aged 25 to 34 years:     98% at 1 year 
 Mean Survival 17.82 years   96% at 5 years 
 (SE=0.41; 95% CI: 17.00, 18.63)  89% at 10 years 
 Median Survival 19 years   73% at 15 years 
       44% at 20 years 
Aged ≥35 years:     97% at 1 year 
 Mean Survival 17.11 years   94% at 5 years 
 (SE=0.29; 95% CI: 16.53, 17.68)   86% at 10 years 
 Median Survival 20 years   76% at 15 years 
       47% at 20 years 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
RECIPIENT AGE; EXCLUDING KERATOCONUS 
Aged ≤49 years:     81% at 1 year 
 Mean Survival 10.82 years   62% at 5 years 
 (SE=0.30; 95% CI: 10.24, 11.41)  51% at 10 years 
 Median Survival 11 years   36% at 15 years 
       15% at 20 years 
Aged 50 - 59 years:     83% at 1 year 
 Mean Survival 9.80 years   64% at 5 years 
 (SE=0.25; 95% CI: 9.11, 10.49)  46% at 10 years 
 Median Survival 9 years   29% at 15 years 
       10% at 20 years 
Aged 60 - 69 years:     82% at 1 year 
 Mean Survival 10.31 years   62% at 5 years 
 (SE=0.37; 95% CI: 9.59, 11.03)   45% at 10 years 
 Median Survival 9 years   26% at 15 years 
       23% at 20 years 
Aged 70 - 79 years:     83% at 1 year 
 Mean Survival 10.03 years   61% at 5 years 
 (SE=0.41; 95% CI: 9.22, 10.83)   42% at 10 years 
 Median Survival 8 years   30% at 15 years 
       21% at 20 years 
Aged ≥80 years:     83% at 1 year 
 Mean Survival 8.70 years   61% at 5 years 
 (SE=0.35; 95% CI: 8.02, 9.38)   41% at 10 years 
 Median Survival 10 years    
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
p = probability  
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3.1.1 Infant, child and adolescent recipients 
 
3.1.1.1 Paediatric recipients 
 
The Registry database has records of 793 penetrating graft recipients who were under the 
age of 20 years at the time of graft and who had been followed since graft. Figure 3.4 
shows the effect of age group of recipients on corneal graft survival (Log Rank 
Statistic=87.022; df=2; p=0.001). The inset highlights corneal graft survival in the first 24 
months post graft. 
 
Figure 3.4 Infant (aged 0-4 years at graft), child (aged 5-12 years at graft) and 
adolescent (aged 13-19 years at graft) recipients 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
0 – 4 years 69 28 14 8 8 5 2 n/a n/a 
5 – 12 years 74 36 20 11 7 3 2 1 n/a 
13 – 19 years 650 342 158 97 58 30 14 4 1 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
0 – 4 years 69 .65 .50 .39 n/a n/a 
5 – 12 years 74 .86 .73 n/a n/a n/a 
13 – 19 years 650 .94 .90 .84 .79 .56 
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PENETRATING CORNEAL GRAFT SURVIVAL 
INFANT, CHILD AND ADOLESCENT RECIPIENTS 
Aged 0 - 4 years:     65% at 1 year 
 Mean Survival 8.30 years   50% at 5 years 
 (SE=1.20; 95% CI: 5.95, 10.65)  39% at 10 years 
 Median Survival 5 years   29% at 15 years 
Aged 5 - 12 years:      86% at 1 year 
 Mean Survival 15.99 years   73% at 5 years 
 (SE=1.33; 95% CI: 13.38, 18.61)   
 Median Survival approx. 22 years    
Aged 13 - 19 years:     94% at 1 year 
 Mean Survival 18.82 years   90% at 5 years 
 (SE=0.75; 95% CI: 17.35, 20.30)   84% at 10 years 
 Median Survival 21 years   79% at 15 years 
       56% at 20 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
p = probability  
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Figure 3.5 shows main indications for corneal grafts in recipients under 20 years of age at 
time of graft (Log Rank Statistic=174.190; df=6; p=0.001). 
 
Figure 3.5  Main indication for graft in paediatric recipients (0-19 years) 
 
Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Keratoconus 582 313 149 89 54 29 15 4 1 
Failed previous graft 21 8 2 1 1 1 n/a n/a n/a 
Corneal dystrophies, bullous 
keratopathy, corneal ulcer and 
congenital glaucoma  
44 20 7 5 3 1 n/a n/a n/a 
Scars and opacities 64 36 16 10 6 4 0 n/a n/a 
Corneal deformity  25 10 9 7 5 3 2 n/a n/a 
Peters’ anomaly 36 12 4 2 2 1 n/a n/a n/a 
Other 21 7 5 2 2 0 n/a n/a n/a 
 
Graft survival (at years post-graft) 
Identity 
No. 
initially  
at risk 1 5 10 15 20 
Keratoconus 582 .97 .95 .89 .88 .60 
Failed previous graft 21 .52 .24 n/a n/a n/a 
Corneal dystrophies, bullous 
keratopathy, corneal ulcer and 
congenital glaucoma 
44 .76 .47 n/a n/a n/a 
Scars and opacities 64 .89 .75 .65 .49 n/a 
Corneal deformity  25 .63 .57 n/a n/a n/a 
Peters’ anomaly 36 .62 .46 .31 n/a n/a 
Other 21 .71 .60 .36 n/a n/a 
Note: Corneal dystrophies, bullous keratopathy, corneal ulcer and congenital glaucoma have been combined in these 
analyses due to small numbers in each category. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
INDICATION FOR GRAFT - PAEDIATRIC RECIPIENTS 
Other:      71% at 1 year 
 Mean Survival 7.17 years   60% at 5 years 
 (SE=1.60; 95% CI: 4.03, 10.30)  36% at 10 years 
 Median Survival 6 years     
Keratoconus:     97% at 1 year 
 Mean Survival 19.92 years   95% at 5 years 
 (SE=0.77; 95% CI: 18.41, 21.43)  89% at 10 years 
 Median Survival 21 years   88% at 15 years 
       60% at 20 years 
Failed previous graft:     52% at 1 year 
 Mean Survival 4.28 years   24% at 5 years 
 (SE=1.30; 95% CI: 1.73, 6.83)    
 Median Survival 2 years     
        
Corneal dystrophies, bullous keratopathy,  
corneal ulcer and congenital glaucoma:  92% at 1 year 
 Mean Survival 11.38 years    
 (SE=2.00; 95% CI: 7.47, 15.29)    
 Median Survival 5 years    
        
Scars and opacities:     89% at 1 year 
 Mean Survival 12.06 years   75% at 5 years 
 (SE=1.10; 95% CI: 9.90, 14.23)  65% at 10 years 
 Median Survival 16 years   49% at 15 years 
        
Corneal deformity:      63% at 1 year 
 Mean Survival 11.18 years   57% at 5 years 
 (SE=1.90; 95% CI: 7.45, 14.91)    
 Median Survival approx. 19 years    
        
Peters’ anomaly:      62% at 1 year  
 Mean Survival 6.94 years   46% at 5 years 
 (SE=1.54; 95% CI: 3.92, 9.97)  31% at 10 years 
 Median Survival 6 years    
 
 
KEY: n/a  =  not applicable  
 SE = standard error 
 Cl = confidence interval  
 df = degrees of freedom 
p = probability  
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3.1.1.2 Congenital abnormalities 
 
One hundred and four first ipsilateral grafts were performed for congenital abnormalities, 
including Peters’ anomaly (32), congenital glaucoma (29), aniridia (15), congenital cataract 
(13), congenital opacities (7), anterior segment anomalies (3), congenital endothelial 
dystrophy (1), anophthalmos (1) and unspecified anomaly (3). 
 
Figure 3.6 shows the effect of Peters' anomaly, congenital glaucoma or other congenital 
abnormality as the indication for graft (Log Rank Statistic=0.761; df=2; p=0.603). Trial time 
is plotted at monthly intervals. Corneal grafts for these conditions were performed at any 
age, not only during childhood. 
 
Figure 3.6 Peters' anomaly or other congenital abnormalities 
(overall first grafts only) 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Peters’ anomaly  32 14 4 2 1 n/a n/a n/a n/a 
Other congenital 
abnormality 43 19 13 9 8 4 2 n/a n/a 
Congenital 
glaucoma 29 9 5 3 1 1 n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 3 8 12 20 
Peters’ anomaly  32 .78 .61 .23 n/a n/a 
Other congenital abnormality 43 .76 .65 .56 .49 n/a 
Congenital glaucoma 29 .75 .61 .20 n/a n/a 
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FIRST OVERALL CORNEAL GRAFT SURVIVAL 
CONGENITAL ABNORMALITIES 
Peters’ anomaly:     78% at 1 year 
 Mean Survival 6.49 years   61% at 3 years 
 (SE=1.38; 95% CI: 3.77, 9.20)  23% at 8 years 
 Median Survival 7 years  
Other congenital abnormality:    76% at 1 year 
 Mean Survival 10.65 years   65% at 3 years 
 (SE=1.47; 95% CI: 7.76, 13.53)  56% at 8 years 
 Median Survival 12 years   49% at 12 years 
Congenital glaucoma:     75% at 1 year 
 Mean Survival 8.61 years   61% at 3 years 
 (SE=1.51; 95% CI: 3.85, 9.77)  20% at 8 years 
 Median Survival 8 years    
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
p = probability  
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3.1.1.3 Visual Acuity in Paediatric Recipients 
 
 
Figure 3.7 Best corrected Snellen acuity in grafted eye of paediatric recipients at 
most recent follow-up, stratified by age group 
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Figure 3.8 Best-corrected Snellen acuity in grafted eye at most recent follow-up, 
stratified by indication for graft 
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By plotting Snellen visual acuity in the operated eye against the pre-graft Snellen acuity in 
the contralateral eye Figure 3.9 compares the overall vision in paediatric patients pre-graft 
and post-graft.  
 
 
 
Figure 3.9 Pre-graft and post-graft best-corrected Snellen acuity in operated and 
contralateral eyes in paediatric patients 
 
 
 
 
 
Pre-graft, 41% of patients in the cohort possessed a visual acuity of 6/15 or worse in both 
eyes. At most recent follow-up overall vision in the paediatric cohort had improved so that 
this figure reduced to 12%. Pre-graft, 21% had a Snellen acuity of 6/36 or better in both 
eyes, increasing to 78% at the time of the last follow-up. 
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3.1.2 Older recipients 
 
Figure 3.10 compares graft survival of those recipients under 60 years of age at the time of 
graft with recipients over 60 years of age at time of graft (Log Rank Statistic=544.679; df=1; 
p<0.001).  
 
Figure 3.10 Older recipients compared to younger recipients 
 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
0 to 59 years 7969 3730 2035 1126 674 348 128 32 1 
≥60 years 8315 2869 1217 459 186 52 8 4 0 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
0 to 59 years 7969 .91 .82 .72 .58 .31 
≥60 years 8315 .83 .62 .45 .29 .21 
 
Older recipients had a significantly poorer survival rate than younger recipients. This is 
most likely due to a large proportion (58%) of younger recipients being grafted for 
keratoconus. 
Australian Corneal Graft Registry Report 2012 73 
RECIPIENT AGE AND SEX 
 
As shown in Figure 3.11, the graft survival rate was not significantly different over the age 
ranges 80-84, 85-89 and ≥ 90 years at graft (Log Rank Statistic=0.531; df=2; p=0.767). 
 
Figure 3.11 Elderly recipients (over 80 years of age at graft) 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
≥80 & <85 years 1544 396 123 25 3 1 n/a n/a n/a 
≥85 & <90 years 729 141 29 6 0 n/a n/a n/a n/a 
≥90 years 208 24 5 2 n/a n/a n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
≥80 & <85 years 1544 .83 .61 .40 n/a n/a 
≥85 & <90 years 729 .84 .59 n/a n/a n/a 
≥90 years 208 .84 .53 .27 n/a n/a 
 
Of the 208 recipients over 90 years of age, 166 received a first graft and 42 were regrafted. 
A total of 35 grafts (17%) in the 90 years and over age group had failed. Of the 42 regrafts, 
14 had failed. 
 
The most common indication for graft in the 90 years and over age group was 
pseudophakic bullous keratopathy (51%). The most common cause of graft failure was 
rejection (31%). Of the 208 recipients 90 years of age or over at time of graft, the longest 
recorded survival time was 14 years, with the patient having since died. Of the 173 
surviving grafts in this group, 34 patients were still alive at the last follow-up. Of the 163 
graft recipients recorded as having died, all except 24 died with functioning grafts. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
YOUNGER VERSUS ELDERLY RECIPIENTS 
<60 years of age:     91% at 1 year 
 Mean Survival 14.98 years   82% at 5 years 
 (SE=0.21; 95% CI: 14.57, 15.40)  72% at 10 years 
 Median Survival 17 years   58% at 15 years 
       31% at 20 years 
≥60 years of age:     83% at 1 year 
 Mean Survival 10.26 years   62% at 5 years 
 (SE=0.28; 95% CI: 9.70, 10.81)  45% at 10 years 
 Median Survival 9 years   29% at 15 years 
       21% at 20 years 
 
 
 
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
VERY ELDERLY RECIPIENTS 
≥80 & <85 years of age:    83% at 1 year 
 Mean Survival 8.61 years   61% at 5 years 
 (SE=0.40; 95% CI: 7.82, 9.39)  40% at 10 years 
 Median Survival 10 years  
≥85 & <90 years of age:    84% at 1 year 
 Mean Survival 7.31 years   59% at 5 years 
 (SE=0.33; 95% CI: 6.67, 7.95)    
 Median Survival approx. 11 years   
≥90 years of age:     84% at 1 year 
 Mean Survival 7.56 years   53% at 5 years 
 (SE=1.27; 95% CI: 5.08, 10.04)  27% at 10 years 
 Median Survival 9 years    
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
p = probability  
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3.2 RECIPIENT SEX 
 
Figure 3.12 shows the influence of recipient sex on penetrating corneal graft survival (Log 
Rank Statistic=0.010; df=1; p=0.921). Sex played no significant role in graft survival overall. 
 
Figure 3.12 Recipient sex 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Female 8053 3387 1687 828 446 201 78 22 1 
Male 8238 3213 1565 757 414 199 58 14 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Female 8053 .87 .73 .60 .46 .28 
Male 8238 .87 .73 .60 .47 .22 
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PENETRATING CORNEAL GRAFT SURVIVAL 
RECIPIENT SEX 
Female:      87% at 1 year 
 Mean Survival 12.98 years   73% at 5 years 
 (SE=0.23; 95% CI: 12.54, 13.43)  60% at 10 years 
 Median Survival 14 years   46% at 15 years 
       28% at 20 years 
Male:       87% at 1 year 
 Mean Survival 12.74 years   73% at 5 years 
 (SE=0.21; 95% CI: 12.32, 13.15)  60% at 10 years 
 Median Survival 14 years   47% at 15 years 
       22% at 20 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
p = probability  
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3.3 SUMMARY OF RECIPIENT AGE AND SEX 
AT GRAFT 
 
 The distribution of recipient age at graft was bimodal, with peaks at around 
20-40 years and around 60-80 years. 
 Although recipient age appeared to influence graft survival, it is more likely 
that the indication for graft associated with different age groups affected 
survival. Keratoconus was the main indication for graft in 58% of grafts 
performed in recipients <60 years of age and 73% of recipients <20 years 
of age. 
 Recipient sex had no influence on graft survival.  
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4. RECIPIENT FACTORS   
 
All Kaplan-Meier plots and associated tables in this chapter have been calculated 
using penetrating grafts only. 
 
4.1 PRE-GRAFT VISUAL ACUITY 
Figure 4.1 shows the effect of pre-graft visual acuity on graft outcome. Decreased graft 
survival was related to worse pre-graft visual acuity (Log Rank Statistic =390.593; df=3; 
p<0.001). Unknown pre-graft visual acuity was also related to decreased graft survival. 
 
Figure 4.1 Pre-graft visual acuity, penetrating grafts 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
6/12 or better 556 285 141 78 44 16 n/a n/a n/a 
6/15 – 6/60 4321 1961 963 460 225 94 13 3 0 
CF or worse 7770 2648 1155 459 193 69 10 2 n/a 
Unknown 3644 1700 989 588 398 221 113 31 1 
 
* CF = count fingers at 6 metres 
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Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10     15 20 
6/12 or better 556 .97 .89 .82 .65 n/a 
6/15 – 6/60 4321 .94 .84 .71 .52 .31 
CF or worse 7770 .84 .65 .50 .36 .25 
Unknown 3644 .84 .70 .59 .49 .27 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
PREGRAFT VISUAL ACUITY 
6/12 or better:     97% at 1 year 
 Mean Survival 14.16 years   89% at 5 years 
 (SE=0.37; 95% CI: 13.43, 14.89)  82% at 10 years 
 Median Survival 17 years   65% at 15 years 
6/15 – 6/60:      94% at 1 year 
 Mean Survival 14.63 years   84% at 5 years 
 (SE=0.38; 95% CI: 13.90, 15.37)  71% at 10 years 
 Median Survival 16 years   52% at 15 years 
       31% at 20 years 
CF or worse:     84% at 1 year 
 Mean Survival 11.43 years   65% at 5 years 
 (SE=0.38; 95% CI: 10.69, 12.17)   50% at 10 years 
 Median Survival 10 years   36% at 15 years 
       25% at 20 years 
Unknown:      84% at 1 year 
 Mean Survival 12.91 years   70% at 5 years 
 (SE=0.24; 95% CI: 12.43, 13.39)   59% at 10 years 
 Median Survival 15 years   49% at 15 years 
       27% at 20 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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4.2 PRE-GRAFT MORBIDITIES 
 
4.2.1 Vascularization 
 
The effect of pre-graft vascularization on graft outcome is shown in Figure 4.2. Graft 
survival decreased according to the number of quadrants of the cornea that contained 
vessels at the time of graft (Log Rank Statistic =1036.175; df=4; p<0.001). 
 
Figure 4.2 Pre-graft vascularization, penetrating grafts 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Not vascularized 11168 4871 2488 1266 703 336 123 34 1 
1 quadrant 1158 417 182 60 22 7 n/a n/a n/a 
2 quadrants 1721 614 267 136 71 25 4 n/a n/a 
3 quadrants 844 312 153 67 34 18 5 2 n/a 
4 quadrants 1400 386 162 63 30 14 4 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
Not vascularized 11168 .91 .80 .68 .54 .31 
1 quadrant 1158 .87 .66 .46 .38 n/a 
2 quadrants 1721 .80 .58 .45 .31 n/a 
3 quadrants 844 .77 .57 .41 .30 .12 
4 quadrants 1400 .69 .45 .26 .15 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
PREGRAFT CORNEAL NEOVASCULARIZATION 
Not vascularized:     91% at 1 year 
 Mean Survival 14.51 years   80% at 5 years 
 (SE=0.20; 95% CI: 14.12, 14.90)  68% at 10 years 
 Median Survival 17 years   54% at 15 years 
       31% at 20 years 
1 quadrant vascularized:    87% at 1 year 
 Mean Survival 9.80 years   66% at 5 years 
 (SE=0.38; 95% CI: 9.06, 10.54)  46% at 10 years 
 Median Survival 9 years   38% at 20 years 
2 quadrants vascularized:    80% at 1 year 
 Mean Survival 9.18 years   58% at 5 years 
 (SE=0.30; 95% CI: 8.59, 9.78)   45% at 10 years 
 Median Survival 8 years   31% at 15 years 
3 quadrants vascularized:    77% at 1 year 
 Mean Survival 9.23 years   57% at 5 years 
 (SE=0.48; 95% CI: 8.29, 10.18)   41% at 10 years 
 Median Survival 7 years   30% at 15 years 
       12% at 20 years 
4 quadrants vascularized:    69% at 1 year 
 Mean Survival 6.70 years   45% at 5 years 
 (SE=0.31; 95% CI: 6.09, 7.32)  26% at 10 years 
 Median Survival 4 years   15% at 15 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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4.2.2 Inflammation 
 
Figure 4.3 shows the effect of inflammation on graft outcome of first ipsilateral grafts. A 
history of inflammation was judged to have occurred in any graft where there had been a 
record of steroids being administered during the 2 week period prior to graft, or where the 
grafted eye had undergone previous surgery (Log Rank Statistic=1354.38; df=3; p<0.001). 
 
Figure 4.3 Pre-graft inflammation 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Never inflamed 7100 3483 1891 1035 604 290 105 28 1 
Inflamed in past, not at graft,  3998 1392 585 225 112 50 9 3 n/a 
Not in past, inflamed at graft  372 115 54 19 10 3 1 n/a n/a 
Inflamed at graft and in past 1518 451 197 80 28 17 4 1 n/a 
 
Graft survival (at years post-graft) 
Identity 
No. 
initially 
at risk 1 5 10 15 20 
Never inflamed 7100 .96 .91 .82 .67 .38 
Inflamed in past, not at graft 3998 .86 .64 .46 .36 .19 
Not in past, inflamed at graft 372 .73 .56 .33 .19 n/a 
Inflamed at graft and in past 1518 .75 .50 .37 .30 .13 
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4.2.3 Intraocular pressure (pre-graft or at graft) 
 
The effect of raised intraocular pressure (IOP) on graft survival is shown in Figure 4.4. 
Recipients with raised pressure at time of graft and in the past were compared with 
recipients in whom there had been a history of raised pressure but who had a normal 
pressure at the time of graft, with those with raised pressure at graft but not in the past, and 
with those in whom raised intraocular pressure had never been recorded (Log Rank 
Statistic=842.241; df=3; p<0.001).  
 
Figure 4.4 Intraocular pressure (pre-graft/at time of graft) 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Never raised 12200 5179 2592 1270 693 331 111 30 1 
Raised in past only 2037 675 284 95 41 20 5 2 n/a 
Raised at graft only 49 20 4 1 n/a n/a n/a n/a n/a 
Raised in both past and graft 367 120 56 28 16 3 n/a n/a n/a 
 
Graft survival (at years post-graft) 
Identity 
No. 
initially at 
risk 1 5 10 15 20 
Never raised 12200 .90 .79 .68 .53 .29 
Raised in past only 2037 .76 .45 .28 .19 .10 
Raised at graft only 49 .79 .54 n/a n/a n/a 
Raised in both past and graft 367 .72 .50 .37 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
EFFECT OF INFLAMMATION 
Never inflamed:     96% at 1 year 
 Mean Survival 16.83 years   91% at 5 years 
 (SE=0.25; 95% CI: 16.35, 17.32)  82% at 10 years 
 Median Survival 18 years   67% at 15 years 
       38% at 20 years 
Inflamed in past, not at graft:   86% at 1 year 
 Mean Survival 10.73 years   64% at 5 years 
 (SE=0.32; 95% CI: 10.09, 11.36)   46% at 10 years 
 Median Survival 9 years   36% at 15 years 
       19% at 20 years 
Not in past, inflamed at graft:   73% at 1 year 
 Mean Survival 7.74 years   56% at 5 years 
 (SE=0.61; 95% CI: 6.56, 8.93)   33% at 10 years 
 Median Survival 8 years   19% at 15 years 
Inflamed at graft and in past:   75% at 1 year 
 Mean Survival 8.77 years   50% at 5 years 
 (SE=0.45; 95% CI: 7.88, 9.65)  37% at 10 years 
 Median Survival 6 years   30% at 15 years 
       13% at 20 years 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
HISTORY OF RAISED IOP 
IOP never raised:     90% at 1 year 
 Mean Survival 14.17 years   79% at 5 years 
 (SE=0.20; 95% CI: 13.78, 14.57)  67% at 10 years 
 Median Survival 16 years   53% at 15 years 
       29% at 20 years 
IOP raised in past only:    76% at 1 year 
 Mean Survival 7.50 years   45% at 5 years 
 (SE=0.34; 95% CI: 6.82, 8.17)  28% at 10 years 
 Median Survival 5 years   19% at 15 years 
       10% at 20 years 
IOP raised at graft only:    79% at 1 year 
 Mean Survival 5.23 years   54% at 5 years 
 (SE=0.66; 95% CI: 3.93, 6.52)   
 Median Survival 6 years   
IOP raised in both past and graft:  72% at 1 year 
 Mean Survival 7.68 years   50% at 5 years 
 (SE=0.52; 95% CI: 6.66, 8.70)  38% at 10 years 
 Median Survival 5 years   
 
 
KEY: n/a  =  not applicable   df = degrees of freedom 
 SE = standard error   p = probability 
 Cl = confidence interval 
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4.3 MAIN INDICATION FOR GRAFT 
 
Table 4.1 Main indications for penetrating keratoplasty 
 
 
 
Indication for graft Sub-total Total % 
Keratoconus   6249 31% 
Uncomplicated  5959   
With hydrops  271   
Keratoglobus  19   
Bullous keratopathy   4338 22% 
Pseudophakic  3402   
Aphakic  646   
Phakic pre-graft  290   
Failed previous graft   4227 21% 
Corneal dystrophy   2156 11% 
Fuchs' dystrophy 
 
1902 
  
Granular dystrophy  57   
Lattice dystrophy  40   
Macular dystrophy  38   
Polymorphous dystrophy  31   
Crystalline dystrophy  15   
Juvenile dystrophy  9   
Anterior dystrophy  2   
Unspecified dystrophy  62   
Herpetic eye disease   811 4% 
Scar resulting from herpetic eye disease  465   
Herpetic perforation 
 
162 
  
Active HSV 
 
116 
  
HZO  13   
Scarring - result of HZO infection  55   
Corneal scars and opacities  
      (no history of herpetic disease) 
  454 2% 
Unspecified scars and opacities1  376   
Trachomatous scar 
 
42 
  
Scarring - result of marginal, central or unspecified ulcer  29   
Possible current trachoma  7   
Corneal ulcers (non HSV)   403 2% 
Perforated  332   
Unperforated 
 
71 
  
Trauma   336 2% 
Unspecified trauma  273   
Burns   53   
Irradiation damage  8   
Trauma (perforated)  2   
Non-herpetic infections   295 1% 
Corneal abscess  140   
Mycotic   42   
Pseudomonas  40   
Acanthamoeba keratitis  32   
Endophthalmitis  14   
Syphilitic interstitial keratitis  6   
Other bacterial  5   
Other non-herpetic viral  5   
Scleral abscess  1 
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Indication for graft Sub-total Total % 
Interstitial keratitis   169 <1% 
Corneal degenerations 3   148 <1% 
Congenital abnormalities   79 <1% 
Peters' anomaly  34   
Other 2  45   
Descemetocoele   75 <1% 
ICE syndrome   67 <1% 
Metabolic deposits 4   48 <1% 
Miscellaneous 5   60 <1% 
Unknown to ACGR   37 <1% 
TOTAL   19952 100% 
1 With: cataract (54); aphakia (25); central opacity (18); neovascularization (9); pterygium (8); keratitis (7); adherent 
leukoma (6); astigmatism (5); irregular astigmatism (5); keratoconjunctivitis (3); iridocyclitis (2); pseudopterygium (2); 
acquired keratodermia (1); benign conjunctival neoplasm (1); diplopia (1); glaucoma (1); lacrimal gland disorder (1); 
metabolism disorder (1); monoclonal paraproteinemia (1) nystagmus (1); pannus (1); retinal detachment (1); 
retrolental fibroplasia (1); rheumatoid arthritis (1); rosacea (1); scleral degenerative disorder (1); stenosis (1); 
unspecified (234).  
2 Congenital glaucoma (11); aniridia (7); corneal opacities (6); anomalies of anterior segment (3); congenital rubella 
(2); congenital syphilis (2); ichthyosis (2); microcornea (2); Crouzon’s syndrome (1); Rothmund syndrome (1); 
Russell Silver syndrome (1); unspecified (7). 
3 Corneal ectasia (92); Salzmann's nodular dystrophy (10); unspecified corneal membrane change (6); rupture in 
Descemet's membrane (5); macular degeneration (2); myopic degeneration (2); Terrien's marginal degeneration (2); 
discrete colliquative keratopathy (1); unspecified (28). 
4 Band shaped keratopathy (18); deposits associated with metabolic disorders (17); stromal pigmentations (6); 
calcareous degeneration (4); unspecified (3).  
5 Glaucoma (8); patient’s other cornea used for autologous graft (7); neovascularization (5); suppurative keratitis (5); 
astigmatism (4); corneal staphyloma (4); squamous cell carcinoma (4); unspecified keratitis (4); retinal detachment, 
defect or haemorrhage (3); benign neoplasm (2); keratoconjunctivitis (2) porphyria (2); superficial keratitis (2); amino 
acid transport disturbance (1); hypopyon (1); monoclonal paraproteinemia (1); pemphigus (1); phthisis (1); scleral 
disorder (1); synechiae (1); vitamin A deficiency (1). 
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Figure 4.5 shows the survival curves for the main indications for graft as shown in Table 
4.1. (Log Rank Statistic= 1930.605; df=12; p<0.001). There was significant variation across 
main indicators, with grafts performed for keratoconus faring best and those for failed 
previous grafts, bullous keratopathy and corneal ulcers faring worst. 
 
Figure 4.5 Main indications for penetrating graft 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Corneal scars & opacities 314 118 68 22 13 2 n/a n/a n/a 
Corneal ulcers (not HSV) 349 71 32 15 6 1 n/a n/a n/a 
Bullous keratopathy 3814 1236 475 168 62 20 4 1 n/a 
Corneal dystrophies 1806 872 429 188 96 35 7 2 n/a 
Non-herpetic infections 221 60 32 12 7 3 n/a n/a n/a 
Herpetic eye disease 692 287 151 87 50 26 4 2 n/a 
Trauma 266 103 54 21 9 3 n/a n/a n/a 
Keratoconus  4930 2444 1367 781 471 251 98 27 1 
Interstitial keratitis 151 81 41 19 11 n/a n/a n/a n/a 
Corneal degeneration 117 33 16 7 3 1 n/a n/a n/a 
Congenital abnormalities 67 25 15 10 10 5 3 n/a n/a 
Failed previous graft 3277 1152 522 225 105 40 17 4 n/a 
Other 287 112 56 30 17 11 3 n/a n/a 
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Graft survival (at years post-graft) 
Identity 
No. 
initially  
at risk 1 5 10 15 20 
Corneal scars & opacities 314 .91 .78 .61 .34 n/a 
Corneal ulcers (not HSV) 349 .68 .48 .32 .21 n/a 
Bullous keratopathy 3814 .83 .56 .37 .21 .06 
Corneal dystrophies 1806 .94 .82 .66 .43 .19 
Non-herpetic infections 221 .68 .54 .43 .32 n/a 
Herpetic eye disease 692 .85 .72 .60 .49 .28 
Trauma 266 .84 .70 .48 n/a n/a 
Keratoconus  4930 .97 .95 .89 .77 .46 
Interstitial keratitis 151 .92 .85 .74 n/a n/a 
Corneal degeneration 117 .82 .77 .50 n/a n/a 
Congenital abnormalities 67 .80 .64 .55 .50 n/a 
Failed previous graft 3277 .76 .54 .36 .21 .10 
Other 287 .83 .66 .52 .45 n/a 
 
 
It should be noted that: 
 the curve for bullous keratopathy includes pseudophakic, aphakic and unspecified 
bullous keratopathy. 
 the curve for corneal dystrophy includes Fuchs' dystrophy, granular, lattice, 
polymorphous, macular, anterior, juvenile, crystalline and unspecified dystrophies.  
 the curve for herpetic eye disease includes active and non-active HSV and HZO. 
 non-herpetic infections include bacterial abscess, mycotic infection, 
endophthalmitis, Acanthamoeba keratitis and Pseudomonas infection. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
INDICATION FOR GRAFT 
Corneal scars & opacities:    91% at 1 year 
 Mean Survival 10.93 years   78% at 5 years 
 (SE=0.68; 95% CI: 9.60, 12.26)   61% at 10 years 
 Median Survival 12 years    34% at 15 years 
Corneal ulcers (not HSV):    68% at 1 year 
 Mean Survival 7.01 years    48% at 5 years 
 (SE=0.58; 95% CI: 5.86, 8.15)   32% at 10 years 
 Median Survival 5 years    21% at 15 years 
Bullous keratopathy:      83% at 1 year 
 Mean Survival 8.557 years   56% at 5 years 
 (SE=0.28; 95% CI: 8.01, 9.09)   37% at 10 years 
 Median Survival 6 years    21% at 15 years 
         6% at 20 years 
Corneal dystrophies:     94% at 1 year 
 Mean Survival 13.34 years   82% at 5 years 
 (SE=0.46; 95% CI: 12.44, 14.24)   66% at 10 years 
 Median Survival 14 years    43% at 15 years 
       19% at 20 years 
Non-herpetic infections:     68% at 1 year 
 Mean Survival 7.52 years    54% at 5 years 
 (SE=0.61; 95% CI: 6.33, 8.70)   43% at 10 years 
 Median Survival 7 years    32% at 15 years 
Herpetic eye disease:      85% at 1 year 
 Mean Survival 12.59 years   72% at 5 years 
 (SE=0.63; 95% CI: 11.35, 13.83)   60% at 10 years 
 Median Survival 13 years    49% at 15 years 
       28% at 20 years 
Trauma:      84% at 1 year 
 Mean Survival 10.50 years   70% at 5 years 
 (SE=0.681; 95% CI: 9.16, 11.85)   48% at 10 years 
 Median Survival 10 years     
Keratoconus:       97% at 1 year 
 Mean Survival 18.18 years   95% at 5 years 
 (SE=0.28; 95% CI: 17.63, 18.73)   89% at 10 years 
 Median Survival 20 years    77% at 15 years 
       46% at 20 years 
Interstitial keratitis:      92% at 1 year  
 Mean Survival 11.11 years   85% at 5 years 
 (SE=0.52; 95% CI: 10.10, 12.13)   72% at 10 years 
 Median Survival 13 years    
Corneal degeneration:      82% at 1 year 
 Mean Survival 11.70 years   77% at 5 years 
 (SE=1.39; 95% CI: 8.98, 14.41)   50% at 10 years 
 Median Survival 9 years   
Congenital abnormalities:    80% at 1 year 
 Mean Survival 10.86 years   64% at 5 years 
 (SE=1.27; 95% CI: 8.37, 13.36)   55% at 10 years 
 Median Survival 12 years    50% at 15 years 
Failed previous graft:      76% at 1 year 
 Mean Survival 8.47 years    54% at 5 years 
 (SE=0.26; 95% CI: 7.65, 8.98)   36% at 10 years 
 Median Survival 6 years    21% at 15 years 
       10% at 20 years 
Other:        83% at 1 year 
 Mean Survival 11.34 years   66% at 5 years 
 (SE=0.75; 95% CI: 9.88, 12.81)   52% at 10 years 
 Median Survival 13 years    45% at 15 years 
 
 
KEY: n/a  =   not applicable    df =   degrees of freedom 
 SE =   standard error    p =   probability 
 Cl =   confidence interval 
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4.4 EFFECT OF SPECIFIC INDICATION FOR 
GRAFT ON GRAFT SURVIVAL 
 
4.4.1 Keratoconus 
 
Figure 4.6 compares graft survival in recipients with first penetrating grafts for keratoconus 
with all other graft recipients (Log Rank Statistic=990.823; df=1; p<0.001). 
 
Figure 4.6 First penetrating grafts for keratoconus and all other 1st penetrating 
grafts 
 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
All other 1st grafts  8120 3018 1369 586 289 112 23 6 n/a 
1st graft for keratoconus  4868 2418 1355 773 465 248 96 26 1 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
All other 1st grafts  8120 .85 .66 .50 .35 .16 
1st graft for keratoconus  4868 .97 .95 .89 .77 .45 
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PENETRATING CORNEAL GRAFT SURVIVAL 
1ST GRAFT FOR KERATOCONUS 
All other 1st grafts:      85% at 1 year 
 Mean Survival 10.94 years   66% at 5 years 
 (SE=0.21; 95% CI: 10.52, 11.35)  50% at 10 years 
 Median Survival 11 years   35% at 15 years 
       16% at 20 years 
1st Graft for Keratoconus:    97% at 1 year 
 Mean Survival 18.22 years   95% at 5 years 
 (SE=0.29; 95% CI: 17.66, 18.78)  89% at 10 years 
 Median Survival 19 years   77% at 15 years 
       45% at 20 years 
 
 
KEY: n/a  =  not applicable   df = degrees of freedom 
 SE = standard error   p = probability 
 Cl = confidence interval 
 
Figure 4.7 compares graft survival in recipients with first penetrating grafts for keratoconus 
with all other graft recipients in whom grafts had survived greater than 14 years (Log Rank 
Statistic=1.103; df=1; p=0.294). 
 
Figure 4.7 First penetrating grafts for keratoconus and all other penetrating grafts 
that have survived 15 years or more from time of graft 
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Figure 4.8 compares the survival of first penetrating corneal grafts for keratoconus by age 
at graft (Log Rank Statistic=19.499; df=3; p<0.001). 
 
 
Figure 4.8   1st grafts for keratoconus by age at graft 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
0 to 19 years 566 309 145 88 53 28 14 4 1 
20 to 39 years 3059 1442 797 437 269 149 57 17 n/a 
40 to 59 years 1045 579 364 221 132 68 24 5 n/a 
≥ 60 years 198 88 49 27 11 3 1 n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
 0 to 19 years 566 .97 .95 .93 .88 .58 
 20 to 39 years 3059 .97 .95 .90 .77 .41 
 40 to 59 years 1045 .97 .95 .87 .75 .53 
 ≥ 60 years 198 .93 .87 .73 .68 n/a 
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Figure 4.9 compares the survival of first penetrating corneal grafts for keratoconus with 
survival of second, third or subsequent regrafts in the same eye                                         
(Log Rank Statistic=359.088; df=2; p<0.001). 
. 
 
Figure 4.9   1st graft  for keratoconus vs 2nd and subsequent grafts  
 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
1st graft for keratoconus 4949 2442 1361 776 466 248 96 26 1 
2nd graft in same eye 659 304 158 64 28 11 8 2 n/a 
3rd or subsequent graft in 
same eye 
185 69 33 16 11 6 3 n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
1st graft for keratoconus 4949 .97 .95 .89 .77 .45 
2nd graft in same eye 659 .91 .78 .58 .33 .21 
3rd or subsequent graft in same 
eye 
185 .77 .61 .45 .28 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
AGE AT GRAFT - KERATOCONUS 
0 to 19 years:      97% at 1 year 
 Mean Survival 19.96 years   95% at 5 years 
 (SE=0.79; 95% CI: 18.40, 21.51)  93% at 10 years 
 Median Survival 21 years   88% at 15 years 
       58% at 20 years 
20 to 39 years:     97% at 1 year 
 Mean Survival 17.79 years   95% at 5 years 
 (SE=0.31; 95% CI: 17.19, 18.39)  90% at 10 years 
 Median Survival 19 years   77% at 15 years 
       41% at 20 years 
40 to 59 years:     97% at 1 year 
 Mean Survival 17.39 years   95% at 5 years 
 (SE=0.36; 95% CI: 16.70, 18.09)  87% at 10 years 
 Median Survival approx. 21 years  75% at 15 years 
       53% at 20 years 
≥60 years:      93% at 1 year 
 Mean Survival 14.26 years   87% at 5 years 
 (SE=0.78; 95% CI: 12.73, 15.79)  73% at 10 years 
 Median Survival 18 years   68% at 15 years 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
1st, 2nd OR SUBSEQUENT GRAFTS - KERATOCONUS 
1st graft for Keratoconus:     97% at 1 year 
 Mean Survival 18.17 years   95% at 5 years 
 (SE=0.29; 95% CI: 17.61, 18.76)  89% at 10 years 
 Median Survival 19 years   77% at 15 years 
       45% at 20 years 
2nd graft for Keratoconus:    91% at 1 year 
 Mean Survival 12.18 years   78% at 5 years 
 (SE=0.66; 95% CI: 10.90, 13.47)  58% at 10 years 
 Median Survival 12 years   33% at 15 years 
       21% at 20 years 
3rd or subsequent graft for Keratoconus: 77% at 1 year 
 Mean Survival 9.26 years   61% at 5 years 
 (SE=0.84; 95% CI: 7.62, 10.91)  45% at 10 years 
 Median Survival 9 years   28% at 15 years 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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Figure 4.10 looks at eyes regrafted for keratoconus in which the previous graft had survived 
for <10 years compared with regrafts where the previous graft had survived for ≥ 10 years 
(Log Rank Statistic=8.327; df=1; p=0.004). 
 
 
Figure 4.10 Regrafts for keratoconus – previous graft surviving <10 or ≥ 10 years. 
 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Previous graft survived 
<10 years 
166 69 38 15 9 5 4 1 n/a 
Previous graft survived 
≥10 years 
54 20 6 1 n/a n/a n/a n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
Previous graft survived <10 
years 
166 .83 .68 .54 .39 n/a 
Previous graft survived ≥10 
years 
54 .98 .90 n/a n/a n/a 
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Figure 4.11 compares graft survival for 1st grafts for keratoconus with and without rejection 
episodes (Log Rank Statistic=26.148; df=1; p<0.001). 
 
 
Figure 4.11 Rejection episodes in 1st grafts for keratoconus 
 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
1st graft for keratoconus with 
no rejection episodes 4216 2023 1114 637 388 201 75 19 1 
1st graft for keratoconus with 
one or more rejection 
episodes  
652 395 241 136 77 47 21 7 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
1st graft for keratoconus with no 
rejection episodes 
4216 .98 .95 .90 .79 .42 
1st graft for keratoconus with 
one or more rejection episodes  
652 .93 .86 .82 .66 .51 
 
Australian Corneal Graft Registry Report 2012 97 
RECIPIENT FACTORS 
 
 
Figure 4.12 looks at the influence of occurrence of episodes of rejection in regrafted eyes 
originally grafted for keratoconus (Log Rank Statistic=14.142; df=1; p<0.001). 
 
 
Figure 4.12 Rejection episodes in keratoconus regrafts 
 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
No rejection episode 175 70 34 13 8 5 4 1 n/a 
1 or more rejection 
episodes 
45 19 10 3 1 n/a n/a n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
No rejection episode 175 .91 .78 .70 .50 n/a 
1 or more rejection episode 45 .71 .52 .22 n/a n/a 
 
98  Australian Corneal Graft Registry Report 2012 
RECIPIENT FACTORS 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
PREVIOUS GRAFT SURVIVAL - KERATOCONUS 
<10 years:       83% at 1 year 
 Mean Survival 12.27 years   68% at 5 years 
 (SE=1.22; 95% CI: 9.88, 14.66)  54% at 10 years 
 Median Survival 11 years   39% at 15 years 
≥10 years:      98% at 1 year 
 Mean Survival 8.34 years   90% at 5 years 
 (SE=0.37; 95% CI: 7.61, 9.07)   
 Median Survival approx. 10 years   
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
REJECTION EPISODES IN 1ST GRAFTS FOR KERATOCONUS 
1st Graft for Keratoconus with  
no rejection episodes:    98% at 1 year 
 Mean Survival 18.33 years   95% at 5 years 
 (SE=0.31; 95% CI: 17.72, 18.94)  90% at 10 years 
 Median Survival 19 years   79% at 15 years 
       42% at 20 years 
1st Graft for Keratoconus with  
one or more rejection episodes:   93% at 1 year 
 Mean Survival 16.17 years   86% at 5 years 
 (SE=0.45; 95% CI: 15.29, 17.06)  82% at 10 years 
 Median Survival 21 years   66% at 15 years 
       51% at 20 years 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
EFFECT OF REJECTION ON REGRAFTS - KERATOCONUS 
No rejection episode:     91% at 1 year 
 Mean Survival 14.68 years   78% at 5 years 
 (SE=1.36; 95% CI: 12.01, 17.36)  70% at 10 years 
 Median Survival 15 years   50% at 15 years 
One or more rejection episodes:   71% at 1 year 
 Mean Survival 6.58 years   52% at 5 years 
 (SE=1.07; 95% CI: 4.49, 8.67)  22% at 10 years 
 Median Survival 8 years   
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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The effects of uncomplicated keratoconus, keratoconus with acute hydrops, keratoconus 
with Down syndrome/intellectual disability, or keratoglobus as reasons for graft are shown 
in Figure 4.13. (Log Rank Statistic=111.899; df=3; p<0.001). 
 
Figure 4.13 Keratoconus, keratoconus with hydrops, keratoconus with Down 
syndrome/intellectual disability, or keratoglobus 
 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Keratoconus  5458 2670 1476 810 482 256 107 28 1 
Keratoconus with hydrops 170 66 30 19 10 5 n/a n/a n/a 
Keratoglobus 26 15 10 8 5 2 2 1 n/a 
Keratoconus with Down 
syndrome 
91 50 31 17 5 2 n/a n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
Keratoconus  5458 .96 .93 .86 .73 .42 
Keratoconus with hydrops 170 .92 .79 .64 .45 n/a 
Keratoglobus 26 .76 .57 .50 .30 n/a 
Keratoconus with Down 
syndrome 
91 .77 .72 .53 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
KERATOCONUS, KERATOCONUS WITH HYDROPS, WITH DOWN 
SYNDROME/INTELLECTUAL DISABILITY OR KERATOGLOBUS 
Keratoconus:      96% at 1 year 
 Mean Survival 17.63 years   93% at 5 years 
 (SE=0.27; 95% CI: 17.10, 18.16)  86% at 10 years 
 Median Survival 19 years   73% at 15 years 
       42% at 20 years 
Keratoconus with hydrops:   91% at 1 year 
 Mean Survival 12.07 years   79% at 5 years 
 (SE=0.79; 95% CI: 10.51, 13.62)  64% at 10 years 
 Median Survival 15 years   45% at 15 years 
Keratoglobus:     76% at 1 year 
 Mean Survival 10.56 years   57% at 5 years 
 (SE=2.07; 95% CI: 6.5, 14.63)  50% at 10 years 
 Median Survival 9 years   30% at 20 years 
Keratoconus with Down syndrome 
or intellectual disability:    77% at 1 year 
 Mean Survival 10.01 years   72% at 5 years 
 (SE=0.94; 95% CI: 8.16, 11.86)  53% at 10 years 
 Median Survival 11 years   
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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4.4.2 Bullous keratopathy 
 
Figure 4.14 shows the effect of transplantation for bullous keratopathy on the survival of a 
first ipsilateral graft (Log Rank Statistic=698.70; df=1; p<0.001).  
 
Figure 4.14 Bullous keratopathy 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Balance of database for 
first grafts 8628 3962 2147 1153 676 331 114 31 1 
Bullous keratopathy 4328 1464 572 203 78 28 5 1 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 
for first grafts 
8628 .92 .86 .76 .63 .37 
Bullous keratopathy 4328 .84 .59 .39 .25 .06 
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Figure 4.15 compares graft survival for bullous keratopathy in aphakes (ABK) and 
pseudophakes (PBK). Pseudophakes are analysed by era (Log Rank Statistic=14.003; 
df=5; p=0.016). The significant difference relates to the better survival of grafts performed 
for PBK in the latest era, 2005-2010, compared to those in the earlier eras (85-89, 90-94 
and 95-99) and those performed for ABK.  
 
Figure 4.15 Types of bullous keratopathy stratified by era 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
ABK 536 176 73 32 10 4 2 n/a n/a 
PBK 1985-1989 338 151 65 25 15 6 2 1 n/a 
PBK 1990-1994 1025 342 159 68 33 14 n/a n/a n/a 
PBK 1995-1999 814 302 132 47 6 n/a n/a n/a n/a 
PBK 2000-2004 789 271 75 1 n/a n/a n/a n/a n/a 
PBK 2005-2010 384 66 n/a n/a n/a n/a n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
ABK 536 .80 .57 .40 .23 n/a 
PBK 1985-1989 338 .80 .53 .39 .25 .06 
PBK 1990-1994 1025 .82 .60 .43 .29 n/a 
PBK 1995-1999 814 .83 .62 .40 n/a n/a 
PBK 2000-2004 789 .88 .57 n/a n/a n/a 
PBK 2005-2010 384 .90 n/a n/a n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
BULLOUS KERATOPATHY 
Balance of database for first grafts:  92% at 1 year 
 Mean Survival 15.87 years   86% at 5 years 
 (SE=0.22; 95% CI: 15.43, 16.31)  76% at 10 years 
 Median Survival 18 years   63% at 15 years 
       37% at 20 years 
Bullous keratopathy:     84% at 1 year 
 Mean Survival 9.06 years   59% at 5 years 
 (SE=0.26; 95% CI: 8.54, 9.58)  39% at 10 years 
 Median Survival 8 years   25% at 15 years 
         6% at 20 years 
  
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
APHAKIC AND PSEUDOPHAKIC BULLOUS KERATOPATHY 
Aphakic bullous keratopathy:    80% at 1 year 
 Mean Survival 8.76 years   57% at 5 years 
 (SE=0.64; 95% CI: 7.52, 10.01)  40% at 10 years 
 Median Survival 7 years   23% at 15 years 
PBK 1985-1989:     80% at 1 year 
 Mean Survival 8.49 years   53% at 5 years 
 (SE=0.61; 95% CI: 7.29, 9.69)  39% at 10 years 
 Median Survival 6 years   25% at 15 years 
         6% at 20 years 
PBK 1990-1994:     82% at 1 year 
 Mean Survival 8.78 years   609% at 5 years 
 (SE=0.34; 95% CI: 8.11, 9.45)  43% at 10 years 
 Median Survival 8 years   29% at 15 years 
PBK 1995-1999:     83% at 1 year 
 Mean Survival 7.37 years   62% at 5 years 
 (SE=0.24; 95% CI: 6.90, 7.83)  40% at 10 years 
 Median Survival 9 years    
PBK 2000-2004:     88% at 1 year 
 Mean Survival 5.79 years   57% at 5 years 
 (SE=0.19; 95% CI: 5.42, 6.16)   
 Median Survival 6 years    
PBK 2005-2010:     90% at 1 year 
 Mean Survival 3.45 years    
 (SE=0.07; 95% CI: 3.31, 3.59)   
 Median Survival approx. 4 years   
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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4.4.3 Previous failed ipsilateral graft 
 
The influence of ipsilateral graft number is shown in Figure 4.16. Graft survival fell with 
increasing graft number (Log Rank Statistic=880.019; df=4; p<0.001). 
 
Figure 4.16 The effect of previous grafts in the grafted eye 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
1st graft 12988 5441 2727 1359 754 360 119 32 1 
2nd graft 2412 887 411 181 86 31 14 4 n/a 
3rd graft 607 191 82 32 16 6 3 n/a n/a 
4th graft 161 51 25 11 3 2 n/a n/a n/a 
5th & subsequent graft 123 30 7 2 1 n/a n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
1st graft 12988 .90 .78 .66 .53 .30 
2nd graft 2412 .80 .58 .41 .25 .13 
3rd graft 607 .71 .47 .29 .13 n/a 
4th graft 161 .68 .44 .18 n/a n/a 
5th & subsequent graft 123 .49 .20 .05 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
GRAFT NUMBER 
1st graft:       90% at 1 year 
 Mean Survival 14.07 years   78% at 5 years 
 (SE=0.19; 95% CI: 13.69, 14.44)  66% at 10 years 
 Median Survival 16 years   53% at 15 years 
       30% at 20 years 
2nd graft:      80% at 1 year 
 Mean Survival 9.25 years   58% at 5 years 
 (SE=0.32; 95% CI: 8.61, 9.88)  41% at 10 years 
 Median Survival 8 years   25% at 15 years 
       13% at 20 years 
3rd graft:      71% at 1 year 
 Mean Survival 6.74 years   47% at 5 years 
 (SE=0.44; 95% CI: 5.88, 7.61)  29% at 10 years 
 Median Survival 5 years   13% at 15 years 
4th graft:      68% at 1 year 
 Mean Survival 5.95 years   44% at 5 years 
 (SE=0.63; 95% CI: 4.71, 7.19)  18% at 10 years 
 Median Survival 4 years  
5th and subsequent grafts:   47% at 1 year 
 Mean Survival 3.05 years   20% at 5 years 
 (SE=0.52; 95% CI: 2.02, 4.07)    5% at 10 years 
 Median Survival 1 year  
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability  
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Figure 4.17 investigates the effect of different reasons for failure of a previous ipsilateral 
graft on the survival of the current graft. The data in this figure have been analysed using 
the reason given at time of failure of the previous graft (Log Rank Statistic=74.014; df=9; 
p<0.001). 
 
Figure 4.17 The effect of reason for failure of a previous graft 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Rejection 462 125 49 19 12 5 n/a n/a n/a 
Endothelial cell failure 257 88 37 11 4 1 n/a n/a n/a 
Non herpetic infections 103 25 8 4 2 0 n/a n/a n/a 
Glaucoma 81 25 12 4 1 n/a n/a n/a n/a 
Primary graft failure 109 38 22 9 7 4 3 1 n/a 
Herpetic infections 46 18 6 2 n/a n/a n/a n/a n/a 
Corneal ulcer/perforation 64 13 9 3 1 n/a n/a n/a n/a 
Astigmatism 31 17 8 1 n/a n/a n/a n/a n/a 
Unspecified graft failure 308 94 36 12 7 2 2 n/a n/a 
Other 159 46 20 7 2 2 n/a n/a n/a 
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Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Rejection 462 .67 .38 .25 .19 n/a 
Endothelial cell failure 257 .79 .50 .34 .08 n/a 
Non herpetic infections 103 .59 .35 .22 n/a n/a 
Glaucoma 81 .64 .33 .14 n/a n/a 
Primary graft failure 109 .76 .69 .57 n/a n/a 
Herpetic infections 46 .62 .30 n/a n/a n/a 
Corneal ulcer/perforation 64 .51 .42 .19 n/a n/a 
Astigmatism 31 .95 n/a n/a n/a n/a 
Unspecified graft failure 308 .79 .54 .29 .23 n/a 
Other 159 .67 .44 .32 .16 n/a 
 
 
 
Regrafts for astigmatism and primary graft failures showed better graft survival than those 
for other reasons, whilst those regrafted for infections, glaucoma and ulcers had poorer 
graft survival. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
REASON FOR FAILURE OF PREVIOUS GRAFT 
 
Rejection: 
          Mean Survival 5.87 years   67% at 1 year 
 (SE=0.41; 95% CI: 5.06, 6.68)  37% at 5 years 
 Median Survival 3 years   25% at 10 years 
       19% at 15 years 
Endothelial cell failure: 
          Mean Survival 6.93 years   79% at 1 year 
 (SE=0.61; 95% CI: 5.74, 8.11)  50% at 5 years 
 Median Survival 5 years   34% at 10 years 
         8% at 15 years 
Non herpetic infection: 
          Mean Survival 5.09 years   59% at 1 year 
 (SE=0.78; 95% CI: 3.55, 6.60)  35% at 5 years 
 Median Survival 3 years   22% at 10 years 
 
Glaucoma: 
 Mean Survival 4.20 years   62% at 1 year 
 (SE=0.54; 95% CI: 3.14, 5.27)  33% at 5 years 
 Median Survival 2 years   14% at 10 years 
 
Primary graft failure:   
 Mean Survival 13.92 years   76% at 1 year 
 (SE=1.41; 95% CI: 11.15, 16.69)  69% at 5 years 
 Median Survival approx. 22 years  57% at 10 years 
 
Herpetic infection: 
          Mean Survival 3.62 years   62% at 1 year 
 (SE=0.56; 95% CI: 2.53, 4.72)  30% at 5 years 
 Median Survival 3 years   
 
Corneal ulcer/perforation: 
          Mean Survival 4.77 years   51% at 1 year 
 (SE=0.78; 95% CI: 3.25, 6.29)  42% at 5 years 
 Median Survival 2 year   19% at 10 years 
 
Astigmatism: 
          Mean Survival 13.45 years   96% at 1 year 
 (SE=0.53; 95% CI: 12.41, 14.50)   
 Median Survival approx 14 years    
 
Unspecified graft failure:    79% at 1 year 
 Mean Survival 8.24 years   541% at 5 years 
 (SE=0.85; 95% CI: 6.57, 9.92)  29% at 10 years 
 Median Survival 6 years   23% at 15 years 
 
Other:      67% at 1 year 
 Mean Survival 6.62 years   44% at 5 years 
 (SE=0.69; 95% CI: 5.27, 7.98)  32% at 10 years 
 Median Survival 5 years   16% at 15 years 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom M   
 p = probability  
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4.4.4 Corneal dystrophy 
 
Figure 4.18 shows the survival of first grafts for Fuchs' dystrophy compared with other 
corneal dystrophies (Log rank Statistic=3.814; df=1; p=0.051). The difference does not 
reach significance. 
 
Figure 4.18 Fuchs’ and other corneal dystrophies 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Fuchs’ dystrophy 1609 775 377 160 75 21 4 1 n/a 
Other dystrophies 245 112 61 34 25 14 3 1 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Fuchs’ dystrophy 1609 .94 .81 .64 .37 .17 
Other dystrophies 245 .92 .86 .79 .63 .29 
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PENETRATING CORNEAL GRAFT SURVIVAL 
FUCHS’ DYSTROPHY 
Fuchs’ dystrophy:      94% at 1 year 
 Mean Survival 12.50 years   81% at 5 years 
 (SE=0.45; 95% CI: 11.61, 13.39)  64% at 10 years 
 Median Survival 14 years   37% at 15 years 
       17% at 20 years 
Other dystrophies:     92% at 1 year 
 Mean Survival 15.72 years   86% at 5 years 
 (SE=0.91; 95% CI: 13.93, 17.51)  80% at 10 years 
 Median Survival 20 years   63% at 15 years 
       29% at 20 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom M   
 p = probability  
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4.4.5 Herpetic infection 
 
The effect of herpetic eye disease on a first graft is shown in Figure 4.19. Outcomes of 
grafts for inactive herpetic disease, active herpetic disease and for perforated herpetic 
ulcers are compared (Log rank Statistic=26.502; df=2; p<0.001). The major reasons given 
for the failure of grafts performed for active herpetic infection or herpetic perforation were a 
recurrence of herpetic infection at some time during the post-graft period (17%) and 
rejection (17%) followed by herpetic ulcer (10%). In contrast, the major reasons given for 
the failure of grafts with inactive herpetic disease or scars were rejection (20%), recurrence 
of herpetic infection (13%) and microbial keratitis (8%). 
 
Figure 4.19 The effect of herpetic eye disease on graft survival 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Herpetic perforation 148 42 21 11 7 4 1 n/a n/a 
Active HSV/HZO at graft 
& herpetic ulcers 86 30 13 7 5 3 2 1 n/a 
Inactive HSV/HZO & 
herpetic scars 594 272 151 89 55 28 4 1 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Herpetic perforation 148 .73 .54 .46 n/a n/a 
Active HSV/HZO at graft 
& herpetic ulcers 
86 .73 .52 .48 .40 .20 
Inactive HSV/HZO & 
herpetic scars 
594 .88 .77 .64 .48 .28 
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PENETRATING CORNEAL GRAFT SURVIVAL 
HERPETIC INFECTION 
Herpetic perforation:    73% at 1 year 
          Mean Survival 9.67 years   54% at 5 years 
 (SE=0.93; 95% CI: 7.84, 11.50)  46% at 10 years 
 Median Survival 10 years    
Active HSV/HZO at graft & herpetic ulcers: 73% at 1 year 
 Mean Survival 10.20 years   52% at 5 years 
 (SE=1.48; 95% CI: 7.29, 13.11)  48% at 10 years 
 Median Survival 7 years   40% at 15 years 
       20% at 20 years 
Inactive HSV/HZO & herpetic scars:  88% at 1 year 
 Mean Survival 12.85 years   77% at 5 years 
 (SE=0.57; 95% CI: 11.74, 13.96)  64% at 10 years 
 Median Survival 14 years   48% at 15 years 
       28% at 20 years 
 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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4.4.6 Non-herpetic infections 
 
Graft survival for various infective indications for transplantation is shown in Figure 4.20 
(Log Rank Statistic=70.513, df=4; p<0.001).  
 
Figure 4.20 Non-herpetic infections 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
Microbial/interstitial keratitis 
(not perforated) 547 211 110 41 18 4 1 n/a 
Fungal infection 107 28 8 1 n/a n/a n/a n/a 
Endophthalmitis 26 8 3 n/a n/a n/a n/a n/a 
Acanthamoeba 28 12 9 3 2 0 n/a n/a 
Perforated 
microbial/interstitial keratitis 93 14 6 2 1 1 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Microbial/interstitial keratitis 
(not perforated) 
547 .81 .71 .54 .36 n/a 
Fungal infection 107 .53 .40 .20 n/a n/a 
Endophthalmitis 26 .72 .29 n/a n/a n/a 
Acanthamoeba 28 .71 .65 n/a n/a n/a 
Perforated 
microbial/interstitial keratitis 
93 .56 .34 .11 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
INFECTIONS 
Microbial/interstitial keratitis (not perforated):  81% at 1 year 
 Mean Survival 10.07 years   71% at 5 years 
 (SE=0.56; 95% CI: 8.97, 11.18)  54% at 10 years 
 Median Survival 12 years   36% at 15 years 
 
Fungal infection:     53% at 1 year 
 Mean Survival 4.81 years   40% at 5 years 
 (SE=1.03; 95% CI: 2.80, 6.82)  20% at 10 years 
 Median Survival 2 years    
 
Endophthalmitis: 
         Mean Survival 3.49 years   72% at 1 year 
 (SE=0.68; 95% CI: 2.15, 4.83)  29% at 5years 
 Median Survival 3 years    
 
Acanthamoeba: 
          Mean Survival 8.83 years   71% at 1 year 
 (SE=1.36; 95% CI: 6.16, 11.50)  65% at 5 years 
 Median Survival 14 year  
 
Perforated microbial/interstitial keratitis: 
          Mean Survival 4.50 years   56% at 1 year 
 (SE=0.98; 95% CI: 2.57, 6.42)  34% at 5 years 
 Median Survival 3 years   11% at 10 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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4.4.7 Burns and trauma 
 
Outcome of first grafts performed for burns (chemical or thermal) or trauma is shown in 
Figure 4.21 (Log Rank Statistic=3.873, df=1; p=0.049). 
 
Figure 4.21 The effect of burns and trauma 
 
Number at Risk 
 
Identity Initially  3 years 6 years 9 years 12 years 
15 
years 
18 
years 
21 
years 
Trauma 297 121 60 23 8 4 n/a n/a 
Burns 73 24 14 6 3 n/a n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Trauma 297 .86 .70 .49 n/a n/a 
Burns 73 .74 .59 .35 n/a n/a 
 
116  Australian Corneal Graft Registry Report 2012 
RECIPIENT FACTORS 
 
 
 
 
 
 
 
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
BURNS AND TRAUMA 
Trauma:      86% at 1 year 
 Mean Survival 10.28 years   70% at 5 years 
 (SE=0.65; 95% CI: 9.00, 11.55)  49% at 10 years 
 Median Survival 10 years    
Burns:      74% at 1 year 
 Mean Survival 6.75 years   59% at 5 years 
 (SE=0.74; 95% CI: 5.31, 8.20)  35% at 10 years 
 Median Survival 7 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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4.4.8 Descemetocoele 
 
The influence of a descemetocoele as the indication for transplantation on the survival of a 
first graft is shown in Figure 4.22. The presence of descemetocoele was a risk factor for 
graft failure (Log Rank Statistic=43.226; df=1; p<0.001). 
 
Figure 4.22 The effect of descemetocoele on graft survival 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
tears 
Balance of database 12887 5408 2710 1353 749 356 118 32 1 
Descemetocoele 101 28 14 6 5 4 1 n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 12887 .90 .78 .66 .53 .30 
Descemetocoele 101 .66 .54 .40 n/a n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
DESCEMETOCOELE 
Balance of database:    90% at 1 year 
 Mean Survival 14.10 years   78% at 5 years 
 (SE=0.19; 95% CI: 13.72, 14.48)  66% at 10 years 
 Median Survival 16 years   53% at 15 years 
Descemetocoele:     66% at 1 year 
 Mean Survival 9.17 years   54% at 5 years 
 (SE=1.26; 95% CI: 6.70, 11.63)  40% at 10 years 
 Median Survival 6 years    
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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4.5 SUMMARY OF RECIPIENT-RELATED 
FACTORS 
 
 The sequelae of corneal vascularization, inflammation and raised IOP prior 
to, or at the time of graft, all exerted significant negative influences on graft 
survival. 
 The main indications for penetrating keratoplasty were keratoconus (30%), 
bullous keratopathy (26%), failed previous graft (20%), corneal dystrophy 
(8%), and herpetic eye disease (4%). These broad indications accounted 
for 88% of penetrating grafts. 
 The number of previous ipsilateral grafts influenced the survival of 
subsequent grafts significantly. However, repeat grafts that had previously 
failed due to primary non-function or astigmatism showed better graft 
survival than those that had failed due to rejection or infection. 
 Although corneal grafts for keratoconus showed better survival than grafts 
for all other indications, these grafts were also influenced by rejection 
episodes, number of previous grafts, age at graft, other pre-graft morbidities 
and complications. 
 Graft survival for uncomplicated keratoconus and for the corneal 
dystrophies was very good. Graft survival for bullous keratopathy, previous 
failed graft, burns, trauma, corneal ulcers, active HSV, infection, corneal 
perforations, endophthalmitis and mycotic ulcers was relatively poor. 
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5. PROCEDURES AT TIME OF 
GRAFT AND INFLUENCE OF 
INTRAOCULAR LENSES  
 
 
 
5.1 OPERATIVE PROCEDURES AT GRAFT 
 
 
5.1.1 Hostbed size of graft  
 
The hostbed size of the graft was recorded for 18,829 penetrating grafts, and ranged from 
2.5 mm to 16.0 mm. Figure 5.1 shows the effect of graft size on the outcome of the 15,440 
followed grafts with recorded graft size (Log Rank Statistic=466.63; df=6; p<0.001). Grafts 
sized between 7.5 mm and 8.5 mm fared better than grafts that are larger or smaller.  
 
Table 5.1 shows the reasons for failure of grafts of different sizes. Rejection was the major 
cause of failure, except in grafts larger than 9 mm, where infection became a problem.  
 
All Kaplan-Meier plots and associated tables in this chapter have been calculated 
using penetrating grafts only. 
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Figure 5.1 Graft size 
 
Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Less than 7 mm 222 67 30 16 9 4 2 1 n/a 
7.0 - 7.4 mm 1780 741 365 195 122 66 13 2 n/a 
7.5 – 7.9 mm 6633 2789 1437 737 408 193 64 15 0 
8.0 - 8.4 mm 5783 2345 1112 537 274 119 52 17 1 
8.5 – 8.9 mm 675 257 115 35 19 7 3 n/a n/a 
9.0 – 9.9 mm 233 71 33 7 2 1 1 1 n/a 
10.0 mm thru highest 114 22 6 2 2 2 1 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Less than 7 mm 222 .63 .47 .30 .23 .12 
7.0 - 7.4 mm 1780 .83 .62 .49 .39 .18 
7.5 – 7.9 mm 6633 .89 .75 .63 .50 .22 
8.0 - 8.4 mm 5783 .89 .77 .64 .50 .37 
8.5 – 8.9 mm 675 .83 .66 .58 .39 n/a 
9.0 – 9.9 mm 233 .74 .57 .27 .13 n/a 
10.0 mm thru highest 114 .45 .28 .11 .11 n/a 
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PENETRATING CORNEAL GRAFT SURVIVAL 
GRAFT SIZE 
< 7.0 mm:      63% at 1 year 
 Mean Survival 7.41 years   47% at 5 years 
 (SE=0.82; 95% CI: 5.80, 9.02)  30% at 10 years 
 Median Survival 5 years   23% at 15 years 
       12% at 20 years 
≥ 7.0 – 7.4 mm:     83% at 1 year 
 Mean Survival 10.89 years   62% at 5 years 
 (SE=0.35; 95% CI: 10.20, 11.58)  49% at 10 years 
 Median Survival 10 years   39% at 15 years 
       18% at 20years 
≥ 7.5 – 7.9 mm:     89% at 1 year 
 Mean Survival 13.14 years   75% at 5 years 
 (SE=0.22; 95% CI: 12.72, 13.57)  63% at 10 years 
 Median Survival 15 years   50% at 15 years 
       22% at 20 years 
≥ 8.0 – 8.4 mm:     89% at 1 year 
 Mean Survival 14.18 years   77% at 5 years 
 (SE=0.31; 95% CI: 13.58, 14.78)  64% at 10 years 
 Median Survival 16 years   50% at 15 years 
       37% at 20 years 
≥ 8.5 – 8.9 mm:     83% at 1 year 
 Mean Survival 11.07 years   66% at 5 years 
 (SE=0.59; 95% CI: 9.92, 12.22)  89% at 10 years 
 Median Survival 12 years   38% at 20 years 
≥ 9.0 – 9.9 mm:     74% at 1 year 
 Mean Survival 7.48 years   57% at 5 years 
 (SE=1.16; 95% CI: 5.20, 9.76)  27% at 10 years 
 Median Survival 7 years   13% at 15 years 
≥ 10.0 mm:      45% at 1 year 
 Mean Survival 4.02 years   28% at 5 years 
 (SE=0.92; 95% CI: 2.21, 5.83)  11% at 10 years 
 Median Survival 1 year   11% at 15 years 
 
 
 
 
KEY: n/a    =  not applicable 
 SE     = standard error 
 Cl      = confidence interval 
 df = degrees of freedom 
 p = probability 
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Table 5.1 Main reasons for graft failure according to hostbed size 
 
 
Graft 
size mm 
Total 
followed 
Total 
failed 
% Main reasons for failure No. 
failed 
% 
<7.0 222 106 48% 
 
Rejection 27 25% 
    Infection1 17 16% 
    Unspecified failure 15 14% 
    Endothelial cell failure 13 12% 
    Glaucoma 6 6% 
    Primary non-function 5 5% 
    Neovascularization 3 3% 
    Scarring or opacity 3 3% 
       
7.0 - <8.5 14196 3130 22% Rejection 924 30% 
    Endothelial cell failure 531 17% 
    Unspecified failure 506 16% 
    Infection2 374 12% 
    Glaucoma 214 4% 
    Primary non-function 129 4% 
    Trauma 73 2% 
    Astigmatism 56 2% 
    Neovascularization 50 2% 
    Corneal degeneration 42 1% 
    Scars and opacities 35 1% 
       
8.5 - <9.0 675 176 26% Rejection 52 30% 
    Infection3 45 26% 
    Unspecified failure 19 11% 
    Endothelial cell failure 14 8% 
    Glaucoma 11 6% 
    Corneal degeneration 6 3% 
    Trauma 5 3% 
    Primary non-function 4 2% 
       
≥9.0 347 155 45% Infection4 50 32% 
    Rejection 39 25% 
    Unspecified failure 20 13% 
    Corneal degeneration 9 6% 
    Endothelial cell failure 7 5% 
    Glaucoma 5 3% 
    Neovascularization 4 3% 
 
1 Includes: perforated ulcer (6); endophthalmitis (6); abscess (3); HSV (1); mycotic ulcer (1). 
2 Includes: abscess (137); HSV (90); perforated ulcer (46); corneal ulcer (40); endophthalmitis (36); 
mycotic ulcer (12); Streptococcus (4); unspecified viral infection (3); Acanthamoeba (1); Fusarium (1); 
Gonococcus (1); HZO (1); Pseudomonas (1); trachoma (1). 
3 Includes: abscess (13); HSV (9); perforated ulcer (9); mycotic ulcer (4); Acanthamoeba (3); corneal ulcer 
(3); endophthalmitis (2); Pseudomonas (1); Streptococcus (1). 
4 Includes: endophthalmitis (10); mycotic ulcer (10); abscess (8); perforated ulcer (8); HSV (7); corneal 
ulcer (3); Pseudomonas (3); Acanthamoeba (1). 
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5.1.2 Accompanying procedures at graft 
 
Table 5.2 lists the operative procedures that took place at the time of graft for all 
penetrating grafts in the database; 8,728 procedures were carried out during 6,828 graft 
operations (ie in 34% of the cohort). 
 
It should be noted that data are no longer collected on ECCE/ICCE or the type of 
intraocular lens. Cataract extraction with an IOL inserted at the time of graft is categorised 
as a triple procedure.  
 
Table 5.2 Overview of operative procedures at graft 
 
Procedure Sub-total No. % of total grafts 
Triple procedure   2041 10% 
Vitrectomy  1812 9% 
Iris procedures:  1709 9% 
 Peripheral iridectomy 1268 
  
 Pupilloplasty 107 
  
 Iris repair/reconstruction 174 
  
 Sphincterotomy 36 
  
 Synechiolysis 124   
IOL removed and exchanged at graft  1455 7% 
Other procedures dealing with IOLs  950 5% 
IOL inserted into aphakic eye 552 
  
Removal of IOL - patient left aphakic 290 
  
Reposition existing IOL 108 
  
Cataract removed and patient left aphakic  207 1% 
Glaucoma procedures:  120 <1% 
 Trabeculectomy 62 
  
 Valve (implant/trimming etc) 51   
 Cyclodialysis 7   
Tarsorrhaphy  77 <1% 
Anterior segment clearance/wash/reconstruction  46 <1% 
Gunderson flap/conjunctival flap  24 <1% 
Retinal repair  14 <1% 
Temporary keratoprosthesis  (9 inserted/1 removed)  10 <1% 
Miscellaneous other procedures  263 1% 
TOTAL PROCEDURES 8728 during 6828 graft operations 
(34%) 
TOTAL GRAFTS 
 19952 100% 
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5.1.3 Influence of vitrectomy 
 
The influence of vitrectomy, performed at the time of graft, on subsequent corneal graft 
survival is shown in Figure 5.2 (Log Rank Statistic=172.745; df=1; p<0.001). 
 
Figure 5.2  Vitrectomy 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Balance of 
database 14689 6088 3033 1488 821 381 132 34 1 
Vitrectomy 1602 506 215 97 39 19 4 2 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 14689 .88 .74 .62 .49 .26 
Vitrectomy 1602 .80 .55 .40 .25 .17 
 
The main reasons for failure of grafts where a vitrectomy was performed at the time of graft 
were rejection (30%), bullous keratopathy and aphakia (14%), glaucoma (12%) and 
infection (6%). Of the 530 penetrating grafts that failed, 15 cases were reported to be 
primary non-functions. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
VITRECTOMY 
Balance of database:    88% at 1 year 
 Mean Survival 13.28 years   74% at 5 years 
 (SE=0.18, 95% CI: 12.93, 13.62)  62% at 10 years 
 Median Survival 15 years   49% at 15 years 
       26% at 20 years 
Vitrectomy:      80% at 1 year 
 Mean Survival 9.13 years   55% at 5 years 
 (SE=0.45, 95% CI: 8.26, 10.00)  40% at 10 years 
 Median Survival 6 years   25% at 15 years 
       17% at 20 years 
 
 
 
KEY: n/a    =  not applicable 
 SE     = standard error 
 Cl      = confidence interval 
 df = degrees of freedom 
 p = probability 
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5.1.4 Lens insertion 
 
Figure 5.3 compares graft survival for those recipients who were phakic, aphakic or 
pseudophakic at graft (and have remained so), with those recipients who had an IOL 
inserted or removed at the time of graft (Log Rank Statistic=1051.52; df=7; p<0.001). 
 
Figure 5.3     Lens status before and after graft 
 
 Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Aphakic pre & post graft 781 223 91 40 20 7 3 n/a n/a 
Pseudophakic 1985-1989  757 327 169 92 64 27 6 4 n/a 
Pseudophakic 1990-1994 2135 779 380 181 89 30 1 n/a n/a 
Pseudophakic 1995-1999 1675 631 311 127 23 n/a n/a n/a n/a 
Pseudophakic 2000-2004 1727 632 197 2 n/a n/a n/a n/a n/a 
Pseudophakic 2005-2010 1019 145 n/a n/a n/a n/a n/a n/a n/a 
Phakic pre & post graft 7744 3711 2041 1120 652 330 125 31 1 
IOL removed at time of 
graft 263 92 34 15 7 4 1 1 0 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Aphakic pre & post graft 781 .71 .45 .30 .18 n/a 
Pseudophakic 1985-1989  757 .79 .57 .45 .35 .20 
Pseudophakic 1990-1994 2135 .81 .60 .46 .29 n/a 
Pseudophakic 1995-1999 1675 .83 .63 .44 n/a n/a 
Pseudophakic 2000-2004 1727 .87 .61 n/a n/a n/a 
Pseudophakic 2005-2010 1019 .86 n/a n/a n/a n/a 
Phakic pre & post graft 7744 .92 .86 .75 .61 .33 
IOL removed at time of graft 263 .71 .51 .40 .32 .32 
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PENETRATING CORNEAL GRAFT SURVIVAL 
LENS STATUS 
Aphakic pre & post graft:    71% at 1 year 
 Mean Survival 6.94 years   45% at 5 years 
 (SE=0.44; 95% CI: 6.08, 7.81)  30% at 10 years 
 Median Survival 5 years   18% at 15 years 
Pseudophakic 1985-1989:    79% at 1 year 
 Mean Survival 10.10 years   57% at 5 years 
 (SE=0.50; 95% CI: 9.12, 11.08)  45% at 10 years 
 Median Survival 8 years   35% at 15 years 
       20% at 20 years 
Pseudophakic 1990-1994:    81% at 1 year 
 Mean Survival 9.17 years   60% at 5 years 
 (SE=0.25; 95% CI: 8.69, 9.65)  46% at 10 years 
 Median Survival 9 years   29% at 15 years 
Pseudophakic 1995-1999:    83% at 1 year 
 Mean Survival 7.88 years   63% at 5 years 
 (SE=0.18; 95% CI: 7.53, 8.23)  44% at 10 years 
 Median Survival 9 years   
Pseudophakic 2000-2004:    87% at 1 year 
 Mean Survival 6.02 years   61% at 5 years 
 (SE=0.12; 95% CI: 5.79, 6.25)   
 Median Survival 7 years   
Pseudophakic 2005-2010:    86% at 1 year 
 Mean Survival 3.34 years   
 (SE=0.05; 95% CI: 3.25, 3.42)   
 Median Survival approx 4 years   
Phakic pre & post graft:    92% at 1 year 
 Mean Survival 15.60 years   86% at 5 years 
 (SE=0.22; 95% CI: 15.17, 16.04)  75% at 10 years 
 Median Survival 18 years   61% at 15 years 
       33% at 20 years 
IOL removed at time of graft:   71% at 1 year 
 Mean Survival 9.98 years   51% at 5 years 
 (SE=1.07; 95% CI: 7.88, 12.09)  40% at 10 years 
 Median Survival 6 years   32% at 15 years 
 
 
 
KEY: n/a    =  not applicable 
 SE     = standard error 
 Cl      = confidence interval 
 df = degrees of freedom 
 p = probability 
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5.1.4.1 Triple and staged procedures 
 
Figure 5.4 compares the graft survival of triple and staged procedures, with graft survival in 
those patients who underwent cataract removal at graft but who had remained aphakic 
(Log Rank Statistic=170.263, df=2, p<0.001). 
 
Triple procedures are defined as cataract removal and IOL insertion at the time of corneal 
graft. Staged procedures are defined as cataract removal at time of corneal graft and IOL 
insertion at some time after the graft, during the follow-up period or cataract removal and 
IOL insertion concurrently post graft. 
 
Figure 5.4 Triple versus staged versus cataract removal and continuing aphakic 
 
Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Triple procedure 1718 735 352 161 81 24 5 3 n/a 
Staged procedure 472 295 160 74 39 16 1 n/a n/a 
Cataract removal at 
graft, still aphakic 
148 28 11 5 3 1 n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Triple procedure 1718 .90 .78 .66 .43 .31 
Staged procedure 472 .95 .82 .67 .56 n/a 
Cataract removal at 
graft, still aphakic 
148 .61 .33 .14 .07 n/a 
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We observed a significant difference in graft survival between the cohort who underwent a 
triple procedure compared with the cohort who underwent a staged procedure (Log Rank 
Statistic=6.351; df=1, p=0.012). However, both cohorts showed significantly better graft 
survival than the cohort in whom a cataract was removed at the time of corneal 
transplantation, but who had remained aphakic. The main reasons for corneal graft failure 
in the group who underwent cataract removal at graft and who remained aphakic were: 
rejection (27%), infection (15%) glaucoma (12%), endothelial defects (11%), bullous 
keratopathy and endophthalmitis (5%) and herpetic eye disease (4%).  
 
 
 
 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
TRIPLE AND STAGED PROCEDURES 
Triple procedure:     90% at 1 year 
 Mean Survival 13.21 years   78% at 5 years 
 (SE=0.53; 95% CI: 12.18, 14.24)  66% at 10 years 
 Median Survival 14 years   43% at 15 years 
       31% at 20 years 
Staged Procedure:     95% at 1 year 
 Mean Survival 13.13 years   82% at 5 years 
 (SE=0.45; 95% CI: 12.25, 14.02)  67% at 10 years 
 Median Survival approx. 18 years  56% at 15 years 
Cataract removal at graft, still aphakic:  61% at 1 year 
 Mean Survival 4.77 years   33% at 5 years 
 (SE=0.66; 95% CI: 3.47, 6.07)  14% at 10 years 
 Median Survival 3 years     7% at 15 years 
 
 
 
 
KEY: n/a    =  not applicable 
 SE     = standard error 
 Cl      = confidence interval 
 df = degrees of freedom 
 p = probability 
 
 
 
 
 
 
 
 
 
 
 
 
 PROCEDURES AT TIME OF GRAFT AND INLUENCE OF INTRAOCULAR LENSES 
 
 
 
 
5.2 SUMMARY OF EFFECT OF 
PROCEDURES AT TIME OF GRAFT AND 
INFLUENCE OF INTRAOCULAR LENSES 
 
 Graft size was correlated with graft survival. Grafts within the size range of 
about 7.5 to 8.5 mm in diameter fared best. By comparison, larger and 
smaller grafts showed reduced survival. Rejection was a major cause of 
graft failure across all groups, but infection also caused the loss of very 
large and very small grafts. 
 In 34% of corneal grafts, some other specified procedure was carried out 
at the same time. The most frequently-performed of these procedures 
were a manipulation involving the crystalline lens or an intraocular lens 
(10%) and vitrectomy (9%). 
 Graft survival was better in phakic than in aphakic or pseudophakic 
recipients. 
 Graft survival did not differ greatly between the cohorts who had 
undergone a triple procedure or a staged lens implant but the difference 
was significant (p=0.01), favouring the staged procedure. 
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6. POST-GRAFT EVENTS 
 
6.1 REASONS FOR GRAFT FAILURE 
 
 
Table 6.1 lists the main reasons for failure of 3,794 failed penetrating grafts. 
 
Table 6.1 Reason for graft failure 
 
Reason Sub-total Total % 
Rejection   1161 31% 
unspecified/endothelial cell failure  957   
with glaucoma  57   
with non-herpetic infection  27   
with herpetic infection  26   
with vascularization  23   
with ulcer   16   
with scars and opacities  7   
with corneal degeneration  6   
with epithelial defect  6   
with injury  5   
with keratoconus/keratoglobus  3   
with ICE syndrome  3   
with retinal detachment  2   
Other  23   
     
Endothelial cell failure   568 15% 
with pseudophakic bullous keratopathy  149   
with bullous keratopathy  66   
with aphakic bullous keratopathy  49   
not specified  304   
     
Non-herpetic infections   291 8% 
Corneal abscess  175   
unspecified 113    
with perforation/dehiscence 17    
with scars 8    
with glaucoma 3    
with endothelial cell failure 2    
Other 32    
Endophthalmitis  62   
Mycotic ulcers  30   
Pseudomonas  7   
Streptococcus  6   
Acanthamoeba  5   
Fusarium  1   
Adenoviral conjunctivitis  1   
Unspecified viral infection  1   
Gonococcus  1   
Scleral abscess  1   
Trachoma  1   
 
    
Glaucoma   287 8% 
unspecified  171   
with endothelial cell failure  55   
with iris disorders   11   
with ulcers  8   
with epithelial defect  5   
with vascularization  4   
with corneal degeneration  3   
with scars 
 3   
Other   27   
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Reason Sub-total Total % 
Primary graft failure   151 4% 
Ulcers (not from infection)   120 3% 
perforated  74   
central  10   
with hypopyon  2   
unspecified 20 34   
with neovascularization 4    
with scars 3    
other 7    
Herpetic Infection   109 3% 
HSV  108   
unspecified 61    
with ulcer 16    
with perforation 6    
with endothelial cell failure 5    
with abscess 5    
with neovascularization 5    
other 10    
HZO  1   
Injury/trauma   82 2% 
Astigmatism   59 2% 
Corneal degeneration   56 2% 
Vascularization   51 1% 
Epithelial defect   44 1% 
Scars and opacities   42 1% 
Iris disorders   20 <1% 
Phthisis bulbi   18 <1% 
Wound dehiscence   14 <1% 
Metabolic deposits   13 <1% 
Corneal dystrophies   12 <1% 
Keratoconus    11 <1% 
Retinal detachment   10 <1% 
Keratitis   9 <1% 
Descemetocoele    9 <1% 
Miscellaneous*   48 1% 
Unspecified   609 16 % 
TOTAL   3794 100% 
 
 
* choroidal haemorrhage (7); hypotony (7); buphthalmos (6); cataract (3); dry eye syndrome (3); squamous cell carcinoma (3); 
conjunctival melanoma (2); vitreous disorders (2); Stevens-Johnson syndrome (2); aniridia (1); complications from cataract 
removal (1); congenital nystagmus (1);  erythroderma (1); meibomianitis (1); nuclear sclerosis (1); ocular Munchausen 
syndrome (1); ocular pemphigus (1); Peters' anomaly (1); pterygium (1); retinal vein occlusion (1); scleral degeneration (1); 
unspecified immune deficiency (1). 
  
 
All Kaplan-Meier plots and associated tables in this chapter have been calculated 
using penetrating grafts only. 
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Figure 6.1 uses the same data as for Table 6.1 and therefore represents only failed grafts. 
Primary graft failure was removed from the dataset as such grafts have a graft survival time 
of ≤ 1 day (Log Rank Statistic=312.641; df=8; p<0.001). 
 
Figure 6.1   Reason for graft failure 
 
Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Irreversible rejection 1161 336 140 67 32 8 1 n/a n/a 
Endothelial failure 568 294 143 83 35 17 8 1 n/a 
Infection 291 56 25 16 5 1 1a n/a n/a 
Glaucoma 287 79 25 5 3 0 n/a n/a n/a 
Herpetic infection 109 33 16 8 3 3 n/a n/a n/a 
Ulcers/perforation 120 24 12 6 4 2 2 n/a n/a 
Astigmatism 59 46 36 31 25 18 6 2 n/a 
Graft failure 609 320 186 114 70 32 14 4 1 
Other  439 137 83 48 31 22 13 2 n/a 
 
Graft survival (at years post-graft) 
Identity 
No. initially at 
risk 1 5 10 15 20 
Irreversible rejection 1161 .44 .12 .04 .003 .00 
Endothelial failure 568 .66 .25 .09 .02 .002 
Infection 291 .30 .09 .03 .003 n/a 
Glaucoma 287 .45 .09 .01 n/a n/a 
Herpetic infection 109 .42 .15 .04 n/a n/a 
Ulcers/perforation 120 .32 .10 .03 .02 n/a 
Astigmatism 59 .86 .61 .46 .27 .03 
Graft failure 609 .64 .31 .14 .04 .007 
Other  439 .44 .19 .08 .05 .005 
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6.2 TIME TO SUTURE REMOVAL 
 
 
Figure 6.2 shows the influence of time of suture removal on graft survival  
(Log Rank Statistic=178.951; df=4; p<0.001). Of the 558 grafts in which sutures were 
removed by 6 months post graft, 165 (29%) failed. 
 
Figure 6.2 Time from graft to suture removal 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Less than 6 
months 558 198 115 74 37 24 11 1 n/a 
  6-12 months 1814 876 475 256 163 80 22 7 1 
12-18 months 3123 1627 796 388 215 101 48 14 0 
18-24 months 1486 787 386 170 93 48 17 3 n/a 
Over 24 months 1705 1319 696 357 206 96 23 9 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Less than 6 months 558 .78 .68 .64 .52 .17 
  6-12 months 1814 .91 .82 .73 .60 .36 
12-18 months 3123 .96 .86 .71 .58 .42 
18-24 months 1486 .97 .86 .73 .61 .33 
Over 24 months 1705 .99 .89 .78 .65 .45 
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The reasons for failure of these grafts are shown in Table 6.2. Reasons for graft failure in 
the cohort for early suture removal were very similar to those of the whole cohort. 
 
 
Table 6.2 Reasons for graft failure associated with removal of all sutures by        
<6 months post-operatively 
 
 
 
 
 
 
 
 
Reason for failure Sub-total Total % 
Rejection  51 31% 
with ulcers 4  
 
with endothelial cell failure 3  
 
with glaucoma 3  
 
with vascularization 2  
 
with scars 2  
 
with pannus 1  
 
with dry eye syndrome 1  
 
with corneal degeneration 1  
 
with injury 1  
 
with epithelial defect 1  
 
with band-shaped keratopathy 1  
 
unspecified 31  
 
Infection  21 13% 
abscess 8   
herpetic 6  
 
endophthalmitis 5  
 
mycotic ulcer 2  
 
Glaucoma  15 9% 
with endothelial decompensation 2  
 
with iris disorders 2  
 
with neovascularization 1  
 
with keratitis 1  
 
with epithelial defects 1  
 
unspecified 8  
 
Endothelial cell failure  14 8% 
Ulcers  7 4% 
perforated 4   
central 2   
unspecified 1   
Astigmatism  6 4% 
Neovascularization  6 4% 
Scars and opacities  5 3% 
Epithelial defect  3 2% 
Miscellaneous¹  16 10% 
Unspecified  21 13% 
TOTAL  165 100% 
¹    corneal degeneration (2); keratitis (2); phthisis bulbi (2); retinal detachment (2); trauma (2);  buphthalmos (1);  
choroidal haemorrhage (1);  descemetocoele (1); granular dystrophy (1); keratoconus (1); primary graft failure (1).  
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PENETRATING CORNEAL GRAFT SURVIVAL 
TIME TO SUTURE REMOVAL 
Less than 6 months:     78% at 1 year 
 Mean Survival 12.01 years   68% at 5 years 
 (SE=0.54; 95% CI: 10.96, 13.06)  64% at 10 years 
 Median Survival 16 years   52% at 15 years 
       17% at 20 years 
6-12 months:     91% at 1 year 
 Mean Survival 15.57 years   82% at 5 years 
 (SE=0.47; 95% CI: 14.64, 16.50)  73% at 10 years 
 Median Survival 18 years   60% at 15 years 
       36% at 20 years 
12-18 months:     96% at 1 year 
 Mean Survival 15.38 years   86% at 5 years 
 (SE=0.32; 95% CI: 14.75, 16.01)  71% at 10 years 
 Median Survival 18 years   58% at 15 years 
       42% at 20 years 
18-24 months:     97% at 1 year 
 Mean Survival 14.70 years   86% at 5 years 
 (SE=0.40; 95% CI: 13.91, 15.49)  73% at 10 years 
 Median Survival 17 years   61% at 15 years 
       33% at 20 years 
Over 24 months:     99% at 1 year 
 Mean Survival 16.41 years   89% at 5 years 
 (SE=0.35; 95% CI: 15.73, 17.10)  78% at 10 years 
 Median Survival 19 years   65% at 15 years 
       45% at 20 years 
 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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6.3 POST-GRAFT COMPLICATIONS 
 
6.3.1 Microbial keratitis/stitch abscess 
 
The development of microbial keratitis or stitch abscess was associated with poor corneal 
graft survival (Log Rank Statistic=284.398; df=1; p<0.001). 
 
Figure 6.3 Microbial keratitis/stitch abscess 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Balance of 
database 
15862 6417 3178 1559 855 399 136 36 1 
Microbial keratitis 
or stitch abscess 
429 177 70 26 5 1 n/a n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 15862 .88 .74 .61 .48 .26 
Microbial keratitis or 
stitch abscess 429 .69 .41 .17 .00 n/a 
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6.3.2 Uveitis 
 
Post-operative uveitis was another risk factor for corneal graft failure (Log Rank         
Statistic= 62.133; df=1; p=<0.001). 
 
Figure 6.4 Uveitis 
 
Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Balance of 
database 
16085 6493 3197 1565 850 399 136 36 1 
Uveitis 206 101 51 20 10 1 n/a n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 16085 .87 .73 .60 .47 .26 
Uveitis 206 .74 .50 .32 n/a n/a 
 
The main indications for grafts with uveitis were failed previous graft (27%), bullous 
keratopathy (26%) and keratoconus (11%). 
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6.3.3 Synechiae 
 
Development of synechiae was a risk factor for graft failure, as shown in Figure 6.5 (Log 
Rank Statistic= 75.333; df=1; p=<0.001). 
 
Figure 6.5 Synechiae 
 
 
Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Balance of 
database 
15962 6457 3187 1558 849 397 135 36 1 
Synechiae 329 137 61 27 11 3 1 n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 15962 .87 .73 .60 .47 .26 
Synechiae 329 .75 .53 .35 .21 n/a 
 
The main indications for grafts with synechiae were bullous keratopathy (38%) and failed 
previous graft (20%). Sixty eight (21%) of these grafts had vitrectomy at graft. 
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PENETRATING CORNEAL GRAFT SURVIVAL 
MICROBIAL KERATITIS/STITCH ABSCESS 
Balance of database:     88% at 1 year 
 Mean Survival 13.18 years   74% at 5 years 
 (SE=0.17; 95% CI: 12.85, 13.52)  61% at 10 years 
 Median Survival 14 years   48% at 15 years 
       26% at 20 years 
Microbial keratitis or stitch abscess:  69% at 1 year 
 Mean Survival 5.18 years   41% at 5 years 
 (SE=0.31; 95% CI 4.58, 5.78)  17% at 10 years 
 Median Survival 4 years    
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
UVEITIS 
Balance of database:     87% at 1 year 
 Mean Survival 13.02 years   73% at 5 years 
 (SE=0.17, 95% CI: 12.69, 13.35)  60% at 10 years 
 Median Survival 14 years   47% at 15 years 
       26% at 20 years 
Uveitis:      74% at 1 year 
 Mean Survival 6.79 years   50% at 5 years 
 (SE=0.49, 95% CI: 5.85, 7.75)  32% at 10 years 
 Median Survival 6 years    
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
SYNECHIAE 
Balance of database:     87% at 1 year 
 Mean Survival 13.04 years   73% at 5 years 
 (SE=0.17, 95% CI: 12.71, 13.37)  60% at 10 years 
 Median Survival 14 years   47% at 15 years 
       26% at 20 years 
Synechiae:      75% at 1 year 
 Mean Survival 7.95 years   53% at 5 years 
 (SE=0.59, 95% CI: 6.79, 9.11)  35% at 10 years 
 Median Survival 7 years   21% at 15 years 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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6.3.4 Post-graft vascularization 
 
The effect of post-graft vascularization on graft survival is shown in Figure 6.6 (Log Rank 
Statistic=451.148; df=1; p<0.001). Graft neovascularization was a significant risk factor for 
graft failure. 
 
Figure 6.6 Post-graft vascularization 
 
 
Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Balance of database 15314 6218 3077 1509 824 385 131 36 1 
Post-graft 
vascularization 
977 376 171 76 36 15 5 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 15394 .88 .75 .62 .48 .27 
Post-graft vascularization 977 .67 .46 .32 .21 n/a 
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6.3.5 Post operative rise in intraocular pressure 
 
A post-operative rise in intraocular pressure was a significant risk factor for corneal graft 
failure (Log Rank Statistic=192.978; df=1; p<0.001). 
 
 
Figure 6.7 Post-operative rise in intraocular pressure 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
No rise in intraocular 
pressure since graft 
13591 5331 2629 1312 735 347 120 31 1 
Post-operative rise in 
intraocular pressure 
2700 1263 619 273 125 53 16 5 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
No rise in intraocular 
pressure since graft 13591 .88 .76 .63 .49 .28 
Post-operative rise in 
intraocular pressure 2700 .83 .60 .46 .36 .16 
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6.3.5.1 Effect of post-operative rise in intraocular pressure 
 
Of the 2,700 penetrating grafts recording a rise in intraocular pressure in the post-graft 
period, 987 (37%) have failed. The main reasons for failure of these grafts are shown in 
Table 6.3. 
 
Table 6.3 Reasons for graft failure in cases where raised intraocular pressure 
was recorded in the post-graft period 
 
Reason Sub-total Total % 
Graft rejection  299 30% 
no other indication reported 196   
with glaucoma 57   
with endothelial cell failure 17   
with vascularization 5   
with non-herpetic infection 4   
with HSV 3   
with ulcer 3   
Miscellaneous 14   
Glaucoma  287 29% 
no other indication reported 171   
with endothelial cell failure 55   
with iris disorders 11   
with ulcers 8   
with epithelial defects 5   
with vascularization 4   
with corneal degeneration 3   
with scars 3   
with metabolic deposits 3   
Miscellaneous 24   
Endothelial cell failure  134 14% 
unspecified 66   
with pseudophakic bullous keratopathy 35   
with aphakic bullous keratopathy 17   
with bullous keratopathy 16   
Non-herpetic infections  43 4% 
abscess 31   
endophthalmitis 7   
mycotic ulcer 2   
Acanthamoeba keratitis 1   
streptococcus 1   
unspecified viral infection 1   
Herpetic Infections  15 2% 
Ulcers  12 1% 
Injury  12 1% 
Epithelial defects  12 1% 
Neovascularization  10 1% 
Unspecified  111 11% 
Miscellaneous  52 5% 
TOTAL  987 100% 
 
Glaucoma was the primary reason for graft failure in 29% of failed penetrating grafts. This 
disease featured as a primary or secondary cause of failure in 351 (36%) of the cases 
listed. 
 
Australian Corneal Graft Registry Report 2012 145 
POST-GRAFT EVENTS 
 
6.3.5.2 Post-graft operative procedures for glaucoma 
 
Post-graft operative surgery for glaucoma was performed on 433 (16%) of grafts in which a 
post-operative rise in IOP was recorded. Table 6.4 lists the procedures that were 
performed. 
 
Table 6.4 Operative procedures used to control post-graft raised intraocular 
pressure 
 
Name No. % of grafts 
Trabeculectomy 245 57% 
Valve implantation 125 29% 
    Valve adjustments/removals etc 19 4% 
Cyclocryotherapy 52 12% 
Miscellaneous 65 15% 
TOTAL PROCEDURES  
 
506 over 433 grafts (100%) 
 
∗ Please note that in many cases surgeons have performed two or three operative 
procedures, and in these cases, all procedures have been included. 
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6.3.6 Rejection episodes since graft 
 
The effect of occurrence of a rejection episode during the post-operative period is shown in 
Figure 6.8 (Log Rank Statistic=1037.627; df=1; p<0.001). 
 
Figure 6.8 Rejection episodes since graft 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
No rejection episodes 13328 5228 2534 1236 685 324 110 28 1 
One or more rejection 
episodes 
2963 1372 718 349 175 76 26 1 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
No rejection episodes 13328 .90 .79 .68 .55 .29 
One or more rejection 
episodes 2963 .73 .50 .35 .24 .15 
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PENETRATING CORNEAL GRAFT SURVIVAL 
POST-GRAFT VASCULARIZATION 
Balance of database:     88% at 1 year 
 Mean Survival 13.32 years   75% at 5 years 
 (SE=0.17, 95% CI: 12.99, 13.66)  62% at 10 years 
 Median Survival 15 years   48% at 15 years 
       27% at 20 years 
Post-graft vascularization:   67% at 1 year 
 Mean Survival 7.22 years   46% at 5 years 
 (SE=0.33, 95% CI: 6.57, 7.88)  32% at 10 years 
 Median Survival 4 years   21% at 15 years 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
RISE IN IOP 
No rise in intraocular pressure since graft:  88% at 1 year 
 Mean Survival 13.61 years   76% at 5 years 
 (SE=0.19; 95% CI: 13.25, 13.98)  63% at 10 years 
 Median Survival 15 years   49% at 15 years 
       28% at 20 years 
Post-operative rise in intraocular pressure: 83% at 1 year 
 Mean Survival 10.18 years   60% at 5 years 
 (SE=0.29; 95% CI: 9.62, 10.74)  46% at 10 years 
 Median Survival 9 years   36% at 15 years 
       16% at 20 years 
 
 
 
PENETRATING CORNEAL GRAFT SURVIVAL 
REJECTION EPISODES 
No rejection episodes:     90% at 1 year 
 Mean Survival 14.40 years   79% at 5 years 
 (SE=0.20; 95% CI: 14.00, 14.79)  68% at 10 years 
 Median Survival 17 years   55% at 15 years 
       29% at 20 years 
One or more rejection episodes:   73% at 1 year 
 Mean Survival 8.18 years   50% at 5 years 
 (SE=0.20; 95% CI: 7.79, 8.57)  35% at 10 years 
 Median Survival 6 years   24% at 15 years 
       15% at 20 years 
 
 
KEY: n/a  =  not applicable  SE = standard error 
 Cl = confidence interval  df = degrees of freedom 
 p = probability 
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6.4 POST-GRAFT OPERATIVE PROCEDURES 
 
Table 6.5 Post-graft operative procedures 
 
Procedure Number of grafts1 
 Sub- total Total 
% of grafts 
followed 
Refractive surgery  1947 (2469) 12% 
          Relaxing incision 826 
  
          Suture adjustment 691 
  
          Compression sutures 328 
  
          Excimer laser - LASIK 145 
  
          Wedge resection 96 
  
          Excimer laser - PRK 66 
  
          Other refractive surgery 301 (317) 
  
Repeat graft (reported to ACGR in follow-up2)  1729 11% 
Cataract extraction and IOL implant  682 4% 
Yag laser  591 4% 
Glaucoma surgery   450 (535) 3% 
 Trabeculectomy 252   
 Valve implant 126   
 Cyclocryotherapy 65   
 Other valve procedure 19   
 Miscellaneous 65 (73)   
Wound repair  279 2% 
Enucleation following graft failure  142 <1% 
Vitrectomy/anterior vitrectomy  107 <1% 
IOL implant into aphakic eye  105 <1% 
Tarsorrhaphy  71 <1% 
Gunderson/conjunctival flap  69 <1% 
Retinal surgery  59 <1% 
Cataract extraction - no IOL implant  52 <1% 
Laser (unspecified)  22 <1% 
Remove IOL - eye left aphakic  21 <1% 
Exchange IOL and replace new IOL  18 <1% 
Scraping/biopsy  18 <1% 
Ectropion/entropion repair  17 <1% 
Ptosis repair  16 <1% 
Division of anterior synechiae  16 <1% 
Miscellaneous procedures  280 (320) 2% 
Total procedures 7338 
Total grafts followed 16291 
 
The number of grafts does not necessarily equate to the number of procedures as some grafts have had more than one 
operative procedure since graft. Where multiple occurrences of the same type of procedure were recorded, the total number 
of procedures recorded is also shown in parenthesis. 
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6.4.1 Refractive surgery 
 
Figure 6.9 shows the effect of any form of post-graft refractive surgery on graft survival 
(Log Rank Statistic=294.318; df=1; p<0.001). Data were carried over from one follow-up to 
the next. 
 
Figure 6.9 The effect of refractive surgery 
 
 
 
Number at Risk 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Balance of database 14343 5352 2548 1227 651 305 103 27 1 
Any refractive surgery  
post-graft 
1947 1248 704 358 209 95 33 9 n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Balance of database 14343 .85 .69 .56 .44 .23 
Any refractive surgery 
post-graft 1947 .99 .91 .79 .59 .40 
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PENETRATING CORNEAL GRAFT SURVIVAL 
EFFECT OF REFRACTIVE SURGERY 
Balance of database:     85% at 1 year 
 Mean Survival 12.29 years   69% at 5 years 
 (SE=0.17, 95% CI: 11.95, 12.63)  56% at 10 years 
 Median Survival 13 years   44% at 15 years 
       23% at 20 years 
Any refractive surgery post-graft:  99% at 1 year 
 Mean Survival 16.41 years   91% at 5 years 
 (SE=0.37, 95% CI: 15.68, 17.13)  79% at 10 years 
 Median Survival 18 years   59% at 15 years 
       40% at 20 years 
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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6.5 SUMMARY OF POST-GRAFT EVENTS 
 
 The major reasons for failure of penetrating grafts are irreversible 
rejection (31%), endothelial cell failure (15%), infection including 
recurrent HSV keratitis (8%), and glaucoma (8%). 
 Removal of graft sutures within 6 months of the time of transplantation is 
a risk factor for graft failure. 
 A variety of post-operative events are associated with graft failure.  
These include development of microbial keratitis or a stitch abscess 
(affecting 3% of grafts), uveitis (1%), synechiae (2%), graft 
neovascularization (6%), rejection episodes (18%) and a rise in 
intraocular pressure (16%) in the grafted eye. 
 Over 33% of grafted eyes have undergone some form of operative 
procedure since the time of corneal transplantation. 
 In 12% of cases, a refractive procedure has been performed on the 
grafted eye.  
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7. VISUAL OUTCOME 
 
All plots and tables in this chapter have been calculated using penetrating grafts 
only. Details of visual outcomes for lamellar grafts are analysed in Chapter 8. 
 
7.1 DESIRED OUTCOME 
 
The Australian Corneal Graft Registry has recorded a desired outcome for 16,228 (81%) of 
the 19,952 penetrating grafts entered. These outcomes are shown in Figure 7.1 and  
Table 7.1. 
 
Figure 7.1 Desired outcome of graft 
 
 
Table 7.1 Desired outcomes 
 
Desired Outcome Number % 
Improvement in visual acuity only 11935 74% 
Structural repair only 597 4% 
Pain relief only 578 4% 
Improved cosmesis only 26 <1% 
Improved visual acuity and pain relief*  2470 15% 
Improved visual acuity and other (not pain relief)  560 3% 
Mixture of reasons not including improved visual acuity 62 <1% 
TOTAL 16228 100% 
*Including where desired outcomes were improved visual acuity, pain relief plus cosmesis, structural repair or 
both. 
Improve visual 
acuity 74%
Pain/visual 
acuity 15%
Improved 
cosmesis <1%
Structural repair 4%
Pain relief 4%
Mixture not 
visual acuity <1%
Other/visual 
acuity 3%
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7.2 OVERALL VISUAL ACUITY 
 
Figure 7.2 shows the best corrected visual acuity in the grafted eye at the time of the most 
recent follow-up. Post-graft visual acuity had been recorded for 13,463 penetrating grafts. 
Of these 5,959 (44%) have recorded a best corrected acuity of 6/12 or better; 7,258 (54%) 
had achieved 6/18 or better; and 3,618 (27%) record a visual acuity of less than 6/60. In an 
additional 2,828 cases, information was not available. 
 
 
Figure 7.2 Best corrected visual acuity in grafted eye at last follow-up 
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BEST CORRECTED SNELLEN ACUITY AT MOST 
RECENT POST-OPERATIVE VISIT 
6/12 or better 5959 37% 
6/18 or better 7258 45% 
6/24 - 6/60 2589 16% 
Less than 6/60 3618 22% 
Unknown/not recorded 2828 17% 
Percentages shown in this box are for all 16291 followed penetrating grafts 
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7.2.1 Comparison of recipient characteristics for whom 
post-graft visual acuity is ≥ 6/18 or <6/18 
 
The categories below are not mutually exclusive for either set of comparisons. 
 
Table 7.3 Comparison where post-graft vision is  ≥6/18 or <6/18 
 
Description VA equal to or better than 
6/18 
VA is worse than 6/18 
 No. % No. % 
Reasons for grafting     
Vision only 5133 64% 2927 36% 
Cosmesis only 7 41% 10 59% 
Pain only 71 18% 334 82% 
Tectonic only 56 18% 250 82% 
Vision and pain 541 36% 976 64% 
Other combinations involving vision 147 35% 270 65% 
Other combinations not involving vision 4 11% 34 89% 
Not advised 1299 48% 1404 52% 
Presenting disease     
Keratoconus 4028 80% 996 20% 
Keratoconus with hydrops 122 69% 55 31% 
Fuchs' dystrophy 954 60% 628 40% 
Scar (non-herpetic) 502 51% 485 49% 
HSV - history (not at graft) 293 48% 314 52% 
Previous graft failure 960 37% 1617 63% 
HSV – active at graft 47 29% 116 71% 
Pseud. bullous keratopathy 750 27% 2059 73% 
Aphakic bullous keratopathy 116 22% 410 78% 
Perforation  80 20% 318 80% 
Lens at last follow-up 
    
Phakic 4505 74% 1597 26% 
Pseudophakic 2611 40% 3885 60% 
Aphakic 142 16% 723 84% 
Operative procedure at graft     
Triple procedure 769 54% 655 46% 
Cataract removed  785 53% 694 47% 
Peripheral iridectomy 271 46% 320 54% 
Trabeculectomy 12 25% 36 75% 
Anterior vitrectomy 281 23% 925 77% 
Operative procedure post-graft     
Refractive surgery performed 831 70% 364 30% 
Cataract removed; IOL inserted 270 67% 131 33% 
Insertion of IOL  295 63% 171 37% 
Yag/mechanical capsulotomy 226 57% 169 43% 
Cataract removed; no IOL 14 37% 24 63% 
Complications in follow-up     
Major astigmatism 1785 64% 1015 36% 
Cataract affecting VA 199 45% 244 55% 
Amblyopia 150 36% 265 64% 
Rejection episodes  596 31% 1342 69% 
Raised IOP post-graft 718 31% 1617 69% 
Neovascularization 264 30% 603 70% 
Uveitis 49 28% 123 72% 
Stitch abscess/microbial keratitis 100 27% 264 73% 
HSV in post-operative period 73 26% 213 74% 
Maculopathy 315 24% 1017 76% 
Synechiae 65 22% 228 78% 
CME 154 18% 698 82% 
Retinal detachment 28 13% 184 87% 
Graft has failed 122 5% 2476 95% 
Recipient age 
    
Recipient age ≥ 80 years 525 28% 1343 72% 
Overall 7258 54% 6205 46% 
TOTAL GRAFTS 13463 (100%) 
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In summary, slightly more than half of recipients achieved vision of 6/18 or better. This level 
of vision was proportionately more likely to be achieved by recipients who had undergone 
their graft for the sole purpose of improved vision, for keratoconus, who were phakic at their 
last follow-up, and/or who had had post-graft refractive surgery performed, or insertion of 
an IOL. These recipients were also more likely to report having major astigmatism, likely 
due to the frequent co-morbidity of this condition with keratoconus. All other specified 
complications were more likely to have occurred in recipients with post-graft visual acuity 
worse than 6/18, particularly cystoid macular oedema, retinal detachment or graft failure. 
The recipients with poor visual outcome were also more likely to have undergone 
trabeculectomy or anterior vitrectomy at graft, be aphakic, have a history of graft failure, 
have undergone the graft because of active HSV or bullous keratopathy, and/or have 
undergone the graft for pain relief or tectonic repair. 
 
7.2.2 Post-graft changes in visual acuity 
 
In 10,543 cases, both pre-operative and post-operative Snellen visual acuities were 
available. Figure 7.3 shows the number of lines of improvement or worsening in visual 
acuity since graft, as measured at the most recent follow-up. 
 
Figure 7.3 Changes in Snellen acuity after graft 
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Number of lines on the 
Snellen Chart 
Surviving grafts 
No.           % 
Failed grafts 
No.           % 
Total Grafts 
No.           % 
VA worse by > 10 lines 2 <1 1 <1 3 <1 
VA worse by 5-10 lines 41 <1 56 3 97 <1 
VA worse by 2-4 lines 316 4 331 18 647 6 
VA worse by 1 line 331 4 398 21 729 7 
VA unchanged 804 9 590 31 1394 13 
VA better by 1 line 874 10 289 15 1163 11 
VA better by 2-4 lines 2397 28 181 10 2578 24 
VA better by 5-10 lines 3841 44 40 2 3881 37 
VA better by > 10 lines 51 <1 0 0 51 <1 
Sub Totals 8657 82% 1886 18% 10543 100% 
TOTAL   10543   (100%) 
In 73% of cases post graft Snellen acuity was better than pre-graft, 13% showed no change 
and in 14%, Snellen acuity was worse than pre-graft. 
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The visual acuity in 14% of these recipients was worse following the graft, in 13% it 
remained unchanged, while 73% exhibited improvement. Of the 1,476 grafts for which 
acuity had decreased, 786 (53%) had failed, and of the 1,394 grafts for which visual acuity 
remained unchanged, 590 (42%) had failed. Interestingly, 510 grafts reported as having 
failed actually recorded a better visual acuity at the last follow-up than they did at the time 
of graft. Data stratified by change in visual acuity are examined more closely in Table 6.4.  
Categories are not mutually exclusive. 
 
Table 7.4 Change in visual acuity post-graft 
 
Description Better VA Same VA Worse VA 
 No. % No. % No. % 
Reasons for graft       
Vision only 5230 68% 673 48% 832 56% 
Cosmesis only 4 <1% 4 <1% 3 <1% 
Tectonic only 118 2% 64 5% 59 4% 
Pain only 164 2% 84 6% 56 4% 
Pain & vision 930 12% 276 20% 231 16% 
Other combinations involving vision 262 3% 69 5% 61 4% 
Other combinations not involving vision 16 <1% 9 <1% 10 <1% 
Not advised 949 12% 215 15% 224 15% 
Presenting disease       
Bullous keratopathy (no Fuchs’) 164 21% 39 3% 35 2% 
  Pseudophakic  1335 17% 489 35% 419 28% 
  Aphakic  220 3% 89 6% 69 5% 
Previous graft failure 1288 17% 383 27% 348 24% 
Keratoconus (including with hydrops) 3605 47% 239 17% 312 21% 
Fuchs’ dystrophy 958 12% 149 11% 241 16% 
Scar (non-herpetic) 520 7% 94 7% 118 8% 
HSV – history (not  at graft) 291 4% 70 5% 75 5% 
Perforation (non-herpetic) 165 2% 75 5% 59 4% 
HSV – active at graft 63 <1% 25 2% 17 1% 
Lens status at last follow-up       
Pseudophakic 3459 45% 916 66% 891 60% 
Phakic 3915 51% 344 25% 453 31% 
Aphakic 299 4% 134 10% 132 9% 
Operative procedure at graft       
Triple procedure  846 11% 146 10% 173 12% 
Cataract removed 867 11% 158 11% 184 12% 
Anterior vitrectomy 520 7% 189 14% 176 12% 
Peripheral iridectomy 387 5% 63 5% 74 5% 
Trabeculectomy 18 <1% 6 <1% 15 1% 
Operative procedure post-graft       
Refractive surgery performed 658 9% 76 5% 91 6% 
YAG/mechanical capsulotomy 231 3% 28 2% 32 2% 
Cataract removed; IOL inserted 254 3% 27 2% 28 2% 
Cataract removed; no IOL 19 <1% 4 <1% 3 <1% 
Complications in follow-up       
Graft has failed 510 7% 590 42% 786 53% 
Raised IOP post-graft 1041 14% 358 26% 413 28% 
Any rejection episodes since graft 789 10% 320 23% 335 23% 
Major astigmatism 1866 24% 199 14% 190 13% 
Maculopathy 632 8% 242 17% 173 12% 
Neovascularization 344 4% 129 9% 141 10% 
CME 335 4% 134 10% 97 7% 
Stitch abscess or microbial keratitis 125 2% 59 4% 95 6% 
Cataract affecting VA 238 3% 57 4% 60 4% 
Retinal detachment 58 <1% 35 3% 63 4% 
HSV in post-operative period 108 1% 43 3% 46 3% 
Synechiae 99 1% 56 4% 38 3% 
Uveitis 61 <1% 16 1% 24 2% 
Amblyopia 228 3% 47 3% 33 2% 
Recipient age       
Recipient age ≥ 80 916 12% 319 23% 285 19% 
Overall 7673 73% 1394 13% 1476 14% 
TOTAL GRAFTS 10543 (100%) 
Australian Corneal Graft Registry Report 2012 157 
VISUAL OUTCOME 
 
 
 
 
The change in Snellen acuity following corneal transplantation was unknown in 5,748 
cases. In the majority of these, the Registry was unaware of the pre-operative acuity. The 
overall percentages of recipients in each category can be seen in the box below, along with 
the percentage of each group as a proportion of all penetrating grafts followed. 
 
 
 
CHANGE IN SNELLEN ACUITY AFTER GRAFT 
 
Better      7673    (47%) 
Same      1394    (  9%) 
Worse      1476    (  9%) 
VA not advised to ACGR   5748    (35%) 
[Calculated as a percentage of all followed penetrating grafts (16,291)] 
 
 
 
 
 
7.3 VISUAL OUTCOME RELATED TO 
PRESENTING DISEASE 
 
 
The following pages show the visual outcome of penetrating grafts performed for 
keratoconus, Fuchs' dystrophy, aphakic or pseudophakic bullous keratopathy, previously 
failed grafts or herpetic infection. These were the most common indications for penetrating 
corneal transplantation in our database. 
 
In each case we provide two charts - the first showing the post-graft Snellen visual acuities, 
and the second showing the number of lines of improvement or worsening in visual acuity 
compared with the pre-operative acuity. 
 
Where there were multiple reasons for graft provided (e.g. Fuchs’ dystrophy AND herpetic 
infection), the data for these grafts is included in both sections. Failed grafts were included 
where information is available. 
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7.3.1 Keratoconus 
 
Figure 7.4 Visual outcome:   keratoconus 
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Sixty five percent of all grafts performed for keratoconus achieved a post-graft visual acuity 
of 6/12 or better, 73% achieved 6/18 or better and 85% achieved 6/60 or better. In 87% of 
cases where the visual acuity was provided both before and after graft, at least one line of 
improvement on the Snellen chart was achieved after graft. 
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7.3.2 Fuchs' dystrophy 
 
Figure 7.5 Visual outcome:   Fuchs' dystrophy 
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Forty percent of all grafts performed for Fuchs' dystrophy achieved a post-graft visual 
acuity of 6/12 or better, 52% achieved 6/18 or better and 69% achieved 6/60 or better. In 
71% of cases where the ACGR was provided with VA both before and after graft, at least 
one line of improvement on the Snellen chart was achieved after graft. 
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7.3.3 Aphakic bullous keratopathy 
 
Figure 7.6 Visual outcome:  aphakic bullous keratopathy 
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Ten percent of grafts performed for aphakic bullous keratopathy achieved a visual acuity of 
6/12 or better, 16% achieved 6/18 or better and 36% achieved 6/60 or better. In 58% of 
cases where visual acuities were provided both before and after graft, at least one line of 
improvement on the Snellen chart was achieved after graft. 
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7.3.4 Pseudophakic bullous keratopathy 
 
Figure 7.7 Visual outcome:  pseudophakic bullous keratopathy 
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Thirteen percent of grafts performed for pseudophakic bullous keratopathy achieved a post-
graft visual acuity of 6/12 or better, 20% achieved 6/18 or better and 40% achieved 6/60 or 
better. In 57% of cases where visual acuities were provided both before and after graft, at 
least one line of improvement on the Snellen chart was achieved after graft. 
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7.3.5 Previous failed graft 
 
Figure 7.8 Visual outcome:   previous failed graft 
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Twenty three percent of grafts performed for a previously failed graft achieved a post-graft 
visual acuity of 6/12 or better, 29% achieved 6/18 or better and 45% achieved 6/60 or 
better. In 64% of cases in which visual acuity was reported both before and after graft, at 
least one line of improvement on the Snellen chart was achieved after graft. 
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7.3.6 Herpetic infection 
 
Figure 7.9 Visual outcome:   herpetic infection 
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In recipients in whom HSV infection had been recorded at any time pre-graft, 26% of the 
cohort achieved a post-graft visual acuity of 6/12 or better, 34% achieved 6/18 or better and 
51% achieved 6/60 or better. In 65% of cases where visual acuity was provided both before 
and after graft, at least one line of improvement on the Snellen chart was achieved after 
graft. 
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In those cases where HSV was active at the time of graft, 15% achieved a visual acuity of 
6/12 or better, 21% achieved 6/18 or better and 39% achieved 6/60 or better (not 
illustrated). 
 
In those cases where HSV was not active at time of graft, 30% achieved a visual acuity of 
6/12 or better, 39% achieved 6/18 or better and 56% achieved 6/60 or better (not 
illustrated). 
 
In 4% of cases where herpetic infection was a reason for graft, it was not known whether 
this infection was active at the time of graft. 
 
It can be observed that the percentages reporting each level of vision achieved were 
consistently lower than those documented in the previous Registry report. As these data 
were based on the most recent follow-up data for each graft, this is possibly due to the 
increased length of follow-up in the current cohort, with visual acuity decreasing as the 
grafts (and recipients) become older. 
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7.4 FACTORS AFFECTING VISUAL 
POTENTIAL OF THE GRAFTED EYE 
 
 
Table 7.5 lists some of the factors which have affected the visual potential of the grafted 
eye (penetrating grafts only). The factors are not necessarily mutually exclusive. 
 
 
Table 7.5 Factors affecting visual potential of the grafted eye 
 
Description Total % 
Graft failure 3794 23% 
Astigmatism (>5D=2868)  (irregular=98) 2948 18% 
Maculopathy (unspecified) 1514 9% 
Anisometropia 1242 8% 
Aphakia  1151 7% 
Glaucoma 1086 7% 
Cystoid macular oedema 954 6% 
Opacity/scar 593 4% 
Cataract  460 3% 
Amblyopia 457 3% 
Myopia 449 3% 
Retinal detachment 246 2% 
Diabetic retinopathy 74 <1% 
Other factors 722 4% 
Total penetrating grafts                     = 16291 (100%) 
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7.5 MAJOR ASTIGMATISM 
 
 
Figure 7.10 shows the most recent post-operative measure of major regular astigmatism, 
where recorded. 2,868 grafts (18%) were recorded as having major astigmatism (≥ 5 
dioptres) at last follow-up. Of these, the specific dioptres of astigmatism were recorded for 
1,559 (54%) grafts.  
 
Post-operative astigmatism of less than 5 dioptres is no longer recorded in the Registry.  
 
 
Figure 7.10 Dioptres of regular astigmatism in the grafted eye at last follow-up 
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7.6 REFRACTIVE SURGERY 
 
 
Table 7.6 lists refractive surgical procedures performed on penetrating grafts. One or more 
procedures were carried out on 1,940 grafts (12% of penetrating grafts followed). 
 
 
Table 7.6 Refractive surgery 
 
Procedure Number  % 
Relaxing incisions 826 34% 
Suture adjustment 690 28% 
Compression sutures 328 13% 
LASIK 145 6% 
Excimer/PARK/laser  109 4% 
Wedge resection 94 4% 
Other 124 5% 
Unknown procedure 147 6% 
Total procedures 2463 100% 
2463 procedures over 1940 grafts  
(12% of all followed grafts) 
 
 
7.6.1 Correction following refractive surgery 
 
Table 7.7 shows the method of correction used for the 1,940 grafts that had undergone 
refractive surgery. 
 
 
Table 7.7 Correction following refractive surgery 
 
Method of correction Number  % 
Spectacles 997 51% 
Contact lens 135 7% 
Spectacles and contact lens 43 2% 
No correction/not advised 765 39% 
TOTAL 1940 100% 
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7.6.2 Has refractive surgery improved visual acuity? 
 
 
The post graft Snellen acuities were provided for 1,940 penetrating grafts that had 
undergone refractive surgery. Visual acuity was equal to or better than 6/12 in 1,021 (53%) 
of these cases, better than or equal to 6/18 in 1,227 (63%), and better than or equal to 6/60 
in 1,544 (80%). This compares with 37% for 6/12 or better, 45% for 6/18 or better and 60% 
for 6/60 or better in the database as a whole. 
 
Of these 1,316 also had pre-graft Snellen visual acuity recorded. One thousand and fourty 
six (79%) showed an improvement in visual acuity, 116 (9%) were unchanged since before 
graft and 154 (12%) were worse. 
 
Figure 7.11 shows grafts that had not undergone refractive surgery post-operatively.  
 
 
Figure 7.11 Change in lines on the Snellen chart for grafts that have not 
undergone refractive surgery 
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Of those 14,351 grafts that had not undergone refractive surgery, visual acuities, both 
before and after graft, had been provided for 9,226. Of these, 6,626 (72%) showed an 
improvement in visual acuity, 1,278 (14%) showed no change since before graft and 1,322 
(14%) were worse. Snellen acuity appeared slightly better in the group that has undergone 
refractive surgery to the graft.  
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7.7 TRIPLE PROCEDURES 
 
7.7.1 Snellen acuity 
 
Figure 7.12 shows the visual acuity at most recent follow-up for 1,718 triple procedures. 
 
Figure 7.12  Visual acuities for all triple procedure grafts 
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7.7.2 Visual improvement after graft: triple procedure 
 
Figure 7.13 shows the number of lines of change on the Snellen chart for triple procedures. 
 
Figure 7.13 Triple procedures - lines of change 
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7.8 POST-GRAFT CORRECTION 
 
At the last follow-up, 6,197 (50%) of recipients with surviving grafts were reported to wear 
glasses, 5,837 (47%) had an IOL in place and 999 (8%) wore contact lenses. 
 
Table 7.9 shows the post-graft correction prescribed for grafts that had survived for less 
than 2 years; between 2 and 5 years; between 5 and 10 years and over 10 years.   
 
 
Table 7.9 Post-graft correction dependent on survival time 
 
 Survival time of graft 
Method of correction ≤2 years >2 – 5 years >5 – 10 years >10 years 
 No. % No. % No. % No. % 
None or none advised 1465 28% 802 20% 357 16% 133 14% 
Glasses only 949 18% 1051 26% 677 30% 344 36% 
Contact lens only 194 4% 220 6% 164 7% 135 14% 
IOL only 1663 32% 649 19% 352 15% 85 9% 
Glasses & contact lens 34 <1% 72 2% 47 2% 16 2% 
Glasses and IOL 943 18% 1150 34% 650 29% 228 24% 
Contact lens and IOL 20 <1% 31 <1% 23 1% 7 <1% 
Glasses, contact lens 
and IOL 
7 <1% 15 <1% 6 <1% 8 <1% 
Sub-total 5275 100% 3990 100% 2276 100% 956 100% 
TOTAL 12497 surviving penetrating grafts 
 
 
The data suggest that visual rehabilitation following corneal transplantation may take 
several years, with adjustments continuing to be made for as long as 10 years. The use of 
at least one form of visual correction became more likely as time progressed, with 86% of 
grafts surviving for more than 10 years needing at least one form of correction. In the 
longest surviving cohort (over 10 years) the majority of recipients wore glasses (62%). For 
over one-third (36%), this was the only form of correction utilised. 
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7.9 SUMMARY OF VISUAL OUTCOME AFTER 
CORNEAL TRANSPLANTATION 
 Information on the desired outcome after corneal transplantation was 
available for 81% of the cohort. In 74% of cases, the major reason for 
transplantation was improved vision and in a further 15%, the reasons were 
improved vision plus relief of pain. 
 A best-corrected Snellen acuity at last follow-up was available in 83% of 
cases. A best corrected visual acuity (BCVA) of 6/12 or better at the time of 
most recent follow-up was achieved in 44% of these eyes, and of 6/18 or 
better in 54%. A best corrected acuity of less than 6/60 was achieved by 
27% of grafted eyes with follow-up BCVA available. 
 Where information was available, Snellen acuity improved after corneal 
transplantation in 73% of cases, remained the same in 13% of cases and 
worsened in 14% of cases. 
 Visual outcome after corneal transplantation depended, to some extent, on 
indication for graft, lens status and on co-morbidities. 
 
Indication for graft Percent achieving 6/18 or 
better in the grafted eye * 
Keratoconus 80% 
Fuchs' dystrophy 60% 
History of HSV infection (not active) 48% 
Previous failed graft 37% 
Pseudophakic bullous keratopathy 27% 
Aphakic bullous keratopathy 22% 
 
*  unknowns excluded from calculations 
 
 
 The most important factors with a negative influence on the visual outcome 
of the grafted eye were: graft failure, major astigmatism (≥5D), and 
maculopathy. 
 A refractive surgical procedure was performed on 12% of grafts. 
 By 10 years post-graft, 14% of grafted eyes either required no form of 
correction or had been prescribed none, while a further 9% of eyes had an 
IOL in situ but were otherwise uncorrected. 
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8. LAMELLAR GRAFTS 
 
 
8.1 SYNOPSIS OF LAMELLAR GRAFTS 
 
Lamellar grafts have been registered since the Registry’s inception. We refer to these as 
“traditional” lamellar grafts. In recent years, the newer procedures of deep anterior lamellar 
keratoplasty (DALK) and various forms of endothelial cell keratoplasty (endokeratoplasty) 
have been adopted. Tables 8.1 and 8.2 give detailed analyses of each form of these new 
procedures, along with traditional lamellar grafts. 
 
Table 8.1 Synopsis of lamellar grafts (Census date for all grafts in this Chapter is 
12/10/2011)  
 
Number registered  Type of Lamellar Procedure 
No. % 
Traditional lamellar 1165 39% 
Big Bubble 16 <1% 
Melles 6 <1% 
DALK1 unspecified 543 18% 
DALK Total 565 19% 
DSEK2 799 27% 
DMEK3 103 3% 
DSAEK4 135 5% 
Endothelial unspecified 216 7% 
Endothelial Total 1253 42% 
Total Lamellar 2983 100% 
 
1Deep anterior lamellar keratoplasty 
2Descemet’s stripping endothelial keratoplasty 
3Descemet’s membrane endothelial keratoplasty 
4Descemet’s stripping automated endothelial keratoplasty 
 
Table 8.2 Survival of followed lamellar grafts 
 
Of followed 
Number followed 
Failed Surviving 
 
 
Type of Lamellar 
Procedure 
No. % No. % No. % 
Traditional lamellar 934 100% 218 23% 716 77% 
DALK  264 100% 23 9% 241 91% 
Endothelial  553 100% 142 26% 411 74% 
Total Lamellar 1751 100% 383 22% 1368 88% 
 
Eight hundred and six lamellar grafts had been lost to follow-up comprising 552 traditional 
lamellar grafts, 154 DALKs and 100 endothelial keratoplasties. 
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8.2 SURVIVAL OF LAMELLAR GRAFTS 
 
Survival curves for all lamellar and penetrating corneal grafts are presented in Figure 8.1 
(Log Rank Statistic=52.402; df=1; p<0.001).  
 
 
Figure 8.1  Survival of lamellar and penetrating corneal grafts 
 
 
Number at Risk 
 
Identity Initially  3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Penetrating 16736 6960 3428 1761 973 465 187 43 2 
Lamellar 1751 274 90 41 16 5 2 n/a n/a 
 
Probability of Graft Survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
Penetrating  16736 .87 .72 .59 .46 .26 
Lamellar 1751 .80 .67 .53 .41 n/a 
 
      n/a = not applicable 
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Until 2004, the majority (98%) of lamellar grafts performed were traditional grafts. Since 
2004, 792 (78%) of followed lamellar grafts performed were either DALKs or endothelial 
keratoplasties. The indications for these three types of lamellar grafts are very different. 
Figure 8.2 compares graft survival of different types of lamellar grafts performed since 2004 
and was analysed on a monthly basis (Log Rank Statistic=43.706; df=2; p<0.001). Corneal 
graft survival was worst for endothelial lamellar grafts.  
 
 
Figure 8.2 Survival of traditional grafts, DALK and endothelial lamellar grafts 
(post 2003) 
 
 
 
Number at Risk 
 
Identity Initially  12 months 
24 
months 
36 
months 
48 
months 
60 
months 
72 
months 
84 
months 
Traditional 221 133 73 43 20 5 n/a n/a 
DALK 239 195 72 22 11 3 1 n/a 
Endothelial 553 320 72 5 n/a n/a n/a n/a 
 
Probability of Graft Survival (at years post-graft) Identity No. initially 
at risk 1 3 6 
Traditional 221 .82 .75 n/a 
DALK 239 .95 .89 .78 
Endothelial 553 .77 .59 n/a 
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CORNEAL GRAFT SURVIVAL 
PENETRATING AND LAMELLAR GRAFTS 
Penetrating corneal graft survival:  87% at 1 year 
 Mean Survival 12.85 years   72% at 5 years 
 (SE=0.15; 95% CI: 12.55, 13.14)  59% at 10 years 
 Median Survival 14 years   46% at 15 years 
       26% at 20 years 
Lamellar corneal graft survival:   80% at 1 year 
 Mean Survival 10.47 years   67% at 5 years 
 (SE=0.51; 95% CI: 9.47, 11.47)  53% at 10 years 
 Median Survival 13 years   41% at 15 years 
 
 
 
 
 
 
LAMELLAR CORNEAL GRAFT SURVIVAL 
TYPE OF GRAFT (SINCE 2004) 
Traditional lamellar:    80% at 1 year 
 Mean Survival 50.01 months  67% at 5 years 
 (SE=2.44; 95% CI 45.24, 54.79)  53% at 10 years 
 Median Survival 61 months (5.1 years) 42% at 15 years 
       31% at 20 years 
Deep anterior lamellar keratoplasty (DALK): 93% at 1 year 
 Mean Survival 68.99 months  83% at 5 years 
 (SE=3.39; 95% CI: 61.36, 74.64)  69% at 10 years 
 Median Survival approx. 87 months (6.5 years)   
Endothelial keratoplasty:     74% at 1 year 
 Mean Survival 29.32 months   
 (SE=1.05; 95% CI: 27.25, 31.38)   
 Median Survival 38 months (2.6 years)   
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.3 DESIRED OUTCOME 
 
The Australian Corneal Graft Registry has recorded a desired outcome for 2,637 (88%) of 
the 2,983 lamellar grafts entered. Of these, 890 (34%) were traditional lamellar grafts, 542 
(20%) were DALKs and 1,205 (46%) were endothelial lamellar grafts. Desired outcomes for 
each type of lamellar graft are shown in Figure 8.3 and Table 8.3. 
 
 
Figure 8.3 Desired outcome of graft 
 
 
Traditional 
Structural repair 
50%
cosmesis 5%
Improved visual 
acuity 22%
Pain relief 4%Mixture of 
reasons 19%
Pain relief & 
visual acuity 1%
DALK
Pain relief <1%Pain relief & 
visual acuity 1%
Structural repair 
2%
Improved visual 
acuity 92%
Mixture of 
reasons 5%
 
Endothelial 
cosmesis <1%
Structural repair 
<1%
Pain relief & visual 
acuity 23%
Mixture of reasons 
<1%
Improved visual 
acuity 74%
Pain relief 1%
 
 
 
Table 8.3  Desired outcomes 
 
Desired Outcome Traditional DALK Endothelial 
Structural repair 447 50% 9 2% 3 <1% 
Improvement in visual acuity 194 22% 498 92% 896 74% 
Mixture of reasons 167 19% 28 5% 6 <1% 
Pain relief 32 4% 1 <1% 18 1% 
Cosmesis 41 5% 0 0% 1 <1% 
Pain and visual acuity 9 1% 6 1% 281 23% 
TOTAL 890 100% 542 100% 1205 100% 
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8.4 OVERALL VISUAL ACUITY 
 
Figure 8.4 shows the best corrected visual acuity in the grafted eye at the time of the most 
recent follow-up for each type of lamellar procedure.  
 
 
 
 
Figure 8.4 Best corrected Snellen visual acuity in grafted eye at last follow-up by 
percentage of type of lamellar graft 
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∗ The numbers above the bars are numbers of grafts. 
 
∗ Post graft visual acuity has been recorded for 688 traditional lamellar grafts, 251 DALK 
and 522 endothelial lamellar grafts.  
 
∗ A best corrected Snellen acuity of 6/12 or better at most recent follow-up was achieved 
in 34% of cases for traditional lamellar grafts; 37% of DALKs and 18% of endothelial 
lamellar grafts.  
 
∗ Forty seven percent of traditional lamellar grafts, 62% of DALKs and 45% of endothelial 
lamellar grafts achieved 6/18 or better.  
 
∗ A visual acuity of less than 6/60 at last follow-up was recorded in 21% of traditional 
lamellar grafts, 16% of DALK and 33% of endothelial lamellar grafts.  
 
∗ Follow-up visual acuities were not advised for 26% of cases for traditional lamellar 
grafts, 5% of DALKs and 6% of endothelial lamellar grafts. 
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8.5 CORNEAL COLLECTION AND 
STORAGE 
 
Death-to-enucleation and death-to-graft times are shown in Table 8.4.  
 
Table 8.4 Corneal collection times for lamellar grafts 
 
 
Lamellar Grafts 
Median time Time Total 
Days 
Range 
(Days) 
Death-to-enucleation times  2921 <1       0 – 1 
Death-to-graft times 2310 5 0 – 69 
Death-to-graft times for storage in:    
Optisol  
Moist Pot 
Organ Culture  
CSM 
MK medium 
K-Sol 
1549 
447 
158 
69 
55 
21 
4 
7 
16 
10 
3 
5 
0 – 69 
0 – 46 
3 – 27 
1 – 44 
 0 – 19 
1 – 29 
 
The corneal storage media in which donor corneas were preserved are shown in Table 8.5. 
 
Table 8.5 Corneal storage media 
 
Storage medium No. of grafts 
Optisol 
(1991 – present) 
1911 64% 
M-K medium 
(1985 – 2002) 
72 2% 
CSM 
(1987 – 2003) 
79 3% 
Moist pot 
(1985 – present) 
613 20% 
K-Sol 
(1987 – 2000) 
22 <1% 
Organ Culture   
(1985 – 1997) 2 <1% 
(2007 – present) 242 8% 
Other 21 <1% 
Unknown to ACGR 21 <1% 
Total 2983 100% 
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8.6  EFFECT OF SURGEON WORKLOAD 
 
Figure 8.5 shows the survival of lamellar grafts by surgeons who performed 15 or more 
lamellar grafts per year, compared with surgeons who performed fewer than 15 grafts per 
year (Log Rank Statistic=0.021; df=1; p=0.88). The difference was not significant.  
 
Figure 8.5 Outcome according to number of grafts performed per year  
 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
< 15 grafts per year 1052 236 82 38 16 6 3 1 n/a 
≥15 grafts per year 699 39 9 4 2 0 n/a n/a n/a 
 
 
Graft survival (at years post-graft) 
Identity No. initially at 
risk 1 5 10 15 20 
< 15 grafts per year 1052 .79 .66 .55 .51 .38 
≥ 15 grafts per year 699 .82 .66 .37 n/a n/a 
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Of the 699 followed lamellar grafts carried out by surgeons who performed more than 15 
grafts per year, 632 (90%) were performed after 2003. Figure 8.6 looks more closely at 
lamellar grafts performed from 2004 to 2011 and was analysed on a monthly basis (Log 
Rank Statistic=5.460; df=1; p=0.019). When these new procedures were considered, a 
significant difference between surgeons who performed more or less than 15 grafts per 
year was apparent. 
 
Figure 8.6 Number of lamellar grafts performed/year since 2004 
 
 
Number at Risk 
 
Identity Initially 12 months 
24 
months 
36 
months 
48 
months 
60 
months 
72 
months 
84 
months 
< 15 grafts per year 381 243 91 45 21 5 1 n/a 
≥15 grafts per year 632 405 126 25 10 3 n/a n/a 
 
 
Graft survival (at years post-graft) Identity No. initially at 
risk 1 3 6 
< 15 grafts per year 381 .78 .70 .58 
≥15 grafts per year 632 .85 .73 n/a 
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LAMELLAR CORNEAL GRAFT SURVIVAL 
EFFECT OF SURGEON WORKLOAD PER YEAR 
Less than 15 grafts:     79% at 1 year 
 Mean Survival 12.65 years   66% at 5 years 
 (SE=0.86; 95% CI 10.97, 14.33)  55% at 10 years 
 Median Survival 17 years   51% at 15 years 
       38% at 20 years 
More than 15 grafts:      82% at 1 year 
 Mean Survival 7.25 years   66% at 5 years 
 (SE=0.83; 95% CI: 5.63, 8.87)  37% at 10 years 
 Median Survival 7 years    
 
 
 
 
 
 
LAMELLAR CORNEAL GRAFT SURVIVAL 
EFFECT OF SURGEON WORKLOAD PER YEAR SINCE 2004 
Less than 15 grafts:     78% at 1 year 
 Mean Survival 53.14 months  70% at 3 years 
 (SE=2.42; 95% CI 48.39, 57.89)  58% at 6 years 
 Median Survival 80 months (6.6 years)    
More than 15 grafts:      85% at 1 year 
 Mean Survival 47.37 months  73% at 3 years 
 (SE=1.55; 95% CI: 44.33, 50.42)   
 Median Survival 61 months (5.1 years)    
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.7 MAIN INDICATIONS FOR LAMELLAR 
KERATOPLASTY 
 
 
Table 8.6 Main indications for lamellar keratoplasty 
 
 
Traditional 
lamellar DALK 
Endothelial 
keratoplasty All lamellar Indication for graft 
n % n % n % n % 
         
Bullous keratopathy 14 1% 0 0% 416 33% 430 14% 
Keratoconus & keratoglobus 110 9% 427 75% 3 <1% 540 18% 
Failed previous graft 182 16% 18 3% 223 18% 423 14% 
Corneal dystrophy 15 1% 15 2% 590 47% 620 21% 
Fuchs' dystrophy 4 <1% 4 <1% 590 47% 598 20% 
Other dystrophies 11 <1% 11 2% 0 0% 22 <1% 
Pterygium 191 16% 0 0% 0 0% 191 6% 
Trauma 138 12% 7 1% 4 <1% 149 5% 
Corneal ulcers (non HSV) 139 12% 5 <1% 0 0% 144 5% 
Corneal degenerations 69 6% 26 5% 1 <1% 96 3% 
Disorders of the sclera 80 7% 1 <1% 0 0% 81 3% 
Neoplasia 73 6% 1 <1% 0 0% 74 2% 
Herpetic eye disease 45 4% 25 <1% 3 <1% 73 2% 
Corneal scars and opacities  
      (no history of herpetic disease) 31 3% 13 2% 0 0% 44 1% 
Non-herpetic infections 21 2% 20 4% 0 0% 41 1% 
Other** 57 2% 7 <1% 13 0% 77 <1% 
         
TOTALS 1165 100% 565 100% 1253 100% 2983 100% 
 
*Percentages are totalled down each column. 
**Includes - descemetocoele: (19) traditional & (2) DALK; congenital abnormalities: (8) traditional & (4) endothelial 
keratoplasties; metabolic deposits: (10) traditional & (1) each DALK/endothelial keratoplasty; ICE syndrome: (1) traditional & 
(8) endothelial keratoplasties; interstitial keratitis: (5) traditional lamellar & (3) DALK; glaucoma: (4) traditional; corneal 
amyloid: (2) traditional; epithelial defect (1) traditional; neovascularization (1) traditional; Sjogen’s syndrome (1) traditional; 
calcification (1) traditional; infective keratitis (1) DALK;. unknown: (4) traditional lamellar. 
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Figure 8.7 shows the survival curves for the main indication for lamellar grafts, as shown in 
Table 8.5 (Log Rank Statistic= 133.75; df=8; p<0.001). 
 
Figure 8.7 Main indications for all lamellar grafts 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Bullous keratopathy 341 7 n/a n/a n/a n/a n/a n/a n/a 
Keratoconus 266 41 12 4 2 n/a n/a n/a n/a 
Previous failed graft 252 30 12 8 3 n/a n/a n/a n/a 
Corneal dystrophies 126 5 1 n/a n/a n/a n/a n/a n/a 
Pterygium 163 48 17 11 7 3 2 1 n/a 
Trauma 124 37 18 6 2 1 1 n/a n/a 
Corneal Ulcers 126 18 8 2 1 1 n/a n/a n/a 
Infections 82 15 4 2 n/a n/a n/a n/a n/a 
Other 270 74 18 9 2 1 n/a n/a n/a 
 
Graft survival (at years post-graft) 
Identity 
No. initially at 
risk 1 5 10 15 20 
Bullous keratopathy 341 .74 n/a n/a n/a n/a 
Keratoconus 266 .90 .80 .80 n/a n/a 
Previous failed graft 252 .68 .48 .38 n/a n/a 
Corneal dystrophies 126 .78 .44 n/a n/a n/a 
Pterygium 163 .93 .93 .93 .73 .47 
Trauma 124 .92 .82 .62 .62 n/a 
Corneal Ulcers 126 .61 .42 .37 .37 n/a 
Infections 82 .72 .67 .51 n/a n/a 
Other 270 .90 .75 .43 .32 n/a 
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LAMELLAR CORNEAL GRAFT SURVIVAL 
MAIN INDICATION FOR GRAFT 
 
Bullous keratopathy:      74% at 1 year 
 Mean Survival 2.76 years    
 (SE=0.13; 95% CI: 2.50, 3.03)   
 Median Survival 4 years   
Keratoconus:       90% at 1 year 
 Mean Survival 11.55 years   80% at 5 year 
 (SE=0.57; 95% CI: 10.43, 12.68)   
 Median Survival approx. 15 years    
Previous failed graft:      68% at 1 year 
 Mean Survival 6.54 years    48% at 5 years 
 (SE=0.66; 95% CI: 5.24, 7.83)   38% at 10 year 
 Median Survival 5 years    
Corneal dystrophies:      78% at 1 year 
 Mean Survival 4.86 years    44% at 5 years 
 (SE=0.67; 95% CI: 3.55, 6.17)   
 Median Survival 5 years    
Pterygium:      93% at 1 year 
 Mean Survival 17.49 years   73% at 20 years 
 (SE=1.64; 95% CI 14.27, 20.70)   
 Median Survival 17 years    
Trauma:      92% at 1 year 
 Mean Survival 13.48 years   82% at 5 years 
 (SE=1.34; 95% CI 10.86, 16.11)   62% at 10 year 
 Median Survival approx. 19 years    
Corneal ulcers:     61% at 1 year 
 Mean Survival 6.95 years    42% at 5 years 
 (SE=1.04; 95% CI 4.91, 8.99)   37% at 10 year 
 Median Survival 4 years   
Infections:      72% at 1 year 
 Mean Survival 6.59 years    67% at 5 year 
 (SE=0.62; 95% CI: 5.38, 7.80)   51% at 10 year 
 Median Survival 9 years   
Other:       90% at 1 year 
 Mean Survival 9.25 years    75% at 5 years 
 (SE= 0.84; 95% CI 7.61, 10.89)   43% at 10 years 
 Median Survival approx 10 years   32% at 15 years 
  
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.8 REASON FOR GRAFT FAILURE 
 
 
Table 8.7 Overall reasons for failure of lamellar grafts 
 
 
Traditional 
lamellar 
DALK Endothelial 
keratoplasty 
All lamellar 
Reason 
n % n % n % n % 
Primary graft failure 15 7% 4 17% 70 49% 89 23% 
Corneal degeneration 31 14% 0 0% 2 1% 33 9% 
Ulcers (not from infection) 25 12% 1 4% 0 0% 26 7% 
          perforated 17 8% 1 4% 0 0% 18 5% 
          other 8 4% 0 0% 0 0% 8 2% 
Non-herpetic infections 23 11% 2 9% 1 <1% 26 7% 
Endothelial cell failure 8 4% 2 9% 14 10% 24 6% 
Rejection 8 4% 0 0% 12 8% 20 5% 
Scars and opacities 6 3% 2 9% 4 3% 12 3% 
Pterygium 10 5% 0 0% 0 0% 10 3% 
Herpetic infection 9 4% 1 4% 0 0% 10 3% 
HSV 8 4% 1 4% 0 0% 9 2% 
          HZO 1 <1% 0 0% 0 0% 1 <1% 
Astigmatism 8 4% 0 0% 0 0% 8 2% 
Carcinoma 6 3% 0 0% 0 0% 6 2% 
Wound dehiscence 6 3% 0 0% 0 0% 6 2% 
Scleral necrosis 5 2% 0 0% 0 0% 5 1% 
Glaucoma 0 0% 0 0% 4 3% 4 1% 
Vascularization 3 1% 1 4% 0 0% 4 1% 
Miscellaneous* 11 5% 4 17% 1 <1% 16 4% 
Unspecified 43 20% 6 26% 35 24% 84 22% 
TOTALS 217 100% 23 100% 143 100% 383 100% 
    
 
*Epithelial defect (3); injury (2); iris disorders (2); keratoconus (2); Stevens-Johnson syndrome (2); corneal dystrophy (1); 
ocular pemphigoid (1); scleral melt (1); symblepharon (1); Wegener’s granulomatosis (1). 
**Percentages are totalled down each column. 
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8.9 POST-GRAFT OPERATIVE 
PROCEDURES 
 
 
Post-graft operative procedures were carried out in 525 eyes with lamellar grafts (18%). 
These included 22 grafts (<1%) that had undergone both refractive and other surgical 
procedures.  
 
 
 
Table 8.8 Post-graft operative procedures 
 
Procedure Number of grafts 
 Total 
% of grafts 
followed 
Repeat graft (reported to ACGR in follow-up)   299 17% 
Cataract extraction and IOL implant    82 5% 
Yag laser    33 2% 
Wound repair     33 2% 
Refractive surgery 43 (48) 2% 
Glaucoma surgery      18 <1% 
Cataract and IOL surgery     11 <1% 
Miscellaneous procedures 74 (75) 4% 
Total procedures 599 
Total grafts followed 1751 
 
The number of grafts does not necessarily equate to the number of procedures as some grafts have had more than one 
operative procedure since graft. Where multiple occurrences of the same type of procedure were recorded, the total number 
of procedures recorded is also shown in parentheses. 
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8.10 PRIMARY NON FUNCTIONING 
GRAFTS 
 
Table 8.9 Features of primary non-functioning grafts (lamellar grafts only) 
 
Primary failures 
traditional 
Primary failures    
DALK 
Primary failures 
endothelial Feature 
No. % No. % No. % 
       
Procurement source       
Eyebank 15 100% 4 100% 70 100% 
Donor age       
≤ 20 years 0 0% 0 0% 1 1% 
21 – 60 years 2 13% 1 25% 23 33% 
61 – 80 years 12 80% 2 50% 39 56% 
>80 years 1 7% 1 25% 7 10% 
Main indication for graft       
Bullous keratopathy 4 27% 0 0% 38 54% 
Keratoconus  1 7% 4 100% 0 0% 
Previous failed graft 4 27% 0 0% 15 21% 
Corneal dystrophy 0 0% 0 0% 16 23% 
Corneal ulcers 4 27% 0 0% 1 1% 
Herpetic eye disease 1 7% 0 0% 0 0% 
Congenital 
abnormalities 1 7% 0 0% 0 0% 
Total corneas 15 100% 4 100% 70 100% 
 
Seventy nine (89%) of the 89 primary graft failures in lamellar grafts occurred in the past 
five years. The largest proportion (79%) of primary graft failures occurred in endothelial 
grafts. 
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8.11 DEEP ANTERIOR LAMELLAR 
KERATOPLASTY 
 
8.11.1 Main indications for graft – DALK 
 
 
Table 8.10 lists the main indications for graft for deep anterior lamellar keratoplasty. The 
majority of DALKs (76%) were performed for keratoconus. 
 
 
Table 8.10 Main indications for DALK 
 
 
Indication for graft Total % 
Keratoconus 427 76% 
Corneal degenerations 26 4% 
Herpetic eye disease 25 4% 
Non-herpetic infections 20 4% 
Failed previous graft 18 3% 
Corneal dystrophy 15 3% 
Corneal scars & opacities 13 2% 
Trauma 7 2% 
Corneal ulcers (non HSV) 5 <1% 
Interstitial keratitis 3 <1% 
Descemetocoele 2 <1% 
Scleral degeneration 1 <1% 
Unspecified keratitis 1 <1% 
Corneal neoplasm 1 <1% 
Metabolic deposits 1 <1% 
TOTAL 565 100% 
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8.11.2 DALK for Keratoconus 
 
Figure 8.8 compares corneal graft survival for penetrating and deep anterior lamellar 
keratoplasty (DALK) performed for keratoconus since the first DALK was recorded in 1996 
(Log Rank Statistic= 15.826; df=1; p<0.001). Data have been analysed on a monthly basis. 
The inset plot looks more closely at the first 4 years post graft. 
 
Figure 8.8 Grafts for keratoconus performed post 1995 – penetrating and DALK 
 
 
Number at Risk 
 
Identity Initially  3  years 
6  
years 
9  
years 
12 
years 
15 
years 
18 
years 
Penetrating 2736 1156 498 206 71 1 n/a 
DALK 183 18 4 n/a n/a n/a n/a 
 
 
Probability of Graft Survival (at years post-graft) Identity No. initially 
at risk 1 5 10 15 20 
Penetrating 2736 .98 .94 .89 .66 n/a 
DALK 183 .94 .90 n/a n/a n/a 
 
190 Australian Corneal Graft Registry Report 2012 
LAMELLAR GRAFTS 
 
 
CORNEAL GRAFT SURVIVAL 
PENETRATING AND DALK – KERATOCONUS (POST 1995) 
Penetrating:      98% at 1 year 
 Mean Survival 160.37 months  94% at 5 years 
 (SE=2.06; 95% CI 156.33, 164.40)  89% at 10 years 
 Median Survival 180 months (15 years) 66% at 15 years 
        
DALK:       94% at 1 year 
 Mean Survival 90.67 months  90% at 5 years 
 (SE=2.42; 95% CI: 85.93, 95.40)   
 Median Survival approx. 100 months (8.3 years)  
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
 
Figure 8.9 compares graft survival for penetrating and DALK grafts performed for 
keratoconus since 1996, as in Figure 8.8. However, grafts that survived less than 1 month 
have been removed, in an attempt to address a possible learning curve for this procedure 
(Log Rank Statistic=8.574; df=1; p=0.003). The inset plot looks more closely at the first 4 
years post graft. 
 
Figure 8.9 Grafts for keratoconus performed post 1995 with survival longer than 1 
month – penetrating and DALK 
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8.11.3 Visual Acuity – Keratoconus 
 
The majority of DALKs (76%) have been performed for keratoconus. Figure 8.10 compares 
Snellen visual acuity at most recent follow-up for DALK and penetrating grafts performed 
for keratoconus since 1996.  
 
 
Figure 8.10 Post graft Snellen visual acuity for DALK vs penetrating grafts 
performed for keratoconus post 1995 as a percentage of each type of 
graft 
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∗ Fifty six percent of DALKs had a best corrected Snellen visual acuity of 6/12 or better at 
the time of last follow-up compared to 67% of penetrating grafts performed since 1996.  
 
∗ Fifteen percent of DALKs had a best corrected Snellen visual acuity of 6/60 or worse in 
comparison to 9% of penetrating grafts for these indications. 
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8.12 ENDOTHELIAL KERATOPLASTY 
 
8.12.1 Main indications for graft – endothelial 
keratoplasty 
 
 
Table 8.11 lists the main indications for graft for endothelial keratoplasty. The majority 
(80%) were performed for corneal dystrophies (predominantly Fuchs’ dystrophy) and 
bullous keratopathy. 
 
Table 8.11 Main indications for endothelial keratoplasty 
 
 
Indication for graft Total % 
Corneal dystrophy 590 47% 
Bullous keratopathy 417 33% 
Failed previous graft 127 10% 
Primary graft failure 51 4% 
Rejection 45 4% 
ICE syndrome 8 <1% 
Congenital abnormalities 4 <1% 
Trauma 4 <1% 
Herpetic eye disease 3 <1% 
Keratoconus* 2 <1% 
Corneal degeneration 1 <1% 
Metabolic deposits 1 <1% 
TOTAL 1253 100% 
 
  * As described by surgeon 
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8.12.2 Fuchs’ Dystrophy and Bullous Keratopathy 
 
 
Over 80% of all endothelial grafts recorded were performed for either Fuchs’ dystrophy or 
bullous keratopathy. Figure 8.11 compares corneal graft survival for these grafts against 
penetrating grafts performed for the same indications since 2004, when endothelial grafts 
were first recorded by the registry (Log Rank Statistic= 86.289; df=1; p<0.001). A significant 
difference in corneal graft survival was apparent between endothelial and penetrating grafts 
performed during this period. 
 
Figure 8.11  Penetrating and endothelial corneal grafts for Fuchs’ dystrophy and 
bullous keratopathy post 2003 
 
 
 
Number at Risk 
Identity Initially  12 months 
24 
months 
48 
months  
72 
months 
96 
months 
Penetrating 965 778 517 163 19 n/a 
Endothelial 417 243 61 n/a n/a n/a 
 
Probability of Graft Survival  
(at years post-graft) Identity No. initially 
at risk 1 2 4 6 
Penetrating 965 .94 .88 .74 .51 
Endothelial 417 .77 .70 n/a n/a 
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PENETRATING AND ENDOTHELIAL CORNEAL GRAFT SURVIVAL 
FUCHS’ DYSTROPHY AND BULLOUS KERATOPATHY (POST 2003) 
Penetrating:      94% at 1 year 
 Mean Survival 63.51 months  88% at 2 years 
 (SE=1.46; 95% CI 60.65, 66.37)  74% at 4 years 
 Median Survival 84 months (7 years) 51% at 6 years 
Endothelial:       77% at 1 year 
 Mean Survival 27.60 months  70% at 2 years 
 (SE=0.90; 95% CI: 25.84, 29.36)   
 Median Survival 38 months (3.2 years)  
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
 
 
Figure 8.12 compares corneal graft survival for endothelial grafts with penetrating grafts 
performed for Fuchs’ dystrophy or bullous keratopathy since 2004 as in figure 8.11, 
however, grafts that survived less than 1 month have been removed in an attempt to 
address a possible learning curve for this procedure (Log Rank Statistic=22.891; df=1; 
p<0.001). 
 
Figure 8.12  Penetrating and endothelial corneal grafts for Fuchs’ dystrophy and 
bullous keratopathy post 2003 with survival longer than 1 month 
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8.12.3 Visual Acuity – Bullous Keratopathy & Fuchs’ 
Dystrophy 
 
 
 
The majority of endothelial keratoplasty (80%) had been performed for Fuchs’ dystrophy 
and bullous keratopathy. Figure 8.13 compares Snellen visual acuity at most recent follow-
up for endothelial lamellar grafts and penetrating grafts performed for these indications 
since 2004.  
 
 
Figure 8.13 Post graft Snellen visual acuity for endothelial vs penetrating grafts 
performed post 2003 for bullous keratopathy or Fuchs’ dystrophy as a 
percentage of each type of graft 
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∗ Thirty two percent of endothelial lamellar grafts exhibited a best corrected Snellen 
visual acuity of 6/12 or better, compared to 34% of penetrating grafts performed since 
2004. 
 
∗ Twenty four percent of endothelial grafts had a best corrected Snellen visual acuity of 
6/60 or worse, in comparison to 34% of penetrating grafts for these indications. 
 
 
 
196 Australian Corneal Graft Registry Report 2012 
LAMELLAR GRAFTS 
8.12.4 Procedure Type 
 
Three main types of procedures for endothelial keratoplasties have been recorded by the 
Registry – Descemet’s stripping endothelial keratoplasty (DSEK), Descemet’s membrane 
endothelial keratoplasty (DMEK) and Descemet’s stripping automated endothelial 
keratoplasty (DSAEK). The majority (68%) were recorded as DSEK although for a large 
number, no details were given. It is possible some other endothelial grafts fit into one of the 
above categories. Figure 8.14 analyses the different procedures used (Log Rank Statistic= 
7.30; df=3; p=0.063). No significant difference was seen amongst types of grafts. 
 
Figure 8.14 Types of endothelial grafts 
 
 
Number at Risk 
 
Identity Initially 12 months 24 months 36 months 48 months 
Other Endothelial grafts 109 64 15 1 n/a 
DSEK 375 217 54 4 n/a 
DMEK 28 13 n/a n/a n/a 
DSAEK 41 26 3 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at 
risk 1 2 3 4 
Other Endothelial grafts 109 .78 .72 .72 n/a 
DSEK 375 .78 .71 .61 n/a 
DMEK 28 .61 n/a n/a n/a 
DSAEK 41 .75 .64 n/a n/a 
 
DSEK – Descemet’s Stripping Endothelial Keratoplasty 
DMEK – Descemet’s Membrane Endothelial Keratoplasty 
DSAEK – Descemet’s Stripping Automated Endothelial Keratoplasty 
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8.12.5 Effect of surgeon workload - number of grafts 
performed per year 
 
 
Until 2004 the majority (98%) of lamellar grafts performed were traditional grafts. Since 
then, 58% (1,252) of lamellar grafts have been endothelial keratoplasties. Figure 8.15 
shows the survival of endothelial lamellar grafts performed by surgeons who had grafted 15 
or more per year, compared with surgeons who had performed fewer than 15 grafts per 
year (Log Rank Statistic=9.445; df=1; p=0.002). The data were analysed on a monthly 
basis due to the shorter survival time. When the new procedure was considered, a 
significant difference between surgeons who had performed more or less than 15 grafts per 
year was apparent. 
 
Figure 8.15 Effect of surgeon workload – endothelial lamellar grafts only 
 
 
 
Number at Risk 
 
Identity Initially 12 months 24 months 36 months 48 months 
< 15 grafts per year 177 98 22 2 n/a 
≥15 grafts per year 376 222 50 3 n/a 
 
Graft survival (at years post-graft) Identity No. initially at 
risk 1 2 3 4 
< 15 grafts per year 177 .69 .60 .60 n/a 
≥15 grafts per year 376 .81 .75 .60 n/a 
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ENDOTHELIAL LAMELLAR CORNEAL GRAFT SURVIVAL 
TYPE OF GRAFT 
Other endothelial grafts:    78% at 1 year 
 Mean Survival 29.28 months  72% at 2 years 
 (SE=1.60; 95% CI 26.15, 32.40)  72% at 3 years 
 Median Survival approx. 38 months (3.2 years)    
             
DSEK:      78% at 1 year 
 Mean Survival 29.46 months  71% at 2 years 
 (SE=1.26; 95% CI: 26.99, 31.93)  61% at 3 years 
 Median Survival 38 months (3.2 years)    
DMEK:       61% at 1 year 
 Mean Survival 11.38 months    
 (SE=1.52; 95% CI: 8.40, 14.37)   
 Median Survival approx. 18 months (1.5 years)   
      
DSAEK:       65% at 1 year 
 Mean Survival 24.08 months  64% at 2 years 
 (SE=2.36; 95% CI: 19.44, 28.71)   
 Median Survival 32 months (2.6 years)   
 
 
 
 
ENDOTHELIAL LAMELLAR CORNEAL GRAFT SURVIVAL 
EFFECT OF SURGEON WORKLOAD PER YEAR  
Less than 15 grafts:    69% at 1 year 
 Mean Survival 25.03 months  60% at 2 years 
 (SE=1.36; 95% CI 22.37, 27.69)   
 Median Survival approx 38 months (3.2 years)    
More than 15 grafts:     81% at 1 year 
 Mean Survival 30.46 months  75% at 2 years 
 (SE=1.27; 95% CI: 27.97, 32.95)  60% at 3 years 
 Median Survival 38 months (3.2 years)    
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.12.6 Endothelial Cell Count 
 
In recent years, the Registry has been collecting information on donor corneal endothelial 
cell counts as depicted in Figure 8.16. Due to the short time period over which these data 
have been collected, all analyses were calculated in months post graft (Log Rank 
Statistic=0.493; df=1; p=0.483). Donor corneal endothelial cell count, as stratified, exerted 
no significant influence on endothelial lamellar graft survival. 
 
Figure 8.16 Endothelial cell count – endothelial lamellar grafts 
 
 
 
 
Number at Risk 
 
Identity Initially 12 
months 
24 
months 
36 
months 
48 
months 
1000 to 2999 cells/mm2 133 74 20 1 n/a 
3000 to 4999 cells/mm2 158 91 19 1 n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 2 3 4 
1000 to 2999 cells/mm2 133 .72 .57 .35 n/a 
3000 to 4999 cells/mm2 158 .73 .67 .54 n/a 
 
*Range chosen as too few donors available with endothelial cell count below 2400 cells/mm2 to 
analyse. 
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ENDOTHELIAL LAMELLAR CORNEAL GRAFT SURVIVAL 
DONOR ENDOTHELIAL CELL COUNT 
1000 to 2999 cells/mm2:    72% at 1 year 
 Mean Survival 22.39 months  57% at 2 years 
 (SE=1.46; 95% CI: 19.52, 25.26)  35% at 3 years 
 Median Survival 29 months (2.4 years)   
3000 to 4999 cells/mm2:    73% at 1 year 
 Mean Survival 26.16 months  67% at 2 years 
 (SE=1.63; 95% CI: 22.97, 29.36)  54% at 3 years 
 Median Survival approx 38 months (3.1 years)   
  
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.12.7 Endokeratoplasty Graft Size 
 
The graft size was recorded for 1,087 endothelial lamellar grafts, and ranged from 6.0 mm 
to 9.5 mm. Figure 8.17 shows the effect of graft size on the outcome of the 481 followed 
grafts with recorded graft size (Log Rank Statistic=9.292; df=3; p=0.026). Endothelial 
lamellar grafts with a larger size appeared to have better corneal graft survival than smaller 
grafts. 
 
Figure 8.17  Graft size – endothelial lamellar grafts only 
 
 
Number at Risk 
 
Identity Initially 12 months 24 months 36 months 48 months 
Less than 8.0 mm 38 20 1 n/a n/a 
8.0 - 8.4 mm 157 83 20 3 n/a 
8.5 – 8.9 mm 213 130 36 2 n/a 
9.0 mm thru highest 73 49 7 n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 2 3 4 
Less than 8.0 mm 38 .64 .58 n/a n/a 
8.0 - 8.4 mm 157 .75 .65 .52 n/a 
8.5 – 8.9 mm 213 .78 .76 .68 n/a 
9.0 mm thru highest 73 .92 .73 n/a n/a 
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ENDOTHELIAL LAMELLAR CORNEAL GRAFT SURVIVAL 
GRAFT SIZE 
< 8.0 mm:      64% at 1 year 
 Mean Survival 17.80 months  58% at 2 years 
 (SE=1.96; 95% CI: 13.96, 21.64)   
 Median Survival approx. 27 months (2.3 years)  
≥ 8.0 – 8.4 mm:     75% at 1 year 
 Mean Survival 28.25 months years 65% at 2 years 
 (SE=1.83; 95% CI: 24.67, 31.84)  52% at 3 years 
 Median Survival approx. 42 months (3.5 years)  
≥ 8.5 – 8.9 mm:     78% at 1 year 
 Mean Survival 29.21 months  76% at 2 years 
 (SE=1.16; 95% CI: 26.94, 31.48)  68% at 3 years 
 Median Survival 38 months (3.2 years)    
≥ 9.0 mm:      92% at 1 year 
 Mean Survival 29.40 months  73% at 2 years 
 (SE=1.76; 95% CI: 25.96, 32.85)    
 Median Survival approx. 35 months (2.9 years)   
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.12.8 Storage Media – Endothelial Grafts 
 
Figure 8.18 shows the influence of storage medium on survival of endothelial lamellar 
grafts (Log Rank Statistic=7.686; df=3; p=0.006). These types of grafts have only been 
stored in Optisol or Organ culture with the former performing better than the latter. 
 
Figure 8.18 Storage media - endothelial lamellar grafts only 
 
 
 
Number at Risk 
 
Identity Initially 12 months 24 months 36 months 48 months 
Organ Culture 47 24 4 n/a n/a 
Optisol 505 296 68 5 n/a 
 
Graft survival (at years post-graft) Identity No. initially at 
risk 1 2 3 4 
Organ culture 47 .65 .48 n/a n/a 
Optisol 505 .78 .71 .60 n/a 
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ENDOTHELIAL LAMELLAR CORNEAL GRAFT SURVIVAL 
STORAGE MEDIA 
Organ Culture:     65% at 1 year 
 Mean Survival 17.62 months  48% at 2 years 
 (SE=1.90; 95% CI 13.91, 21.34)   
 Median Survival 19 months (1.6 years)  
Optisol:       78% at 1 year 
 Mean Survival 29.83 months  71% at 2 years 
 (SE=1.09; 95% CI: 27.70, 31.96)  60% at 3 years 
 Median Survival 38 months (3.2 years)  
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.13 TRADITIONAL LAMELLAR 
KERATOPLASTY 
 
8.13.1 Main indications for graft – traditional lamellar 
keratoplasty 
 
 
Table 8.12 lists the main indications for graft for traditional lamellar keratoplasty.  
 
Table 8.12 Main indications for traditional lamellar keratoplasty 
 
 
Indication for graft Total % 
Pterygium 191 16% 
Failed previous graft 182 16% 
Corneal Ulcers (not HSV) 139 15% 
Trauma 138 12% 
Keratoconus  110 9% 
Scleral disorders 80 6% 
Neoplasm 73 6% 
Corneal degeneration 69 6% 
Herpetic eye disease 45 4% 
Corneal Scars & opacities 31 3% 
Non-herpetic infections 21 3% 
Descemetoceole 19 2% 
Corneal dystrophies 15 1% 
Bullous keratopathy 14 1% 
Other 38 <1% 
TOTAL 1165 100% 
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Figure 8.19 shows the survival curves for the main indication for lamellar grafts (Log Rank 
Statistic= 122.695; df=10; p<0.001). Traditional lamellar grafts in eyes that have had a 
previous failed graft, and those performed for infections and corneal ulcers, had poor 
survival. 
 
 
Figure 8.19  Main indicators for graft – traditional lamellar grafts only 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Keratoconus 76 23 8 4 2 n/a n/a n/a n/a 
Previous failed graft 136 25 11 7 3 n/a n/a n/a n/a 
Pterygium 164 48 18 11 7 3 2 1 n/a 
Trauma 115 35 18 6 2 1 1 n/a n/a 
Corneal ulcers 124 17 7 1 1 1 n/a n/a n/a 
Corneal degeneration 51 16 2 2 n/a n/a n/a n/a n/a 
Disorders of sclera 64 18 7 3 1 1 n/a n/a n/a 
Neoplasia 57 16 3 n/a n/a n/a n/a n/a n/a 
Scars and opacities 27 9 3 1 n/a n/a n/a n/a n/a 
Infections 50 9 4 2 n/a n/a n/a n/a n/a 
Other 70 19 2 1 n/a n/a n/a n/a n/a 
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Graft survival (at years post-graft) 
Identity 
No. initially at 
risk 1 5 10 15 20 
Keratoconus 76 .83 .70 .70 n/a n/a 
Previous failed graft 136 .64 .42 .32 n/a n/a 
Pterygium 164 .93 .93 .93 .70 .47 
Trauma 115 .91 .84 .63 .63 n/a 
Corneal ulcers 124 .60 .40 .34 .34 n/a 
Corneal degeneration 51 .90 .64 .32 n/a n/a 
Disorders of sclera 64 .91 .82 .47 .23 n/a 
Neoplasia 57 .97 .87 n/a n/a n/a 
Scars and opacities 27 .84 .57 .57 n/a n/a 
Infections 50 .57 .50 .38 n/a n/a 
Other 70 .79 .58 n/a n/a n/a 
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TRADITIONAL LAMELLAR CORNEAL GRAFT SURVIVAL 
MAIN INDICATION FOR GRAFT 
 
Keratoconus:       83% at 1 year 
 Mean Survival 10.14 years   70% at 5 year 
 (SE=0.92; 95% CI: 8.33, 11.94)   
 Median Survival approx. 14 years    
Previous failed graft:      64% at 1 year 
 Mean Survival 5.82 years    42% at 5 years 
 (SE=0.71; 95% CI: 4.42, 7.22)   32% at 10 years 
 Median Survival 4 years    
Pterygium:      93% at 1 year 
 Mean Survival 17.49 years   70% at 10 years 
 (SE=1.64; 95% CI 14.28, 20.71)   47% at 20 year 
 Median Survival 17 years    
Trauma:      91% at 1 year 
 Mean Survival 13.65 years   84% at 5 years 
 (SE=1.35; 95% CI 11.00, 16.30)   63% at 10 year 
 Median Survival approx. 18 years    
Corneal ulcers:     60% at 1 year 
 Mean Survival 6.66 years    40% at 5 years 
 (SE=1.07; 95% CI 458, 8.75)   34% at 10 year 
 Median Survival 4 years   
Corneal degeneration:      90% at 1 year 
 Mean Survival 7.34 years    64% at 5 years 
 (SE=0.91; 95% CI: 5.57, 9.12)   32% at 10 year 
 Median Survival 9 years   
Disorders of sclera:      91% at 1 year 
 Mean Survival 9.44 years    82% at 5 years 
 (SE=1.26; 95% CI: 6.97, 11.91)   47% at 10 year 
 Median Survival 10 years    23% at 15 years 
Neoplasia:       97% at 1 year 
 Mean Survival 5.69 years    87% at 5 years 
 (SE=0.17; 95% CI: 5.36, 6.03)   
 Median Survival approx. 6 years   
Scars and opacities:      84% at 1 year 
 Mean Survival 8.50 years    57% at 5 years 
 (SE=1.66; 95% CI: 5.25, 11.76)   
 Median Survival approx. 13 years    
Infections:      57% at 1 year 
 Mean Survival 5.06 years    50% at 5 year 
 (SE=0.78; 95% CI: 3.53, 6.59)   38% at 10 year 
 Median Survival 8 years   
Other:       79% at 1 year 
 Mean Survival 6.03 years    58% at 5 years 
 (SE= 0.65; 95% CI 4.75, 7.31)    
 Median Survival 9 years     
  
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.13.2  Pterygium and Keratoconus 
 
Figure 8.20 shows graft survival for patients grafted with a traditional lamellar keratoplasty 
for pterygium or keratoconus, compared with survival in patients with any other indication 
(Log Rank Statistic= 29.263; df=2; p<0.001). 
 
Figure 8.20 Effect of pterygium and keratoconus  
(traditional lamellar grafts only) 
 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Keratoconus 76 23 8 4 2 n/a n/a n/a n/a 
Pterygium  178 55 24 12 7 3 2 1 n/a 
Other 680 157 51 24 8 3 1 n/a n/a 
 
Graft survival (at years post-graft) 
Identity 
No. initially at 
risk 1 5 10 15 20 
Keratoconus 76 .83 .68 .68 n/a n/a 
Pterygium  178 .92 .89 .84 .63 .42 
Other 680 .77 .61 .42 .42 n/a 
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TRADITIONAL LAMELLAR CORNEAL GRAFT SURVIVAL 
PTERYGIUM AND KERATOCONUS 
Keratoconus:     83% at 1 year 
 Mean Survival 10.14 years   68% at 5 years 
 (SE=0.92; 95% CI 8.33, 11.94)   
 Median Survival approx. 15 years   
Pterygium:       92% at 1 year 
 Mean Survival 16.28 years   89% at 5 years 
 (SE=1.62; 95% CI: 13.10, 19.45)  84% at 10 years 
 Median Survival 17 years   63% at 15 years 
       42% at 20 years 
Other:       77% at 1 year 
 Mean Survival 9.28 years   61% at 5 years 
 (SE=0.66; 95% CI: 8.00, 10.57)  42% at 10 years 
 Median Survival 9 years   
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.13.3 Traditional Lamellar Graft Size 
 
The hostbed size of the graft was recorded for 868 traditional lamellar grafts, and ranged 
from 2.0 mm to 15.0 mm. Figure 8.21 shows the effect of graft size on the outcome of the 
702 followed grafts with recorded graft size (Log Rank Statistic=38.361; df=5; p<0.001). 
Grafts sized between 6.0 mm and 7.9 mm fared better than grafts that were larger or 
smaller. 
 
Figure 8.21  Graft size – traditional lamellar grafts only 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Less than 5.9 mm 156 28 11 3 1 n/a n/a n/a n/a 
6.0 to 6.9 mm 127 32 10 5 1 1 n/a n/a n/a 
7.0 - 7.9 mm 174 54 23 9 6 2 1 n/a n/a 
8.0 - 8.9 mm 153 41 15 8 4 1 1 1 n/a 
9.0 – 9.9 mm 38 8 2 2 n/a n/a n/a n/a n/a 
10.0 mm thru highest 54 18 3 n/a n/a n/a n/a n/a n/a 
 
Graft survival (at years post-graft) Identity No. initially at risk 1 5 10 15 20 
Less than 5.9 mm 156 .74 .58 .58 n/a n/a 
6.0 to 6.9 mm 127 .93 .82 .35 n/a n/a 
7.0 - 7.9 mm 174 .89 .83 .70 .47 n/a 
8.0 - 8.9 mm 153 .79 .67 .61 .61 .61 
9.0 – 9.9 mm 38 .55 .46 .23 n/a n/a 
10.0 mm thru highest 54 .73 .53 n/a n/a n/a 
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TRADITIONAL LAMELLAR CORNEAL GRAFT SURVIVAL 
GRAFT SIZE 
<5.9 mm:      74% at 1 year 
 Mean Survival 8.03 years   58% at 5 years 
 (SE=0.70; 95% CI: 6.66, 9.4)    
 Median Survival 13 years   
≥6.0 – 6.9 mm:     93% at 1 year 
 Mean Survival 9.64 years   82% at 5 years 
 (SE=1.21; 95% CI: 7.27, 12.01)  35% at 10 years 
 Median Survival 10 years    
≥7.0 – 7.9 mm:     89% at 1 year 
 Mean Survival 12.67 years   83% at 5 years 
 (SE=1.10; 95% CI: 10.52, 14.82)  70% at 10 years 
 Median Survival 14 years   47% at 15 years 
≥8.0 – 8.9 mm:     79% at 1 year 
 Mean Survival 14.36 years   67% at 5 years 
 (SE=1.38; 95% CI: 11.66, 17.06)  61% at 10 years 
 Median Survival approx. 22 years   
≥9.0 – 9.9 mm:     55% at 1 year 
 Mean Survival 4.91 years   46% at 5 years 
 (SE=0.83; 95% CI: 3.27, 6.54)  23% at 10 years 
 Median Survival 5 years    
≥10.0 mm:      73% at 1 year 
 Mean Survival 4.53 years   53% at 5 years 
 (SE=0.47; 95% CI: 3.60, 5.46)    
 Median Survival approx. 7 year   
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.13.4 Traditional Lamellar Procurement Source 
 
Figure 8.22 shows the influence of donor procurement source on corneal graft survival. For 
the Kaplan-Meier curves below, the Eye Banks have been de-identified. Procurement 
sources included the Eye Banks in SA, QLD, NSW, WA and VIC (including corneas 
procured from Victorian Forensic Pathology) and corneas that were privately procured, 
years ago, by the operating surgeon. Where a surgeon did not record an eye bank number, 
the graft was included with the eye bank of the State where it was sourced (Log Rank 
Statistic=22.424, df=5; p<0.001). 
 
 
Figure 8.22  Donor cornea procurement source – traditional lamellar grafts only 
 
 
 
 
Graft survival (at years post-graft) Identity 1 5 10 15 20 
Non-eye bank procured .77 .68 .61 .61 .61 
Eye bank 1  .84 .71 .54 .27 n/a 
Eye bank 2  .67 .53 n/a n/a n/a 
Eye bank 3  .83 .71 .71 .71 n/a 
Eye bank 4  .72 .51 .51 n/a n/a 
Eye bank 5  .80 .70 .42 .42 n/a 
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TRADITIONAL LAMELLAR CORNEAL GRAFT SURVIVAL 
DONOR CORNEA PROCUREMENT SOURCE 
Non Eye bank procured:    77% at 1 year 
 Mean Survival 14.44 years   68% at 5 years 
 (SE=1.87; 95% CI: 10.77, 18.11)  61% at 10 years 
 Median Survival approx 22 years  
        
Eye bank 1:      84% at 1 year 
 Mean Survival 10.26 months  71% at 5 years 
 (SE=0.76; 95% CI: 8.76, 11.75)  54% at 10 years 
 Median Survival 11 years   27% at 15 years 
        
Eye bank 2:      67% at 1 year 
 Mean Survival 4.77 years   53% at 5 years 
 (SE=0.54; 95% CI: 3.70, 5.83)   
 Median Survival approx. 8 years  
Eye bank 3:      83% at 1 year 
 Mean Survival 11.14 years   71% at 5 years 
 (SE=0.84; 95% CI: 9.50, 12.78)   
 Median Survival approx. 15 years    
Eye bank 4:      72% at 1 year 
 Mean Survival 6.43 years   51% at 5 years 
 (SE=0.63; 95% CI: 5.19, 7.67)   
 Median Survival approx. 11 years   
Eye bank 5:      80% at 1 year 
 Mean Survival 10.24 years   70% at 5 years 
 (SE=1.58; 95% CI: 7.14, 13.34)  42% at 10 years 
 Median Survival 10 years  
 
 
KEY: n/a  =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.13.5 History of Intraocular Pressure  
 
The effect of raised intraocular pressure (IOP) in the past on graft survival is shown in 
Figure 8.23. Recipients with a history of raised pressure but who had a normal pressure at 
the time of graft were compared with those who were recorded as not having a history of 
raised IOP (Log Rank Statistic=26.187; df=1; p<0.001).  
 
 
 
Figure 8.23 History of intraocular pressure – traditional lamellar grafts only 
 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
No history of raised IOP 759 201 70 32 12 4 1 1 n/a 
History of raised IOP 68 11 3 2 1 n/a n/a n/a n/a 
 
 
Graft survival (at years post-graft) 
Identity No. initially 
at risk 1 5 10 15 20 
No history of raised IOP 759 .82 .67 .54 .42 .21 
History of raised IOP 68 .57 .46 .46 n/a n/a 
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8.13.6 Inflammation 
 
Figure 8.24 shows the effect of inflammation at graft on graft outcome (Log Rank 
Statistic=54.497; df=1; p<0.001). A significant difference in graft survival was apparent 
between traditional lamellar grafts that were inflamed at graft and those that were not. 
 
Figure 8.24 Pre-graft inflammation – traditional lamellar grafts only 
 
 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
Not inflamed 613 181 62 30 12 3 3 1 n/a 
Inflamed 293 49 18 8 4 3 n/a n/a n/a 
 
Graft survival (at years post-graft) 
Identity No. initially 
at risk 1 5 10 15 20 
Not inflamed 613 .88 .73 .61 .41 .41 
Inflamed 293 .64 .52 .39 .39 n/a 
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8.13.7 Microbial keratitis/stitch abscess 
 
The development of microbial keratitis or stitch abscess was associated with poor corneal 
graft survival in traditional lamellar grafts (Log Rank Statistic=27.987; df=1; p<0.001). 
 
 
Figure 8.25 Microbial keratitis or stitch abscess 
 
 
 
Number at Risk 
 
Identity Initially 3 years 
6 
years 
9 
years 
12 
years 
15 
years 
18 
years 
21 
years 
24 
years 
No microbial keratitis 910 231 81 40 17 6 3 1 n/a 
Microbial keratitis or stitch 
abscess 22 4 2 n/a n/a n/a n/a n/a n/a 
 
 
Graft survival (at years post-graft) 
Identity 
No. initially 
at risk 1 5 10 15 20 
No microbial keratitis 910 .81 .68 .54 .42 .42 
Microbial keratitis or 
stitch abscess 22 .37 .28 n/a n/a n/a 
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TRADITIONAL LAMELLAR CORNEAL GRAFT SURVIVAL 
HISTORY OF RAISED IOP 
No history of raised IOP:    82% at 1 year 
 Mean Survival 11.48 years   67% at 5 years 
 (SE=1.05; 95% CI: 9.43, 13.53)  54% at 10 years 
 Median Survival 14 years   42% at 15 years 
       21% at 20 years 
History of raised IOP:    57% at 1 year 
 Mean Survival 6.37 years   46% at 5 years 
 (SE=0.96; 95% CI: 4.49, 8.26)   
 Median Survival 3 years    
 
 
 
TRADITIONAL LAMELLAR CORNEAL GRAFT SURVIVAL 
EFFECT OF INFLAMMATION 
Not inflamed at graft:    88% at 1 year 
 Mean Survival 13.20 years   73% at 5 years 
 (SE=1.11; 95% CI: 11.03, 15.38)  61% at 10 years 
 Median Survival 14 years   41% at 15 years 
        
Inflamed at graft:     64% at 1 year 
 Mean Survival 8.26 years   52% at 5 years 
 (SE=0.82; 95% CI: 6.65, 9.87)  39% at 10 years 
 Median Survival 7 years    
 
 
 
TRADITIONAL LAMELLAR CORNEAL GRAFT SURVIVAL 
MICROBIAL KERATITIS/STITCH ABSCESS 
No microbial keratitis:    81% at 1 year 
 Mean Survival 12.03 years   68% at 5 years 
 (SE=0.86; 95% CI: 10.35, 13.70)  54% at 10 years 
 Median Survival 13 years   42% at 15 years 
        
Microbial keratitis or stitch abscess:  37% at 1 year 
 Mean Survival 2.34 years   28% at 5 years 
 (SE=0.69; 95% CI: 0.99, 3.69)   
 Median Survival <1 year    
 
 
KEY: n/a =  not applicable 
 SE = standard error 
 Cl = confidence interval 
 df = degrees of freedom 
 p = probability 
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8.14 SUMMARY OF FACTORS RELATING TO 
LAMELLAR GRAFTS 
 
 Visual acuity when all lamellar grafts were considered: 
 
 A best corrected Snellen acuity of 6/12 or better was achieved in 48% of cases at 
most recent follow-up.  
 
 Fifty eight percent of cases achieved a follow-up visual acuity of 6/18 or better and 
28% recorded a visual acuity of less than 6/60 at last follow-up. 
 
 Follow-up visual acuities were not advised in 20% of cases.  
 
 Visual acuity when broken down into type of lamellar graft: 
 
 A best corrected Snellen acuity of 6/12 or better at most recent follow-up was 
achieved in 34% of cases for traditional lamellar grafts; 37% of deep anterior 
lamellar grafts (DALK), and 18% of endothelial lamellar grafts.  
 
 Forty seven percent of traditional grafts achieved 6/18 or better, while 62% of DALK 
and 45% of endothelial lamellar grafts achieved this level of acuity.  
 
 A visual acuity of less than 6/60 at last follow-up was recorded in 21% of traditional 
lamellar grafts, 16% of DALKs, and 33% of endothelial lamellar grafts. 
 
 Follow-up visual acuities were not advised in 26% of cases for traditional lamellar 
grafts, 5% of DALK and 6% of endothelial lamellar grafts. 
 
 
 Endothelial cell count had no significant effect on corneal graft survival of DALK or 
endothelial lamellar grafts. There were insufficient traditional lamellar grafts with 
endothelial cell count recorded to analyse in this type of lamellar graft. 
 
 
 Traditional lamellar: 
 
 The main indications for traditional lamellar grafts were pterygium (16%), failed 
previous graft (16%), corneal ulcers (15%), trauma (12%), and keratoconus (9%).  
 
 Grafts sized between 6.0 mm and 7.9 mm fared better than grafts that were larger 
or smaller.  
 
 The main reasons for failure were corneal degeneration (14%), corneal ulcers 
(12%) and infection (11%). 
 
 Pre-graft inflammation, a history of raised IOP and post graft microbial keratitis or 
stitch abscess were associated with poor corneal graft survival. 
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 DALK: 
 
 The main indication for (DALK) was keratoconus (76%).  
 
 When compared to penetrating grafts for keratoconus, DALKs had poorer graft 
survival.  
 
 Fifty six percent of DALKs exhibited a post graft best corrected Snellen visual acuity 
of 6/12 or better compared to 67% of penetrating grafts performed since 1996.  
 
 The main reasons for failure were primary graft failure (17%), infections, endothelial 
cell failure and scars & opacities (9% each). 
 
 
 Endothelial keratoplasty: 
 
 The main indications for endothelial lamellar grafts were reported to be corneal 
dystrophy (47%), bullous keratopathy (33%) and failed previous graft (10%).  
 
 Endothelial lamellar grafts performed for Fuchs’ dystrophy and bullous keratopathy 
had poorer corneal graft survival than penetrating grafts performed for the same 
indications. 
 
 Thirty two percent of endothelial lamellar grafts exhibited a post graft best corrected 
Snellen visual acuity of 6/12 or better compared to 34% of penetrating grafts 
performed since 2004. 
 
 A significant difference in graft survival was apparent amongst surgeons who had 
performed a larger number of endothelial lamellar grafts per year (over 15 grafts) 
and surgeons who had performed fewer grafts per year, favouring the higher 
volume surgeons.  
 
 Different types of procedures for endothelial lamellar grafts had no significant 
influence on corneal graft survival.  
 
 Endothelial lamellar grafts with a larger graft size had better corneal graft survival 
than smaller grafts.  
 
 The main reason for failure of these grafts was primary graft failure (49%). 
 
 Overall, endothelial lamellar grafts exhibited poorer graft survival and displayed a 
larger proportion of primary non-function grafts than any other type of lamellar graft.  
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MULTIVARIATE ANALYSIS 
9. COX PROPORTIONAL HAZARDS 
REGRESSION ANALYSIS 
 
9.1 PENETRATING GRAFTS  
 
9.1.1 METHODS 
 
A multivariate model was used to investigate the combined effect of variables on 
penetrating graft survival, adjusted for all the other variables in the model. Further analysis 
of the data was undertaken using Stata version 11. 
 
In the preceding univariate analyses, each registered penetrating graft, together with its 
archival follow-up records, was treated as a separate and independent entity. Some 
patients had a history of more than one ipsilateral corneal graft and some had a record of 
one or more grafts in the contralateral eye (Table 9.1). Data are calculated with the census 
date of the 1st of June 2010. 
 
Table 9.1 Number of grafts and patients in the cohort with penetrating corneal 
grafts 
 
Group Number 
Registered penetrating grafts 
Number of patients with penetrating grafts 
19952 
15560 
Patients with one registered graft 11974 
Patients with more than one registered graft* 3586 
* additional grafts could be penetrating, lamellar or limbal grafts 
 
Following on from the results of the Kaplan-Meier analyses, which were used to indicate 
variables of interest, Cox Proportional Hazards regression models were used to investigate 
the joint effects of a subset of variables on penetrating corneal graft failure. To control for 
potential inter-graft and/or inter-eye dependence in the multivariate analyses, the Cox 
models were adjusted to allow for clustering by individual patient [see reference 5, Chapter 
10.8]. Limbal and lamellar grafts were excluded from consideration. Some variables which 
were indicated as significant in the univariate analysis were omitted due to non-
convergence of the model or collinearity. 
 
The selected variables were: surgeons with more than 25 grafts per year on average, 
where follow-up occurred, state in which surgery was performed, eye bank, whether the 
surgery was performed in the same state as the donor cornea was sourced from, donor 
age, recipient age, pre-graft visual acuity, indication for graft, number of previous ipsilateral 
grafts, lens status pre- and post-graft, corneal vascularization at time of graft, history of 
inflammation in the grafted eye, history of raised IOP, presence of descemetocoele, graft 
diameter, time to removal of graft sutures, post-operative neovascularization of the graft, 
post-operative rise in IOP, post-operative episodes of immunological rejection, post-
operative synechiae,  microbial keratitis, uveitis or stitch abscess, refractive surgery in 
follow-up, vitrectomy at time of graft, multi-organ donor. 
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The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The assumption of proportional hazards 
appeared reasonable as assessed by Kaplan-Meier plots. 
 
9.1.2 FINAL MODEL 
 
The model excluded variables with a p-value of p>0.05 (or global p-value of p>0.5 for 
variables with more than two categories) in a stepwise manner, beginning with the least 
significant variable. The variables retained in the final Cox proportional hazards regression 
models are presented in Table 9.2. 
 
Table 9.2 Variables retained in final model 
 
 Surgeons with more than 25 grafts per year  
 Indication for graft 
 Lens status pre- and post-graft (phakic, pseudophakic or aphakic) 
 Corneal neovascularization at the time of graft 
 History of inflammation in the grafted eye 
 History of raised intraocular pressure in the grafted eye 
 Graft diameter 
 Time of removal of graft sutures 
 Post-operative neovascularization of the graft 
 Post-operative rise in intraocular pressure 
 Refractive surgery in follow-up 
 Post-operative episodes of immunological rejection 
 Arrangements for follow-up 
 
 
 
Table 9.3 tabulates the parameter estimates resulting from the fit of the best clustered Cox 
model. The table shows the variable, the hazard ratio, the standard error of the regression 
coefficient, the corresponding probability value and the 95% confidence interval for the 
hazard ratio. The first level of each categorical variable was taken as the referent. The 
hazard ratios for a given variable are adjusted for all other variables in the model. 
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9.1.2.1 Model  
 
This model includes variables with a p-value of p<0.05, with variables eliminated in a 
stepwise manner, beginning with the least significant variable. For categorical variables, a 
global test was applied to calculate the overall p-value. The overall model was highly 
significant: chi²=1755.32, p<0.0001. 
 
Table 9.3 Parameter estimates from final Cox regression model: factors influencing 
the survival of penetrating corneal grafts 
 
Variable Hazard 
ratio 
Standard 
error 
P Global 
P  
95% 
confidence 
intervals 
Neovascularization of the graft 
Avascular graft 1.00     
Vascularized graft 2.27 0.20 <0.001  1.91 – 2.70 
Post-operative rise in intraocular pressure 
None 1.00     
Rise in IOP 1.50 0.13 <0.001  1.62 – 1.78 
Refractive surgery in follow-up 
No refractive surgery  1.00     
Refractive surgery 0.66 0.06 <0.001  0.55 – 0.79 
Rejection episodes 
None 1.00     
One or more episodes 3.14 0.20 <0.001  2.77 – 3.57 
Lens status pre and post graft  
Phakic/Phakic 1.00   <0.01  
Pseudophakic/Aphakic 1.61 0.35 0.028  1.05 – 2.45 
Phakic/Pseudophakic 1.15 0.14 0.256  0.90 – 1.46 
Aphakic/Aphakic 1.90 0.28 <0.001  1.43 – 2.53 
Aphakic/Pseudophakic 1.51 0.31 0.043  1.01 – 2.25 
Pseudophakic/Aphakic 1.73 0.33 0.004  1.19 – 2.51 
Pseudo/Pseudo 84-89 1.68 0.30 0.004  1.18 – 2.39 
Pseudo/Pseudo 90-94 1.57 0.21 0.001  1.21 – 2.05 
Pseudo/Pseudo 95-99 1.23 0.18 0.151  0.93 – 1.64 
Pseudo/Pseudo 00-04 1.52 0.21 0.003  1.16 – 2.00 
Pseudo/Pseudo 05-10 1.54 0.32 0.035  1.03 – 2.31 
Time to removal of sutures 
Fewer than 6 months 1.00   <0.001  
6 – 12 months 0.52 0.06 <0.001  0.41 – 0.66 
12 – 18 months 0.41 0.05 <0.001  0.32 – 0.51 
18 – 24 months 0.38 0.05 <0.001  0.29 – 0.49 
Greater than 24 months 0.27 0.03 <0.001  0.21 – 0.35 
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Variable Hazard 
ratio 
Standard 
error 
P global 
P 
95% 
confidence 
intervals 
Surgeon performing more than 25 grafts 
No 1.00     
Yes 0.80 0.08 0.019  0.66 – 0.96 
Follow-up elsewhere 
Follow-up by surgeon 1.00     
Follow-up elsewhere 0.59 0.05 <0.001  0.49 – 0.70 
Corneal vascularization at time of graft grafts 
None 1.00   <0.01  
1 quadrant 0.88 0.11 0.301  0.68 – 1.12 
2 quadrants 0.89 0.10 0.290  0.72 – 1.10 
3 quadrants 1.19 0.14 0.133  0.95 – 1.50 
4 quadrants 1.35 0.15 0.006  1.09 – 1.68 
Main indication for graft 
Keratoconus 1.00   <0.001  
Corneal ulcers 5.67 1.35 <0.001  3.56 – 9.04 
Bullous keratopathy 5.03 0.87 <0.001  3.59 – 7.06 
Corneal dystrophies 2.98 0.44 <0.001  2.23 – 3.96 
Non-herpetic infections 1.90 0.73 0.096  0.89 – 4.03 
Herpetic infections 2.29 0.45 <0.001  1.55 – 3.38 
Trauma 2.46 0.69 0.001  1.42 – 4.27 
Scars and opacities 2.53 0.84 0.005  1.33 – 4.84 
Interstitial keratitis 2.14 0.82 0.046  1.01 – 4.52 
Corneal degeneration 2.19 1.06 0.104  0.85 – 5.64 
Congenital abnormalities 1.60 0.69 0.279  0.68 – 3.73 
Failed graft 4.18 0.75 <0.001  2.95 – 5.93 
Other 2.43 0.61 <0.001  1.49 - 3.99 
Raised intraocular pressure 
Never 1.00   <0.01  
In past only 1.32 0.11 0.001  1.12 – 1.55 
At graft only 1.72 0.74 0.208  0.74 – 4.01 
Both in past and at graft 1.24 0.23 0.231  0.87 – 1.78 
Inflammation in the grafted eye  
Never 1.00   0.02  
In past only 0.91 0.14 0.526  0.68 – 1.22 
At graft only 1.73 0.36 0.008  1.15 – 2.61 
Both in past and at graft 1.01 0.16 0.972  0.74 – 1.37 
Graft diameter  
<7.5 mm 1.00   <0.001  
7.5 – 8.5 mm 0.74 0.06 <0.001  0.63 – 0.87 
> 8.5 mm 1.06 0.22 0.765  0.71 – 1.59 
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9.2  TRADITIONAL LAMELLAR GRAFTS 
 
9.2.1 METHODS 
 
A multivariate model was used to investigate the combined effect of variables on traditional 
lamellar graft survival, adjusted for all the other variables in the model. Further analysis of 
the data was undertaken using Stata version 11. 
 
In the preceding univariate analyses, each registered traditional lamellar graft, together with 
its archival follow-up records, was treated as a separate and independent entity. Some 
patients had a history of more than one ipsilateral corneal graft and some had a record of 
one or more grafts in the contralateral eye (Table 9.4). Data were calculated with the 
census date of the 12th of October 2011. 
 
Table 9.4 Number of grafts and patients in the cohort with traditional lamellar 
corneal grafts 
 
Group Number 
Registered traditional lamellar grafts 
Number of patients with traditional lamellar grafts 
1165 
1059 
Patients with one registered graft 820 
Patients with more than one registered graft* 239 
* additional grafts could be penetrating, lamellar or limbal grafts 
 
Following on from the results of the Kaplan-Meier analyses, which were used to indicate 
variables of interest, Cox Proportional Hazards regression models were used to investigate 
the joint effects of a subset of variables on traditional lamellar corneal graft failure. To 
control for potential inter-graft and/or inter-eye dependence in the multivariate analyses, the 
Cox models were adjusted to allow for clustering by individual patient [see reference 5, 
Chapter 10.8]. Limbal and penetrating grafts were excluded from consideration. Some 
variables which were indicated as significant in the univariate analysis were omitted due to 
non-convergence of the model or collinearity. 
 
The selected variables were: where follow-up occurred, eye bank, whether the surgery was 
performed in the same state as the donor cornea was sourced from, pre-graft lens status, 
post-graft lens status, donor age, pre-graft visual acuity, indication for graft, corneal 
vascularization at time of graft, history of inflammation in the grafted eye, history of steroid 
use in the grafted eye, history of Herpetic infection in the grafted eye, history of raised IOP, 
graft diameter, storage method, microbial keratitis. 
 
The best model was found by a backward elimination process, removing variables not 
appearing to be predictors of graft failure. The assumption of proportional hazards 
appeared reasonable as assessed by Kaplan-Meier plots. 
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9.2.2 FINAL MODEL 
 
The model excluded variables with a p-value of p>0.05 (or global p-value of p>0.5 for 
variables with more than two categories) in a stepwise manner, beginning with the least 
significant variable. The variables retained in the final Cox proportional hazards regression 
models are presented in Table 9.5. 
 
Table 9.5 Variables retained in final model 
 
 Indication for graft 
 History of inflammation in the grafted eye 
 History of raised intraocular pressure in the grafted eye 
 Graft diameter 
 Surgery in same State as donor cornea sourced 
 Arrangements for follow-up 
 Microbial keratitis in follow-up 
 
 
 
Table 9.6 tabulates the parameter estimates resulting from the fit of the best clustered Cox 
model. The table shows the variable, the hazard ratio, the standard error of the regression 
coefficient, the corresponding probability value and the 95% confidence interval for the 
hazard ratio. The first level of each categorical variable was taken as the referent. The 
hazard ratios for a given variable are adjusted for all other variables in the model. 
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9.2.2.1 Model  
 
This model includes variables with a p-value of p<0.05, with variables eliminated in a 
stepwise manner, beginning with the least significant variable. For categorical variables, a 
global test was applied to calculate the overall p-value. The overall model was highly 
significant: chi²=153.60, p<0.0001. 
 
Table 9.6 Parameter estimates from final Cox regression model: factors influencing 
the survival of traditional lamellar corneal grafts 
 
 
Variable Hazard 
ratio 
Standard 
error 
P global 
P 
95% 
confidence 
intervals 
Microbial keratitis 
No 1.00     
Yes 1.99 0.52 0.008  1.19 – 3.31 
Follow-up elsewhere 
Follow-up by surgeon 1.00     
Follow-up elsewhere 0.39 0.11 0.001  0.22 – 0.67 
Donor and recipient State match 
Different States 1.00     
Same State 0.59 0.15 0.044  0.35 – 0.99 
Main indication for graft 
Keratoconus 1.00   <0.001  
Failed graft 2.57 0.97 0.013  1.22 – 5.39 
Pterygium 0.35 0.19 0.050  0.12 – 1.00 
Trauma 0.88 0.45 0.811  0.32 – 2.41 
Corneal ulcers 2.46 0.95 0.020  1.15 – 5.26 
Corneal degeneration 1.03 0.53 0.947  0.38 – 2.83 
Scleral disorders 0.74 0.44 0.619  0.23 – 2.40 
Neoplasia 0.44 0.35 0.300  0.10 – 2.06 
Herpetic infections 3.08 1.44 0.016  1.24 – 7.68 
Scars and opacities 1.39 0.77 0.553  0.47 – 4.12 
Other 3.33 1.30 0.002  1.54 – 7.17 
Raised intraocular pressure in past 
No 1.00     
Yes 1.95 0.35 <0.00
1 
 1.37 – 2.77 
Inflammation in the grafted eye in past 
No 1.00     
Yes 1.57 0.28 0.012  1.10 – 2.23 
Graft diameter  
<6.0mm 1.00   <0.001  
6.0 – 7.9mm 0.60 0.13 0.014  0.40 – 0.90 
≥ 8.0mm 1.38 0.27 0.092  0.95 – 2.02 
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9.3   INTERPRETATION OF THE MODELS 
 
The hazard ratio can be interpreted in the same manner as a relative risk – the relative 
hazard of a variable compared with the referent. To calculate the hazard ratio for a 
combination of variables, the individual hazard ratios were multiplied together. For 
example, if there was post-operative vascularization of a penetrating graft and it had had at 
least one rejection episode, the combined hazard ratio using the penetrating graft model is:  
 
Relative hazard (combined) = HR (vascularized graft) x HR (one or more rejection 
episodes) = 2.27 x 3.14 = 7.13 compared with a reference graft (avascular with no rejection 
episodes). 
 
This is also the case where the comparison group performs better than the reference 
group. For example, a traditional lamellar graft for which the donor cornea was sourced 
from the same state in which the surgery was performed and had a graft diameter of 
between 6 mm and 7.9 mm, would have a combined hazard ratio of 0.59 x 0.6 = 0.35 
compared to a graft where the donor cornea was sourced from a different State and the 
graft diameter was less than 6 mm. 
 
These models are only relevant in relation to other grafts of the same type; hazard ratios 
comparing penetrating grafts to traditional lamellar grafts cannot be calculated using these 
models. 
 
 
9.4  OTHER LAMELLAR GRAFTS 
 
Multiple significant variables were not detected during the univariate analyses of data 
relating to DALKs, making multivariate analyses non-applicable to this data. While several 
significant differences were found across groups in the univariate analyses for endothelial 
keratoplasties, these variables did not fit together in a multivariate model.  
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10. SUMMARY 
 
10.1  GRAFTS AND CONTRIBUTORS  
 
Analyses were performed on cumulative data entered into the ACGR from its inception until 
the census date for this report of 01/06/2010 for penetrating grafts and 12/10/11 for 
lamellar grafts. Data were available on 23,048 corneal grafts, 86.5% of which were 
penetrating, 13% of which were lamellar and 0.5% of which were limbal. Of the penetrating 
corneal grafts, 82% had been followed at least once. Of the lamellar grafts, follow-up was 
available for 59% and for the limbal grafts, follow-up was available for 86%. Kaplan-Meier 
survival of penetrating and lamellar grafts was 73% and 67%, respectively, at 5 years. 
Kaplan-Meier survival of limbal grafts was 43% at 5 years. 
 
Grafts were recorded from each Australian State and territory, with about 60% of all grafts 
being entered from two States, New South Wales and Victoria. A total of 713 individuals 
contributed data to the Registry. Of the contributors, 384 performed corneal graft 
procedures and 329 were involved in patient follow-up. Approximately 82% of all records of 
graft were registered by 62 ophthalmologists (16% of transplant surgeons). 
 
 
10.2  CORNEAL DONORS AND EYE BANKING 
 
Historically, corneas were procured privately and from hospital-based banks, but surgeons 
currently procure donor corneas almost exclusively from Therapeutic Goods 
Administration-licensed Eye Banks in NSW, QLD, VIC, SA and WA. 
 
Causes of donor death related to the cardiac/circulatory system in 30% of cases, the 
cerebrovascular system in 19%, to malignancy in 19%, to trauma, accident, poisoning or 
medical misadventure in 10%, to the respiratory system in 10%, to other specified causes 
in 7%, and to causes unknown to the ACGR in 5%. Most corneas were retrieved from 
cardiac death donors, with 7% of all corneas for penetrating grafts obtained from multi-
organ donors. Sixty one percent of donors were male and 35% were female. Donors 
ranged in age from infancy to 99 years at the time of death, but the majority (66%) were 
aged from 51-80 years. 
 
The median death-to-enucleation time for corneas used for penetrating keratoplasty was 7 
hours. Historically, most donor corneas were preserved in McCarey-Kaufman medium but 
for the past 14 years, Australian eye banks have predominantly used Optisol storage. 
There has also been a resurgence in the use of Organ Culture as a storage since 2007. 
The median time between donor death and penetrating corneal graft surgery for corneas 
stored in Optisol was 102 hours. Storage time in Optisol medium did not affect corneal graft 
survival. 
 
Grafts performed in the same State from which the cornea originated showed significantly 
better survival than those performed in a different state. This is particularly pronounced in 
the first 10 years post graft. The endothelial cell count of the donor had no significant 
influence on corneal graft survival. 
 
A penetrating corneal graft that never clears and thins in the immediate post-operative 
period is considered to be a primary non-functioning graft. Thus far, 151 such penetrating 
grafts have been reported to the ACGR, representing <1% of followed penetrating grafts. 
Australian Corneal Graft Registry Report 2012  231 
SUMMARY 
10.3 CORNEAL GRAFT RECIPIENT AGE AND 
SEX 
Recipient age varied from less than one month old to greater than 97 years, with peaks at 
20-40 years and 60-80 years. Although recipient age appeared to influence penetrating 
corneal graft survival in univariate analysis, it was not significant in multivariate analysis. 
Keratoconus was the main indication for graft in 58% of grafts performed in recipients <60 
years of age and 73% of recipients <20 years of age. Approximately equal numbers of 
women and men received a corneal graft and sex had no influence on graft survival. 
 
 
10.4 CORNEAL GRAFT RECIPIENT FACTORS 
Approximately one third of recipients displayed evidence of corneal neovascularization at 
the time of graft. In about 45% of cases where information on past history was available, 
the eye to be grafted had been inflamed in the past or was inflamed at the time of graft. In 
about 17% of cases, the intraocular pressure in the eye to be grafted had been raised at 
some time in the past or was raised at graft. Raised intraocular pressure at any time prior 
to, or at graft, was a significant risk factor for corneal graft failure. The main indications for 
penetrating keratoplasty were keratoconus (30%), bullous keratopathy (26%), failed 
previous graft (20%), corneal dystrophy (8%), and herpetic eye disease (4%). These broad 
indications accounted for 88% of penetrating grafts. Although corneal grafts for 
keratoconus showed better survival than grafts for all other indications, these grafts were 
also influenced by rejection episodes, number of previous grafts, age at graft, other pre-
graft morbidities and complications. About one-fifth of recipients had previously had a 
corneal graft in the ipsilateral eye. Graft survival fell with increasing numbers of ipsilateral 
grafts performed. 
 
 
10.5  OPERATIVE PROCEDURES 
 
Graft size ranged from 2.0 mm to 16.0 mm in diameter. Grafts within the size range of 
about 7.5 to 8.5 mm in diameter fared best. Rejection was a major cause of graft failure 
across all groups, but infection also caused the loss of very large and very small grafts. In 
34% of cases, an additional operative procedure was carried out at the time of 
transplantation. The most common of these procedures were manipulations associated 
with the lens (10%), vitrectomy (9%) and iris procedures (9%). Graft survival was better in 
phakic recipients than in pseudophakic or aphakic recipients. 
 
 
10.6 POST GRAFT EVENTS AFFECTING 
GRAFT FAILURE 
 
The major reasons for failure of penetrating grafts were irreversible rejection (31%), 
endothelial cell failure (15%), infection including recurrent HSV keratitis (8%), and 
glaucoma (8%). Removal of graft sutures within 6 months of transplantation was a risk 
factor for graft failure. Reasons for graft failure in the cohort with early suture removal were 
very similar to those of the whole cohort.  
 
A variety of post-operative events were associated with graft failure. These included 
development of microbial keratitis or a stitch abscess (affecting 3% of grafts), uveitis (1%), 
synechiae (2%), graft neovascularization (6%), rejection episodes (18%) and a rise in 
intraocular pressure (16%) in the grafted eye. 
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10.7 VISUAL OUTCOME AFTER CORNEAL 
TRANSPLANTATION 
 
In 74% of cases, the sole desired outcome for penetrating corneal transplantation was to 
improve vision in the grafted eye. In a further 15% of cases, the desired outcomes were 
improved vision plus relief of pain after surgery. 
 
For patients with penetrating grafts, 44% of the cohort achieved a Snellen acuity of 6/12 or 
better at the time of the most recent follow-up and 54% achieved 6/18 or better, but for 
27%, Snellen acuity was less than 6/60. Where both pre-operative and post-operative 
Snellen acuities were available an improvement in acuity of at least one line on the Snellen 
chart was recorded by 73% of recipients after corneal transplantation. In 13% there was no 
change, and in 14% the acuity was worse after graft. 
 
Factors affecting the visual potential of the grafted eye included graft failure (23%), 
astigmatism of more than 5 dioptres (18%), and one or more co-morbidity in the grafted 
eye. Refractive surgery was carried out on 12% of all penetrating grafts with follow-up. At 
10 years or more after corneal transplantation, 62% of recipients had been prescribed 
spectacles and approximately 15% had a contact lens. An intraocular lens was in place in 
the grafted eye in about 34% of the cohort. 
 
 
10.8 LAMELLAR GRAFTS 
 
Overall, a best corrected Snellen acuity of 6/12 or better was achieved in 48% of cases at 
most recent follow-up, 58% of cases achieved a follow-up visual acuity of 6/18 or better, 
and 28% recorded a visual acuity of less than 6/60 at last follow-up. When broken down 
into type of lamellar grafts, a best corrected Snellen acuity of 6/12 or better was achieved in 
34% of cases for traditional lamellar grafts; 37% of deep anterior lamellar grafts (DALK) 
and 18% of endothelial lamellar grafts. Forty seven percent of traditional grafts achieved 
6/18 or better, while 62% of DALK and 45% of endothelial lamellar grafts achieved this 
level of acuity. A visual acuity of less than 6/60 at last follow-up was recorded in 21% of 
traditional lamellar grafts, 16% of DALKs and 33% of endothelial lamellar grafts. 
 
The main indications for traditional lamellar graft were pterygium (16%), failed previous 
graft (16%), corneal ulcers (15%), trauma (12%), and keratoconus (9%). The main reasons 
for failure were corneal degeneration (14%), corneal ulcers (12%) and infection (11%). 
Grafts performed for pterygium exhibited the best corneal graft survival and those sized 
between 6.0 mm and 7.9 mm fared better than grafts that were larger or smaller. Pre-graft 
inflammation, a history of raised IOP and post graft microbial keratitis or stitch abscess 
were associated with poor corneal graft survival. 
 
Seventy six percent of DALK grafts were performed for keratoconus. When compared to 
penetrating grafts for keratoconus, DALKs had poorer graft survival. The main reasons for 
failure were primary graft failure (17%), infections, endothelial cell failure and scars and 
opacities (9% each). The main reason for failure of these grafts was primary graft failure 
(49%) and graft survival was better for grafts performed by surgeons who had performed 
>15 of this type of graft per year. 
 
The main indications for endothelial lamellar grafts were corneal dystrophy (47%), bullous 
keratopathy (33%) and failed previous graft (10%). Endothelial lamellar grafts performed for 
Fuchs’ dystrophy and bullous keratopathy had poorer corneal graft survival than 
penetrating grafts performed for the same indications. Endothelial lamellar grafts exhibited 
poorer graft survival and displayed a larger proportion of primary non-function grafts than 
any other type of lamellar graft. 
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10.9 RISK FACTORS FOR FAILURE OF 
PENETRATING GRAFTS 
 
The variables best predicting penetrating corneal graft failure in Cox proportional hazards 
regression analysis were time of removal of graft sutures, follow-up arrangements, 
refractive surgery in follow-up, graft diameter, surgeons with a high workload, corneal 
neovascularization at the time of the graft, history of inflammation in the grafted eye, history 
of raised intraocular pressure in the grafted eye, lens status, indication for graft, post-
operative rise in intraocular pressure, post-operative corneal vascularization, and corneal 
graft rejection episodes. Further information on these variables, with the associated relative 
risks for graft failure, is presented in Table 10.1. More comprehensive information is found 
in Chapter 9. 
 
 
A number of potential risk factors for graft failure were identified in univariate analyses. Of 
these, the factors that did not influence penetrating corneal graft survival significantly in 
multivariate analysis were: State, donor age, donor source, donor/recipient State match, 
multi-organ donor, recipient age, pre-graft visual acuity, descemetocoele, vitrectomy, 
microbial keratitis/stitch abscess, uveitis, and synechiae. 
 
 
Table 10.1 Variables best predicting penetrating corneal graft failure  
 
Variable Hazard ratios 
  Time to removal of graft sutures (referent: <6 months) 0.27 – 1.00 
  Follow-up by other than transplant surgeon 0.59 
  Refractive surgery in follow-up 0.66 
  Graft diameter (referent: <7.5mm) 0.74 – 1.06 
  Surgeons with a high workload compared with all others 0.80 
  Corneal vascularization at graft (referent: none) 0.88 – 1.35 
  Inflammation of eye in history or at graft (referent: never) 0.91 – 1.73 
  Raised IOP in history or at graft (referent: never) 1.00 – 1.72 
  Lens status pre and post graft (referent: phakic/phakic) 1.00 – 1.90 
  Indication for graft (referent: keratoconus) 1.00 – 5.67 
  Post-operative rise in intraocular pressure 1.50 
  Graft neovascularization 2.27 
  One or more rejection episodes 3.14 
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10.10 RISK FACTORS FOR FAILURE OF   
TRADITIONAL LAMELLAR GRAFTS 
 
The variables best predicting traditional lamellar corneal graft failure in Cox proportional 
hazards regression analysis were indication for graft, follow-up arrangements, 
donor/recipient state match, graft diameter, history of inflammation in the grafted eye, 
history of raised intraocular pressure in the grafted eye and post-graft microbial 
keratitis/stitch abscess. 
 
A number of potential risk factors for graft failure were identified in univariate analyses. Of 
these, the factors that did not influence traditional lamellar corneal graft survival 
significantly in multivariate analysis were: storage method, State, pre-graft lens status, 
post-graft lens status, recipient age, pre-graft visual acuity, steroid use in grafted eye, 
history of surgery in grafted eye, history of herpetic infection in grafted eye and corneal 
neovascularization at the time of the graft. Further information on these variables, with the 
associated relative risks for graft failure, is presented in Table 10.2. More comprehensive 
information is found in Chapter 9. 
 
 
Table 10.2 Variables best predicting traditional lamellar corneal graft failure  
 
Variable Hazard ratios 
  Indication for graft (referent: keratoconus) 0.35 – 3.33 
  Follow-up by other than transplant surgeon 0.39 
  Eye bank and surgery in same state 0.59 
  Graft diameter (referent: <6.0mm) 0.60 – 1.38 
  History of inflammation in eye 1.57 
  History of raised IOP 1.95 
  Post graft microbial keratitis/stitch abscess 1.99 
 
 
Australian Corneal Graft Registry Report 2012  235 
METHODS AND DEFINITIONS 
 
 
 
 
11. METHODS AND DEFINITIONS 
 
 
11.1 ENTRY AND FOLLOW-UP 
Data are entered into the Registry by the contributing surgeon as soon as possible after the 
graft and follow-up information is requested at intervals of about 12 months. Information is 
obtained by mail; missing data are routinely sought by follow-up letter. Each graft is 
followed until graft failure or until the death or loss to follow-up of the patient. The study 
period for the present analyses was May 1985 to October 2011 (26 years).  
 
 
11.2 DEFINITION OF RISK FACTORS 
A history of past inflammation is recorded if the individual was specifically reported to have 
had such an episode, if the patient had had one or more previous grafts in the ipsilateral 
eye, if any intraocular surgery had ever been performed on that eye, or if there was a 
history of the use of topical corticosteroids in that eye in the weeks immediately preceding 
the graft. 
 
Vessel ingrowth into the cornea at the time of graft is scored on a scale of 0-4,  
with 0 representing no growth in any quadrant extending to the graft-host junction,  
1 representing such growth in 1 quadrant, 2 representing growth in 2 quadrants,  
3 being vessel ingrowth in 3 quadrants and 4 being vessel ingrowth in 4 quadrants. No 
distinction is made between superficial or deep vessels, patent or ghost vessels, or single 
or multiple vessel leashes. After corneal transplantation, the presence of even one vessel 
leash extending into the graft is considered enough to classify that graft as vascularized. 
 
The intraocular pressure (IOP) is generally considered to be raised if a reading of  
25 mm of mercury or greater is made by applanation tonometry, but the decision is at the 
discretion of the ophthalmologist. 
 
Presenting diseases, indications for graft, post-operative complications and reasons for 
graft failure are coded using the ICD.9.CM system (US Department of Health and Human 
Services).  
 
Information is collected on both recipient bed size and donor button size, but for the 
purpose of examining the influence of graft size, the former is used. 
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11.3 DEFINITION OF GRAFT FAILURE, 
REJECTION AND COMPLICATIONS 
Primary graft non-functions are defined as grafts that never thin and clear in the post-
operative period. The trial time for such grafts is arbitrarily adjusted to one day. Any 
existing graft that is replaced by another in the same eye, irrespective of graft clarity and for 
whatever reason, is classified as a failed graft. An example in this category would be a 
clear graft with an unacceptably high degree of irregular astigmatism, not improved by 
refractive surgery, which is then replaced. In all other cases, graft failure is defined as 
oedema and irremediable loss of clarity in a previously thin, clear graft. The day of failure is 
the first day the patient is seen with an oedematous, opaque graft that subsequently fails to 
thin and clear. 
 
Rejection is defined as the development of a rejection line (epithelial or endothelial) or a 
unilateral anterior chamber reaction with corneal infiltrates and spreading corneal oedema 
in a previously thin, clear graft. 
 
Any development with the potential to compromise graft outcome is considered to be a 
complication. Post-operative complications are collected in two ways. First, a number of 
specified complications (stitch abscess, microbial keratitis, neovascularization of the graft, 
synechiae, uveitis, rise in IOP, cataract, rejection episode, herpetic recurrence, early 
changes of bullous keratopathy), refractive and related errors (anisometropia, ≥5 dioptres 
astigmatism) and factors potentially affecting visual outcome but unrelated to the graft 
(cataract, amblyopia, retinal detachment, age related macular degeneration and diabetic 
retinopathy) are listed, requiring a yes/no answer. Second, contributors are asked to 
specify any other relevant complications, information or departures from their preferred 
treatment. 
 
 
11.4 STATISTICAL ANALYSES 
Kaplan-Meier survival functions are constructed to provide a graphical record of  
graft survival. For surviving grafts, trial time is calculated as the time between the date of 
graft and the date on which the patient was last seen. For failed grafts, trial time is 
calculated as the time between the date of graft and the date of failure. For grafts for which 
we have never received follow-up, the default graft survival period is 0.1 day. Kaplan-Meier 
plots were constructed using SPSS versions 18, and 19. Cox proportional hazards 
regression analysis was performed using Stata version 11. 
 
 
11.5 COMPUTER HARDWARE AND SOFTWARE 
Existing hardware comprises a HP Compaq dc7600 computer with 2 hard drives: 74.5 GB, 
and 149 GB, 2 HP Compaq 8000 Elite computers with 500GB hard drives (one with 2 
drives) and a Ricoh Aficio SP4210i printer.  
 
The database is constructed in Microsoft Access. The Access database was designed by 
Ms Sandra Bobleter and has subsequently been modified by Mrs Helene Holland, Ms 
Ngaere Hornsby, Ms Carmel McCarthy, Mrs Chris Bartlett and Mrs Marie Lowe. Kaplan-
Meier curves generated for the 2012 Report were prepared using SPSS versions 18, and 
19. The report was prepared using Microsoft Office 2003. 
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11.6 CORNEAL GRAFT REGISTRATION FORM 
Registry No. 
 
 
Registry use only 
THE AUSTRALIAN CORNEAL GRAFT REGISTRY 
GRAFT REGISTRATION FORM 
SURGEON  STATE 
CONSULTANT   
Performed > 20 of the planned procedure (including this graft) 
 
YES  /  NO       if No, number  
RECIPIENT IDENTIFICATION  
Patient's name   
  SURNAME FIRST NAME 
Patient's record No.  (if applicable) 
Patient's date of birth 
             /          /             Patient gender Male Female 
 
Date of graft 
            /          /                Eye grafted R L 
Time graft performed 
_____________am/pm    
 
 
RECIPIENT HISTORY 
Original pathology/past history/underlying diseases (in words) Office use only 
 
 
 
 
Current pathology/current indications for graft  (in words)  
 
 
 
 
Desired outcomes Pain Relief Improved  Visual Acuity 
Cosmesis Tectonic/ 
Structural 
Repair 
           Please circle or tick as many as apply  
Pre-graft visual acuity 
 
R L 
Number of previous grafts in grafted eye 
(excluding this graft)  
 
 Please advise acuity in both eyes  
If this is a repeat graft in the grafted 
eye, reason and date of failure of 
previous graft 
Reason for failure: 
 
 
Date of failure: 
 
        /          /         
Presence of vessels in the recipient cornea 4 Quadrant 3 Quadrant   2 Quadrant 1 Quadrant    None 
 Please circle/tick the applicable box 
 
        Yes         No Unknown 
Current inflammation of eye    
Use of topical steroids in 2 weeks prior to graft    
History of intraocular surgery in grafted eye 
 
   
Active HSV infection at time of graft    
Does patient have a history of raised intraocular pressure?    
Was intraocular pressure raised at the time of this graft?    
Immediately prior to graft, was the eye to be grafted Phakic Aphakic Pseudophakic 
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DONOR INFORMATION 
Donor age (in years)  Donor gender Male Female 
 Multiple Organ Donor Yes No 
 
 (Please fill in as many as are known using a 24 hour clock) 
Time and date of donor death  Time  Date  
Time and date of enucleation  Time  Date  
Time and date of storage of cornea  Time  Date  
 
Storage method Moist Pot  Organ culture  CSM  Optisol  Other  
 
Endothelial cell count (per mm²)     
 
 
   Immediately following the graft, was the eye grafted Phakic Aphakic Pseudophakic 
OPERATIVE DETAILS  
Penetrating and Limbal Grafts 
 
Graft size Donor Button           mm 
 
Recipient           mm 
 
Type of graft Penetrating              Limbal or  
stem cell /conjunctival  
 
 
 
 
ACCOMPANYING PROCEDURES:  (Tick as many as apply) 
 
Peripheral Iridectomy  Removal of cataract  Vitrectomy  
Trabeculectomy  Triple procedure    
Other procedures     
Lamellar Grafts 
  
Endokeratoplasty 
 
Deep Anterior (Stromal) 
Lamellar Keratoplasty  
Tectonic 
Lamellar 
 DSEK 
 
Big Bubble 
 
Other 
 
 DMEK  Melles 
 
 
 DSAEK 
 
Other 
 
 
 
Other  Graft size 
mm 
Incision size mm Graft size mm Converted to PK Yes No 
Insertion Technique (tick as many as apply)  
Folded  Glide  Forceps  Describe lamellar procedure if necessary 
Suture  Other    
COMMENTS 
 
 
CONSENT: Please remember that you should gain consent from your patient for data to be forwarded to the ACGR 
 
PLEASE RETURN THIS FORM TO: 
Australian Corneal Graft Registry 
Department of Ophthalmology, Flinders Medical Centre 
BEDFORD PARK   S.A.  5042 
PHONE:  (08) 8204 5321 FAX:  (08) 8277 0899     Version June 2011 
 Eye Bank Source SA NSW VIC Eyebank No.   
 QLD WA VIC - Forensic 
  
          Please circle/tick applicable box  
 Cause of donor death  OFFICE USE ONLY 
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11.7 CORNEAL GRAFT FOLLOW-UP FORMS 
Registry No. 
 
 
 
 
Registry use only 
THE AUSTRALIAN 
CORNEAL GRAFT REGISTRY 
FOLLOWUP  
Date Rec'd 
 
 
 
    
   Ver March 2008 
SURGEON  STATE 
PATIENT IDENTIFICATION AND GRAFT OUTCOME 
 
 
 
 
GRAFT STATUS 
DATE PATIENT LAST SEEN  BY YOU 
            /          /           
GRAFT SURVIVING ON DATE LAST SEEN Yes No (Please mark correct box) 
 
     
GRAFT FAILED Yes No DATE GRAFT FAILED 
         /           / 
 
  
 
Office use 
only 
REASONS FOR GRAFT FAILURE 1.    
 2.    
PATIENT STATUS 
     
  DECEASED  DATE OF DEATH (if known)           /      /         
   
 LOST TO FOLLOWUP  DATE LOST                                 /      /         
FOLLOW-UP ELSEWHERE? (Please advise the name and address of the follow-up doctor, if known) 
 
 
POST OPERATIVE EVENTS   
 
DATE OF FINAL SUTURE REMOVAL: /           /            
   HAVE ANY OF THE FOLLOWING OCCURRED: 
NEOVASCULARIZATION OF GRAFT  SYNECHIAE  
SIGNIFICANT RISE IN IOP   UVEITIS  
CATARACT DEVELOPED SINCE GRAFT  STITCH ABSCESS  
RECURRENT HERPETIC DISEASE  OEDEMA  
MICROBIAL KERATITIS    
      
NUMBER & DATES, OF REJECTION 
EPISODES SINCE LAST FOLLOWUP 
 
/          / /          / /          / /          / 
 No. of rejections   
   Office use only 
ANY OTHER SIGNIFICANT EVENTS?    
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 OPERATIVE PROCEDURES ON THE GRAFTED EYE 
HAS AN OPERATIVE PROCEDURE BEEN PERFORMED ON THE GRAFTED EYE SINCE THE LAST 
RECORDED FOLLOW-UP?  
YES NO 
IF "yes", PLEASE TICK AS MANY AS APPLY:    (Please mark which is 
applicable) 
CATARACT REMOVAL  
INSERTION  IOL  
YAG LASER/MECH. CAPSULOTOMY  
 
    GLAUCOMA SURGERY  (Please specify)       OTHER OPERATIVE PROCEDURE   (Please specify) 
  
  
 
 Please mark applicable box 
HAS ANY REFRACTIVE SURGERY BEEN PERFORMED?   YES NO 
IF "yes" PLEASE TICK WHERE APPLICABLE:    
            SUTURE ADJUSTMENT              EXCIMER LASER - PRK  
            COMPRESSION SUTURES              EXCIMER LASER - LASIK  
            RELAXING INCISION              OTHER (Please state) 
            WEDGE RESECTION    
POST-GRAFT VISUAL OUTCOME 
SNELLEN ACUITY (with preferred correction and without pinhole) 
GRAFTED EYE  
 
Please mark all applicable boxes 
ARE SPECTACLES WORN? YES NO 
ARE CONTACT LENS WORN? YES NO 
DOES PATIENT HAVE AN IOL IN PLACE IN THE GRAFTED EYE? YES NO 
 
ANISOMETROPIA  
MAJOR DEGREE ASTIGMATISM (>=5D)  
K-READING (if available)  
CENTRAL GRAFT PACHYMETRY  ENDOTHELIAL CELL COUNT (per mm²)  
  FACTORS AFFECTING VISUAL ACUITY IN GRAFTED EYE (Please tick all that apply) 
 
CATARACT  CME  RETINAL DETACHMENT  
AMBLYOPIA  MYOPIA  ARMD  
GLAUCOMA  OPACITY/SCAR  DIABETIC RETINOPATHY  
  OTHER (please specify)     
    
  EYE  HAS NO VISUAL POTENTIAL    IF GRAFTED FOR PAIN, HAS PAIN BEEN RELIEVED? Yes No 
OTHER COMMENTS 
             
 
             
PLEASE RETURN THIS FORM TO: 
AUSTRALIAN CORNEAL GRAFT REGISTRY 
Department of Ophthalmology, Flinders Medical Centre 
BEDFORD PARK  S.A.  5042 
PHONE:  (08) 8204 5321  FAX:  (08) 8277 0899 
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Registry No. 
 
 
Registry use only 
THE AUSTRALIAN 
CORNEAL GRAFT REGISTRY 
LAMELLAR FOLLOWUP  
Date Rec'd 
 
 
      Ver Mar 2010 
 
 
 
 
GRAFT STATUS 
Date patient last seen by you /          / 
 
 
Graft surviving on date last seen Yes No Graft failed Yes No 
 
 Office use only 
Date graft failed 
       /         / Reason for failure 1  
 
 
 2  
 
PATIENT STATUS 
Deceased          /           /           Lost to follow-up          /           /           
Follow-up elsewhere? (Please advise the name and address of the follow-up doctor, if known) 
 
  REJECTION EPISODES 
 
Number and dates of rejections 
episodes since last follow-up 
 
/          / /          / /          /  
            Number   date   date   date 
 
Any known trigger? 
(eg. Atopy, loose sutures, recent vaccination)  
Yes No     
If Yes, what   
 
METHOD OF CORRECTION 
 
 
Please mark all applicable boxes 
Are spectacles worn? Yes No 
Are contact lenses worn? Yes No 
Does the patient have an IOL in the grafted eye? Yes No 
OPERATIVE PROCEDURES ON THE GRAFTED EYE 
 
Operative procedures  Yes No     
Please specify  
 
POST-GRAFT VISUAL OUTCOME 
 
Corrected visual acuity  
grafted eye  
Corrected visual acuity 
other eye  
With pinhole 
grafted eye  
With pinhole 
other eye  
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IMMEDIATE OPERATIVE OUTCOME 
 
Primary Graft Failure  
(graft never cleared) 
 
Failed within first 
28 days? Yes No 
 
      
Graft dislocation  Successful 
relocation? Yes No 
 
      
Double anterior chamber  Raised IOP    
Interface opacity  Re-bubbled  Successful 
re-bubble? Yes No 
 
 
Other procedures 
    
 
 
 
  ANY OTHER FACTORS AFFECTING VISUAL ACUITY IN GRAFTED EYE  
 
Please specify  
 
 
PLEASE RETURN THIS FORM TO: 
AUSTRALIAN CORNEAL GRAFT REGISTRY 
Department of Ophthalmology, Flinders Medical Centre 
BEDFORD PARK  S.A.  5042 
PHONE:  (08) 8204 5321  FAX:  (08) 8277 0899 
 
Australian Corneal Graft Registry Report 2012  243 
METHODS AND DEFINITIONS 
11.8 REFERENCES 
1 Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am 
Stat Assoc 1958; 53; 475-81. 
2 Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, 
McPherson K, Peto J, and Smith PG. Design and analysis of randomized clinical 
trials requiring prolonged observation of each patient. I Introduction and design. Br J 
Cancer 1976; 34:585-612. 
3 Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, 
McPherson K, Peto J, and Smith PG. Design and analysis of randomized clinical 
trials requiring prolonged observation of each patient. II Analysis and examples. Br J 
Cancer 1977; 35:1-39. 
4 Cleves MA, Gould WW and Gutierrez RG. An introduction to Survival Analysis using 
Stata. 
5 Williams RL. A note on robust variance estimation for cluster-correlated data. 
Biometrics 2000; 56:645. 
 
244 Australian Corneal Graft Registry Report 2012 
ACGR PUBLICATIONS 
 
 
12. ACGR PUBLICATIONS 
 
 
12.1 JOURNAL ARTICLES 
 
Williams KA, Sawyer M, Alfrich SJ, Joseph L, White MA, Coster DJ, Mahmood M, on 
behalf of all contributors. First report of the Australian Corneal Graft Registry. Aust NZ 
J Ophthalmol 1987; 15: 291-302. 
 
Williams KA, Sawyer MA, White MA, Mahmood MI, Coster DJ, on behalf of all 
contributors. Report from the Australian Corneal Graft Registry. Transplant Proc 1989; 
21: 3142-3144. 
 
Williams KA, Muehlberg SM, Coster DJ, on behalf of all contributors. Visual outcome 
after corneal transplantation. Transplant Proc; 1992; 24: 178. 
 
Williams KA, Roder D, Esterman A, Muehlberg SM, Coster DJ, on behalf of all 
contributors. Factors predictive of corneal graft survival: report from the Australian 
Corneal Graft Registry. Ophthalmology 1992; 99: 403-414. 
 
Williams KA, Muehlberg SM, Wing SJ, Coster DJ, on behalf of all contributors. The 
Australian Corneal Graft Registry, 1990-1992 report. Aust NZ J Ophthalmol 1993; 21 
(suppl): 1-48. 
 
Coster DJ, Williams KA, on behalf of all contributors to the ACGR, The Australian 
Corneal Graft Registry (ACGR). Klin Monatsbl Augenheilkd 1994;205: 271-274. 
 
Williams KA, Muehlberg SM, Lewis RF, Coster DJ, on behalf of all contributors to the 
Australian Corneal Graft Registry (ACGR). How successful is corneal transplantation? 
A report from the Australian Corneal Graft Register. Eye 1995; 9: 219-227. 
 
Williams KA, Muehlberg SM, Lewis RF, Coster DJ, on behalf of all contributors to the 
Australian Corneal Graft Registry (ACGR). Influence of lens status on graft and visual 
outcome within a corneal graft register. Transplant Proc 1995; 27: 1389-91. 
 
Williams KA, Muehlberg SM, Lewis RF, Coster DJ, on behalf of all contributors to the 
Australian Corneal Graft Registry (ACGR). Graft survival after corneal transplantation: 
role of factors with the potential for recipient presensitisation. Transplant Proc 1995; 
27: 2141-2. 
 
Williams KA, Muehlberg SM, Lewis RF, Coster DJ, on behalf of all contributors to the 
Australian Corneal Graft Registry. The long term outcome in corneal 
allotransplantation. Transplant Proc 1997; 29: 983. 
 
Williams KA, Muehlberg SM, Lewis RF, Coster DJ, on behalf of all contributors to the 
Australian Corneal Graft Registry. Influence of advanced recipient and donor age on 
the outcome of corneal transplantation. Br J Ophthalmol 1997; 81: 835-839. 
 
Williams KA, Esterman AJ, Bartlett C, Holland H, Hornsby NB, Coster DJ, on behalf of 
all contributors to the Australian Corneal Graft Registry. How effective is penetrating 
corneal transplantation? Factors influencing long-term outcome in multivariate 
analysis. Transplantation 2006; 81: 896-901. 
 
Australian Corneal Graft Registry Report 2012  245 
ACGR PUBLICATIONS 
Williams KA, Lowe MT, Bartlett CM, Kelly MT, Coster DJ. Risk factors for human 
corneal graft failure within the Australian corneal graft registry. Transplantation 2008; 
86: 1720-1724. 
 
Williams KA, Kelly TL, Lowe MT, Coster DJ. The influence of rejection episodes in 
recipients of bilateral corneal grafts. American Journal of Transplantation 2010; 10: 
921-930. 
 
Lowe MT, Keane MC, Coster DJ, Williams KA. The outcome of corneal transplantation 
in infants, children, and adolescents. Ophthalmology 2011; 118: 492-497. 
 
Kelly T-L, Williams KA, Coster DJ. Corneal transplantation for keratoconus, a registry 
study. Arch Ophthalmol 2011; 129: 691-697. 
 
Kelly T-L, Williams KA, Coster DJ. Repeat penetrating corneal transplantation for 
patients with keratoconus. Ophthalmology 2011; 118: 1538-1542. 
 
246 Australian Corneal Graft Registry Report 2012 
ACGR PUBLICATIONS 
12.2 REPORTS 
 
Williams KA, Sawyer MA, Joseph L, Alfrich S, White M, Coster DJ, Mahmood M.  First 
report of the Australian Graft Registry, 1986. 
 
Williams KA, Sawyer MA, White MA, Coster DJ. Report from the Australian Corneal 
Graft Registry, 1988. Flinders Press, Adelaide. 
 
Williams KA, Sawyer MA, White MA, Muehlberg SM, Mahmood M, Coster DJ. Report 
from the Australian Corneal Graft Registry, 1989. Flinders Press, Adelaide. 
 
Williams KA, Muehlberg SM, Lewis RF, Coster DJ. Report from the Australian Corneal 
Graft Registry, 1994. Mercury Press, Adelaide. 
 
Williams KA, Muehlberg SM, Lewis RF, Giles LC, Coster DJ.  Report from the 
Australian Corneal Graft Registry, 1996. Mercury Press, Adelaide. 
 
Williams KA, Muehlberg SM, Bartlett CM, Esterman A, Coster DJ.  Report from the 
Australian Corneal Graft Registry, 1999. Snap Printing, Adelaide. 
 
Williams KA, Hornsby NB, Bartlett CM, Holland HK, Esterman A, Coster DJ.  Report 
from the Australian Corneal Graft Registry, 2004. Snap Printing, Adelaide. 
URL link to permanent repository to view 2004 Report: 
http://dspace.flinders.edu.au/dspace/handle/2328/1002 
 
Williams, KA, Lowe, MT, Bartlett, CM., Kelly, M, & Coster, DJ. The Australian Corneal 
Graft Registry 2007 Report, 2007. Flinders Press, Adelaide. 
URL link to permanent repository to view 2007 Report: 
http://dspace.flinders.edu.au/dspace/handle/2328/1723 
 
Williams, KA, Lowe, MT, Keane MC, Jones, VJ, Loh, RS, & Coster, DJ. The Australian 
Corneal Graft Registry 2012 Report, 2012. Snap Printing, Adelaide. 
URL link to permanent repository to view 2012 Report: 
http://hdl.handle.net/2328/25859  
 
 
 
 
 
 
 
